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 This multi-part research characterizes pulmonary hypertension (PH) from a physiologic 
and genetic point of view using the indicator trait mean pulmonary arterial pressure (PAP). Three 
aims were designed to address the research objective of investigating the genetics underlying 
PAP for the purposes of variant discovery.  
 The first aim sought to identify different PAP phenotypes based on altitude and diet 
during the stocker and finishing phases of production. This longitudinal study evaluated steers 
with a moderate PAP (41-48 mmHg) from yearling age until harvest, collecting PAP and blood 
gas parameters throughout the study and carcass data at the conclusion. Through this 
experimental approach, the role of different finishing systems was able to be evaluated and cattle 
with increased sensitivity to hypoxic conditions were identified. Results from this study 
indicated that regardless of finishing system, animals exhibited signs of respiratory alkalosis with 
renal compensation because of hypoxic conditions. The PAP data from this population 
corroborated that all steers were hypoxic. However, the only carcass quality differences observed 
were those between cattle that were grain finished compared to those that were grass finished, 
regardless of altitude.  
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 Aim two was to perform next-generation whole genome sequencing for 30 Angus bulls 
and steers to compare those with high PAP (HPAP) to those with low PAP (LPAP) measures. 
All cattle sequenced originated from elevations >1,500m and were selected based on their 
pedigree information, as well as PAP observations. The sequence data from these 30 animals 
were then compared such that sequence from HPAP cattle was compared to that of LPAP cattle. 
There were 5,543 variants unique to HPAP cattle and 1,690 variants unique to LPAP cattle. Loci 
across all 30 chromosomes exhibited variation for PAP phenotype. Evaluation of these variants 
and validation will be necessary to sift through variants that are in linkage or may be less 
informative.  
 A multi-omics approach was used to perform variant discovery based on the PAP 
phenotype in aim three. Through combination of RNA sequence with DNA sequence, the list of 
variants relevant to PAP phenotype was filtered from millions of variants to hundreds of 
variants. Transcriptome data was compared for each of six tissues between HPAP and LPAP 
cattle. These variants were then compared to one another to determine which variants were 
detected in each PAP category across all six tissue types. Those variants were then compared to 
the DNA sequence from aim two to elucidate concordant variants for HPAP and LPAP cattle 
respectively. There were three variants that were unique to LPAP cattle and were concordant 
between DNA and RNA sequence. However, none of these variants were within 1,000bp of a 
gene recognized in the ARS-UCD1.2 bovine genome assembly and were therefore considered 
less informative. There were 523 variants unique to HPAP cattle. Within that population there 
was a subset that was either near or within a gene. There were six genes that were considered 
informative for further investigation. Three of those genes were uncharacterized genes on 
chromosome 16. The other three (U6, SIMC1, CDH23), while not well documented in cattle, had 
iv 
 
functions in humans that would indicate their function could affect PAP phenotype expression. 
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High mountain disease (HMD) occurs in susceptible cattle grazing at elevations greater 
than 1,500 m (Pauling et al., 2018; Thomas et al., 2018). The condition results from pulmonary 
hypertension (PH) progressing into vascular remodeling that often culminates in congestive heart 
failure of susceptible cattle (Holt and Callan, 2007; Neary et al., 2015). Diagnosis of PH in cattle 
is conducted via a mean pulmonary arterial pressure (PAP) measurement, which is an indicator 
trait that assesses an animal’s risk of developing HMD. It is well documented that PAP is 
moderately heritable and polygenic in nature, meaning that genetic improvement for PAP is 
possible (Schimmel, 1981; Schimmel, 1983; Enns et al., 1992; Shirley et al., 2008; Zeng, 2016; 
Crawford, 2016).  
Studies to date have relied on SNP chip genotyping panels or gene-targeted approaches to 
detect variation within the genome related to PAP (Newman et al., 2011; Newman et al., 2015; 
Heaton et al., 2016; Zeng et al., 2016; Crawford et al., 2019; Heaton et al., 2020). However, 
these approaches can result in misrepresentation due to the difference in coverage of the genome 
(Hickey, 2013). With increased affordability of sequencing, variant detection approaches have 
been rapidly changing, including multi-omic bioinformatic strategies to combine different 
sequence types such as genomic (DNA) or transcriptomic (RNA) sequence to make inferences 
about biological systems as a whole (Heather and Chain, 2015; Muir et al., 2016; Cánovas et al., 
2014; Nguyen et al., 2018). These next-generation approaches to variant discovery could enable 
for better understanding of PH from a molecular biology systems perspective through 
identification and validation of genes and variants related to PAP. Further, variants related to 
PAP may be utilized to enhance accuracies of genetic predictions through marker assisted 
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selection techniques, thus aiding ranchers of high altitude production systems (Glover and 
Newsom, 1915; Hecht et al., 1962; Northcutt, 2010; Garrick, 2011; Rolf et al., 2014; Neary et 
al., 2014; Zeng, 2016). Therefore, the objective of this research was to detect variants associated 




CHAPTER 2  
A REVIEW OF PULMONARY HYPERTENSION AND ITS IMPACT ON THE BEEF 
INDUSTRY  
Section 1: Introduction 
 Pulmonary hypertension (PH) has impacted cattle in the mountainous regions of the 
western United States. Since its discovery in 1913, the condition has been referred to as dropsy 
of high altitude, brisket disease, or high mountain disease (HMD), among other names. The 
pathophysiology of HMD is characterized as hypoxia-induced pulmonary hypertension, which 
can culminate in congestive heart failure of susceptible cattle. Despite years of research 
characterizing and working to reduce the incidence of this condition, HMD still impacts cattle 
today and results in death loss for ranchers across the mountainous western states (Holt and 
Callan, 2007). This chapter is an overview of the pathophysiology and genetics of HMD. In 
addition, this chapter provides insight into a lesser-known and understood manifestation of 
pulmonary hypertension known as feedlot heart disease and discusses improvements in genetic 
technologies that may aid in alleviating the impact of pulmonary hypertension on cattle 
production. 
Section 2: Pulmonary Hypertension 
Pulmonary hypertension (PH) is commonly recognized as high blood pressure. More 
specifically, PH affects the cardiopulmonary system and results in death if not properly managed 
(Mayo Clinic, 2017). While there are many causes for the development of PH, the disease is 
broadly characterized by cellular changes in the pulmonary system that result in stiffening of 
vessel walls and subsequent vascular remodeling. As these circulatory changes occur within the 
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vasculature of the lungs, greater strain is placed on the heart to maintain efficient blood flow. If 
vascular remodeling continues to progress in severity, the cardiac strain may become so severe 
that the patient succumbs to heart failure (HF). Some cases of PH are irreversible, while other 
incidents of PH may respond to treatment. The World Health Organization (WHO) has 
established five categories of PH based on etiology of the condition (Ryan et al., 2012; World 
Health Organization, 2013; Pulmonary Hypertension Association, 2019). 
2.1 WHO Categories of PH 
2.1.1 Category 1  
The WHO has established that patients with Category 1 PH are experiencing pulmonary 
arterial hypertension (PAH). This condition is often diagnosed via elimination of Categories 2-5 
of PH rather than a positive diagnosis of Category 1 PH. This type of PH includes idiopathic PH, 
familial PH, and PH associated with medical conditions (Ryan et al., 2012). Idiopathic derived 
PAH has no clear origin or cause of onset of the condition. Familial PAH is inherited 
(Pulmonary Hypertension Association, 2019). PAH may develop alongside other medical 
conditions such as liver cirrhosis, human immunodeficiency virus (HIV), and lupus. Further, 
PAH may develop due to past or present drug use or exposure to toxins (Mayo Clinic, 2017). 
Category 1 PH has a few treatments to alleviate the symptoms, but not cure, PAH (Pulmonary 
Hypertension Association, 2019). 
2.1.2 Category 2 
Category 2 PH derives from left-sided heart disease. This could develop from systolic or 
diastolic dysfunction of the left atrium and ventricle. Further, this condition can develop from 
valvular diseases that result in stenotic valves or leaky valves that impact the ability of the heart 
to pump blood without backflow. Ultimately, this type of PH is characterized as the inability to 
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maintain flow of oxygenated blood entering the left heart, resulting in increased pressure in the 
vasculature of the lungs. This form of PH is the most common in humans (Pulmonary 
Hypertension Association, 2019).  
In addition to humans, manifestations of Category 2 PH have been observed in cattle. The 
condition, referred to as feedlot heart disease (FHD), is characterized as heart failure occurring in 
cattle in the latter stages of finishing (Jensen et al., 1976; Neary et al., 2015a; Neary et al., 
2015b; Krafsur et al., 2019; Moxley et al., 2019). During the finishing phase of production, cattle 
are administered high energy diets to increase the rate of weight gain prior to harvest. Krafsur et 
al. (2019) concluded that cardiac and pulmonary tissues of late-fed cattle undergoing heart 
failure exhibited histopathologic features of remodeling similar to that of obesity-associated PH 
in humans. However, Neary et al. (2015b) described pathophysiology of FHD in steers as right-
sided heart failure, which could indicate that FHD should be classified as Category 3 PH. Further 
research characterizing the pathophysiology FHD and comparing it to that of cattle experiencing 
hypoxia-induced PH through chronic high-altitude exposure is necessary to elucidate whether 
FHD should be classified as Category 2 PH. 
2.1.3 Category 3 
Chronic lung diseases, hypoxia, or a combination of both contribute to Category 3 PH 
(Mayo Clinic, 2017; Pulmonary Hypertension Association, 2019). The overall etiology of 
Category 3 PH results from lung restriction or narrowing of the airways that increase the 
difficulty of respiration. The cardiopulmonary system compensates for the decreased oxygen 
intake by reducing blood flow to regions of the lung that are not active in gas exchange. This 
increases pulmonary blood pressure (Pulmonary Hypertension Association, 2019). 
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Chronic lung diseases such as COPD or emphysema can result in Category 3 PH through 
restricting the ability of the lung to expand and contract during respiration. Sleep apnea and 
chronic exposure to high altitude also result in Category 3 PH (Mayo Clinic, 2017; Pulmonary 
Hypertension Association, 2019). Therefore, high mountain disease (HMD) in cattle is classified 
as Category 3 PH. High mountain disease is observed in cattle at elevations greater than 1,500m 
(Pauling et al., 2018). In extreme cases, HMD can result in vascular remodeling, heart failure, 
and death of susceptible cattle (Holt and Callan, 2007). 
2.1.4 Category 4 
Category 4 PH is caused by the development of pulmonary emboli (Mayo Clinic, 2017; 
Pulmonary Hypertension Association, 2019). The inability of the body to dissolve blood clots 
occludes pulmonary blood flow in the clotted regions of the lung. However, after a clot has 
resolved, scar tissue may remain that can occlude pulmonary blood flow permanently, resulting 
in strain on the right side of the heart due to vascular resistance in the lungs. Remedies exist for 
Category 4 PH, including surgical removal of clots and administration of drugs to resolve 
pulmonary clots (Pulmonary Hypertension Association, 2019). 
2.1.5 Category 5 
Category 5 PH encompasses incidences of PH not well understood (Mayo Clinic, 2017; 
Pulmonary Hypertension Association, 2019). More specifically, this category consists of cases of 
PH that are secondary to other diseases or conditions but have yet to be characterized well 
enough to be classified within WHO Categories 1-4 (Pulmonary Hypertension Association, 
2019). Common conditions that are classified as Category 4 PH are blood disorders, metabolic 
disorders, cancer, and multi-system diseases (Mayo Clinic, 2017). 
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2.2 Physiology of vascular remodeling in response to chronic PH 
The physiological response to chronic hypoxia resulting in PH is vascular remodeling. 
Small arteries (diameter < 500 μm) are the site of the cellular changes recognized in remodeling 
and can manifest as a decreased number of small arteries to transport blood, a loss of luminal 
space in arterial branches, or a combination of both. These changes result in an elevated PAP due 
to increased resistance in the branches narrowing off the pulmonary artery leading to the lungs 
(Rounds and Klinger, 2004; Shimoda and Laurie, 2013). A normal small artery that is part of the 
pulmonary vascular branches is comprised of numerous tissue substances including fibronectin, 
collagen, elastin, smooth muscle, and endothelial cells, which provide a rigid structure while 




Figure 2.1 Comparison of the vascular structure of a normal and remodeled vessel. A.) Normal 
structure of a vascular branch off the pulmonary artery with the tissue composition of each major 
segment labeled. B.) Animals experiencing vascular remodeling from PH can exhibit a 
combination of thickening of the vessel layers, resulting in decreased luminal space. (Image 
created by the author). 
 
Vascular remodeling of the pulmonary arterial circulation results in narrowing of the small 
vessels in the pulmonary branches. This reduction of luminal space derives from both 
hypertrophy and hyperplasia of cellular components in all layers of the vessel (Anderson et al., 
1973; Chazova et al., 1995; Rounds and Klinger, 2004; Stenmark et al., 2009). Hypertrophy in 
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layers such as the tunica adventitia that contain cellular components such as fibrin and collagen 
can result in decreased compliance or increased rigidity of the outer portion of the vessel 
(Rounds and Klinger, 2004). 
Stiffening of pulmonary vasculature due to remodeling leads to increased resistance, which 
puts increased strain on the right side of the heart as it works harder to eject blood through the 
pulmonary artery to the lungs. This increased pulmonary vascular resistance increases blood 
pressure and decreases overall blood flow due to reduced compliance of the vasculature. The 
heart compensates by increasing afterload, resulting in the heart working harder to eject blood. 
Over time, increased pumping efforts of the cardiac tissues will result in right ventricular 
hypertrophy, and loss of fluid in the extravascular spaces resulting from increased hydrostatic 
pressure (Louis and Fernandes, 2002). This loss of fluid is visible in cattle as edema in various 
regions of the body. Under prolonged duress, the right heart muscles will enlarge and, in extreme 
cases, will fail, resulting in death (Voelkel et al., 2006). 
2.3 Factors influencing PH in cattle 
2.3.1 Sex 
Gender may impact the susceptibility or onset of PH through differences in cardiac 
performance and general pathology. Chu et al. (2005) observed that a survival advantage existed 
for females as compared to males when attempting to induce cardiac hypertrophy and heart 
failure. Further, induction of cardiac hypertrophy and subsequent progression to HF took longer 
in females than males (Chu et al., 2005). These results demonstrate that physiological changes 




Quantitative genetic measures of cattle performance across genders have also been 
evaluated utilizing mean pulmonary arterial pressure (PAP) as an indicator of risk of developing 
high mountain disease (HMD) because of PH. In 2008, Shirley et al. evaluated fluctuations in 
PAP over time for males and females. Females exhibited an increased PAP of 0.022 + 0.008 
mmHg per day for each day of age. Conversely, males exhibited a decrease of 0.004 + 0.01 
mmHg per day for each day of age (Shirley et al., 2008). Cockrum et al. (2014) calculated 
different heritabilities for each of three gender categories (heifers, bulls, and steers) in yearling 
Angus cattle. The heritability measured for heifers was 0.21 + 0.04, while the heritabilities for 
steers and bulls were 0.20 + 0.15 and 0.38 + 0.08 respectively (Cockrum et al., 2014). Zeng 
(2016) also estimated the heritability of PAP in yearling Angus heifers, bulls, and steers. The 
calculated heritabilities were 0.19 + 0.03, 0.33 + 0.06, and 0.37 + 0.07 for heifers, steers, and 
bulls respectively (Zeng, 2016). These results suggest that sex could be a valuable source of 
variation when assessing PAP in cattle. Further, these differences could not only be attributed to 
gender itself but also to the fact that management strategies will differ between the three gender 
categories. Heifers, steers, and bulls have different breeding objectives or production endpoints 
to be met, which are achieved through different management strategies. For example, castration 
results in reduced testosterone levels, which increases fat deposition in steers (Owens et al., 
1993). Conversely, heifers and bulls are maintained as breeding stock, and managed for their 
reproductive success. All three categories will have different nutrient requirements (National 
Research Council, 2016). 
2.3.2 Age 
The risk of developing HMD because of PH decreases with age. Majority of death loss 
due to progression of chronic PH. Cattle from birth to two years of age account for 
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approximately 75% of cattle succumbing to HMD (Pierson and Jensen, 1956; Blake, 1968). This 
was confirmed by literature released by a Utah Agriculture Experiment Station, who reported 
that of 397 cases of HMD in cattle, 269 confirmed cases were observed in cattle less than two 
years of age (Blake, 1968). Once cattle reach 2 to 5 years of age, incidence of HMD decreases 
from 75% to 3% (Blake, 1968). These studies did not report an explanation for such a drastic 
decrease in prevalence as age increases. However, this drastic decrease could be attributed to the 
fact that cattle either succumb to HMD or are culled for poor performance within the first two 
years of life.  
The majority of data collected in cattle to infer PH status is recorded when cattle are 
weanling or yearling age. Measures recorded on cattle under one year of age may not be reliable 
as PAP measurements have greater variability in calves. As cattle age, the accuracy of their PAP 
measurement increases. Holt and Callan (2007) report that cattle that are at least 16 months of 
age will have more consistent and accurate PAP observations, which would be better to utilize in 
making management decisions if PAP is within a producer’s breeding objective. However, some 
ranchers may wish to make culling decisions earlier than 12 to 16 months of age to reduce the 
amount of time, money, and resources being utilized on cattle that will not remain in the herd. 
Studies that evaluate PAP over time are limited as most producers take a single 
measurement and utilize that value to determine whether the animal should remain in the herd. 
Neary et al. (2015a) evaluated a population of cattle over time and found that systolic PAP and 
pulmonary arterial pulse pressure increased uniformly with age. Zeng (2016) evaluated the 
correlation between weaning PAP and yearling PAP to determine if weaning PAP may be a good 
indicator of yearling PAP. The calculated correlation was 0.67 + 0.18, coinciding with Holt and 
Callan (2007) who reported greater variability in PAP measurements recorded prior to 12 to 16 
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months of age. While the correlation reported by Zeng et al. (2015) depicts a moderate 
relationship between weaning and yearling PAP measurements, there remains a vast amount of 
variability between the two time points such that producers would be ill-advised to select based 
on weaning PAP. Enns et al. (1992) regressed PAP on age, concluding that for every day of age 
increase, PAP increased by 0.0387 mmHg. A similar study by Crawford (2015) regressed PAP 
on yearling age, reporting that for each day increased beyond weaning age, PAP increased by 
0.03 mmHg. While these studies provide insight into the patterns of increased PAP over time, 
studies with repeated measures over the duration of an animal’s life are limited.  
2.3.3 Adaptation to hypoxic environments 
Duration of exposure to environments with reduced atmospheric oxygen availability is 
one of many factors that can cause hypoxia, impact cardiopulmonary performance, and result in 
PH. However, not all cattle are equally impacted by changes in altitude. Cattle born at high 
elevations have reduced incidence of PH as compared to cattle relocated to high altitude later in 
life (Will and Alexander, 1970; Weir et al., 1974; Holt and Callan, 2007). Further, Tucker and 
Rhodes (2001) concluded that an acclimation period prior to assessment of PH results in the 
most accurate estimates. This acclimation period allows for cattle to overcome the acute hypoxia 
associated with increased altitude and instead evaluate the long-term implications of high altitude 
on an animal’s health status (Tucker and Rhodes, 2001; Neary et al., 2015a).  
The physiology underlying hypoxia-induced PH in cattle at high altitudes is 
predominantly characterized by alveolar hypoxia resulting in pulmonary vascular remodeling. 
Specifically, the reduced oxygen availability at the expense of an increased barometric pressure 
induces hypobaric hypoxia, a condition that also increases the risk of developing alveolar 
hypoxia (Neary et al., 2016a). In an effort to maintain alveolar sufficiency of oxygen ventilation 
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and perfusion, the pulmonary vasculature constricts, increasing pulmonary vascular resistance 
(Kuriyama and Wagner, 1981; Neary et al., 2016a). These changes are observed as an elevated 
PAP (Holt and Callan, 2007; Neary et al., 2016a).  
Regarding cardiac response to vascular remodeling, Kuriyama and Wagner (1981) 
proposed that cattle with greater vascular tone or thicker arteries would have a more rapid and 
intense response to chronic hypoxia than their contemporaries with less vascular tone. This was 
confirmed by Tucker et al. (1975), who calculated a positive correlation between medial 
thickness of the vascular wall, the degree of PH, and right ventricular hypertrophy. Calves 
exhibited increased medial tone within the pulmonary vasculature in response to high altitude 
exposure (Naeye, 1965; Tucker et al., 1975). These findings by Naeye (1965) and Tucker et al. 
(1975) coincide with findings regarding the incidence of PH in calves as compared to cattle of 
yearling age or older.  
Physiologic response to hypoxia induced by high altitude and therapies to lessen the 
impact of such responses from cattle have been evaluated. One of the most commonly 
recommended therapies in human medicine for acute hypoxia is the supplementation of oxygen 
to account for reduced oxygen availability (West et al., 2013). However, despite serving as a 
valuable therapy in humans, oxygen supplementation is not a viable therapy for calves suffering 
from PH (Neary et al., 2013). Neary et al. (2013) administered supplemental oxygen to calves 
unsuccessfully, finding the oxygen diffusion capacity to be low. This suggests that the issue 
results from a ventilation-perfusion mismatch. A 2016 study observed that calves responded to 
the physiological strain induced by high altitude by increasing the rate of alveolar ventilation. 
Increased rate of alveolar ventilation, more commonly called hyperventilation, can be detected 
14 
 
by not only measuring respiration rate, but also evaluating the partial pressure of carbon dioxide 
in arterial blood, which would decrease during hyperventilation (Gulick et al., 2016). 
2.3.4 Health status and medical history 
The medical history of a patient poses a great impact on their risk of developing PH. For 
example, humans with COPD, emphysema, liver disease, lupus, sleep apnea, blood disorders, or 
metabolic disorders have a greater risk of developing at least one form of PH (Mayo Clinic, 
2017). Similarly, cattle with a history of respiratory disease or metabolic disease may be at a 
greater risk of developing PH (Holt and Callan, 2007; Neary et al., 2016a). Diagnosis of cattle 
with PH may be further complicated by the presence of a prior condition such as respiratory 
disease that can result in diagnosis of a recurring condition rather than development of PH in the 
animal (Neary et al., 2016a). This not only provides limited assistance in mitigating a condition 
with few therapeutic remedies but can also result in a gross underestimation of the number of 
cattle developing PH in the United States annually.  
2.3.5 Genetics 
The development of PH far exceeds environmental exposure that induces hypoxia. 
Research to date has demonstrated that genetics may infer tolerance to PH for some organisms, 
while negatively impacting the performance of others. This was demonstrated by Pauling (2017), 
who discovered that a re-ranking of cattle occurred based on mean pulmonary arterial pressure 
(PAP) measurements as cattle moved between high and low altitudes, suggestive of a genotype 
by environment interaction. The trait of interest when evaluating PH in cattle is PAP, which is an 
indicator trait that is utilized to make inferences about an animal’s risk of developing high 
mountain disease (HMD) as a result of PH induced by high altitude (>1,500 m) exposure (Holt 
and Callan, 2007). Heritabilities for PAP have been estimated to be moderate (0.26 to 0.34) in 
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nature, which means that genetic improvement through selection is possible (Shirley et al., 2008; 
Crawford et al., 2016). However, due to a minute proportion of the population that succumbs to 
heart failure annually from progression of PH and HMD, it is difficult to cultivate selection tools 
such as expected progeny differences (EPDs). The establishment of EPDs for PAP is further 
complicated by the limited number of observations that are recorded in comparison to the 
number of animals within the record keeping system of a breed association.  
2.4 Measures of cardiopulmonary performance 
2.4.1 Pulmonary vascular Resistance 
One of the principle assessments of cardiopulmonary health is pulmonary vascular 
resistance. Pulmonary vascular resistance (PVR) is measured by dividing the differential of mean 
pulmonary arterial pressure from mean pulmonary venous pressure and dividing it by the cardiac 
output (Equation 2.1). The units of measure for PVR are mmHg/L/min. Measuring PVR can 
elucidate vascular complications within the cardiopulmonary system compromising the overall 
health of the animal. An elevated PVR would be indicative of occlusion of blood flow. This 
occlusion is commonly classified as either reduction, obstruction, or restriction of flow (Griffin 
et al., 2008). 
Equation 2.1. The calculation of pulmonary vascular resistance (PVR) is obtained by subtracting 
the mean pulmonary venous pressure, measured as the mean left atrial pressure (PLA) from the  
mean pulmonary arterial pressure (PLA). This differential is then divided by the cardiac output 
(Q). 
PVR=
PPA̅̅ ̅̅ ̅-PLA̅̅ ̅̅ ̅
Q   
When measuring PVR in patients experiencing hypoxia, the most likely cause of an 
elevated PVR would be restriction. Restriction can be classified as either anatomic or 
vasoconstrictive in nature. These physiological responses are meant to maintain a normal 
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ventilation-perfusion ratio given reduced oxygen tension in the blood. The presentation of 
restriction will depend on whether the hypoxic state of the animal is considered to be acute or 
chronic in nature. Acute hypoxia will result in vasoconstriction. Vasoconstriction or constriction 
of the arteries within the pulmonary system serves as a temporary change to combat the hypoxic 
state of the animal. However, if an animal is in a long-term or chronic hypoxic state, they 
undergo anatomical changes that result in restriction of blood flow. This anatomical change is 
recognized as vascular remodeling, which is a change in the vascular tone and overall structure 
of the pulmonary vascular trunks to combat the chronic hypoxic state that an animal is facing.  
2.4.2 Systemic oxygen extraction fraction 
Systemic oxygen extraction fraction (sOEF) provides insight into tissue utilization of 
oxygen in the blood. More specifically, sOEF is the proportion of oxygen in arterial blood that is 
taken up by the peripheral tissues and organs of the body. Systemic oxygen extraction fraction is 
measured utilizing arterial oxyhemoglobin saturation, venous oxyhemoglobin saturation, 
hemoglobin concentration, partial pressure of oxygen in arterial blood, and partial pressure of 
oxygen in mixed venous blood (Equation 2.2).  
Equation 2.2. The equation for systemic oxygen extraction fraction where saHbO2 is arterial 
oxyhemoglobin saturation (%), smvHbO2 is mixed venous oxyhemoglobin saturation (%), Hb is 
hemoglobin concentration (g/L), paO2 is the arterial partial pressure of oxygen (mmHg), and 
pmvO2 is the mixed venous partial pressure of oxygen (mmHg). 
sOEF= 
((saHbO2 × Hb × 1.39) + ( 0.003 × PaO2)) - ((smvHbO2 × Hb×1.39) + (0.003 × PmvO2)((saHbO2 × Hb × 1.39) + (0.003 × PaO2))  
 A normal sOEF is approximately 0.2, meaning that only about 1/5 of the oxygen in 
arterial blood is being taken up throughout the systemic circulation to support peripheral tissues 
and basic physiological functions (Dellinger, 2002; Leach and Treacher, 2002; McLellan and 
Walsh, 2004). However, not all tissues have the same oxygen requirements. For example, cardiac 
17 
 
muscle has an oxygen extraction fraction (OEF) of about 68%, while skeletal muscle has an OEF 
of about 25% when at rest (Binak et al., 1967). The sOEF must fluctuate to accommodate an 
increased demand for oxygen by peripheral tissues as well as when delivery of oxygen decreases. 
This fluctuation is important as it serves to increase the systemic OEF as a means to maintain 
aerobic metabolic processes (Olkowski et al., 2005; Rady et al., 1994). 
2.4.3 Pulmonary arterial pressure 
An overview of PAP 
Mean pulmonary arterial pressure (PAP) is a veterinary procedure consisting of threading 
a catheter containing a transducer through the jugular vein into the heart. The catheter is threaded 
through the right side of the heart into the pulmonary artery where a pressure measurement is 
taken. The calculation of PAP is a function of systolic pulmonary arterial pressure (sPAP) and 
diastolic pulmonary arterial pressure (dPAP). The calculation for PAP is not an arithmetic mean, 
meaning it is not a direct average of sPAP and dPAP (Equation 2.3). Modifications have been 
made to the original PAP equation in order to improve the accuracy of estimation (Equation 2.4) 
(Razminia et al., 2004). 




3 sPAP + 
2
3 dPAP 
Equation 2.4 The updated PAP calculation derived by Razminia et al. (2004)  that includes heart 
rate (HR) in order to increase the accuracy of PAP estimation. 
PAP = dPAP+ [13  + (HR × 0.0012)]  × (sPAP - dPAP) 
In livestock, PAP measurements are measured in high altitude production systems, where 
hypoxia-induced pulmonary hypertension (WHO category 3 PH) could be a concern for 
producers. Through measuring PAP, the degree to which cattle are experiencing PH can be 
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elucidated. Further, inferences can be made about an animal’s risk of succumbing to heart failure 




Table 2.1 Interpretations of mean pulmonary arterial pressure (PAP) scores in cattle. (Holt and 
Callan, 2007). 
PAP Interpretation 
30-35 mmHg This score is considered excellent and highly 
reliable. 
 
36-39 mmHg This score is considered excellent for any animal 
over the age of 12 months. If the animal is less 
than 12 months of age, the score is still fairly 
reliable, but retesting before breeding is 
suggested. 
 
<41 mmHg Scores less than 41 mmHg are reliable 
measurements in all animals more than 12 months 
of age. It is recommended that yearling cattle have 
a PAP measurement less than 41 mmHg 
(depending on altitude of the test). The variation 
in scores 41 mmHg and above is inconsistent and 
difficult to predict in some cattle as they age. Any 
animal measuring 41 mmHg and greater should 
always be retested before use. 
 
41-45 mmHg This range is acceptable for older animals (ie, 
more than 16 months of age). Animals less than 
16 months scoring in this range should be retested 
to predict the future PAP of the animal accurately. 
 
45-48 mmHg This range is acceptable only for older animals 
that have been in high elevations for an extended 
period of time. Animals with this score are more 
susceptible to environmental stresses leading to 
HMD and should be considered at some risk. 
Elevation of test site and where the animal lives 
must be evaluated closely for those in this PAP 
score range. 
 
>49 mmHg Animals that score in this range must always be 
considered high-risk candidates for developing 
HMD, not only for themselves but also their 
offspring. Many animals that have scored in this 
range have died of HMD. An option for these 
animals is to move them to a lower elevation for 
use there. It is also recommended that offspring of 




2.5 Clinical assessment of cardiopulmonary health 
2.5.1 Clinical blood panels in cattle  
Ahola et al. (2006) evaluated the efficacy of utilizing arterial blood parameter 
measurements in lieu of recording PAP measurements of cattle in an effort to find an alternative 
to the pricey and invasive procedure. This was evaluated by calculating correlations between 
arterial blood parameters (blood gases, blood electrolytes, and blood cellular components) and 
PAP. These parameters were measured utilizing three current technologies: hemogram, pulse 
oximetry, and portable clinical analyzer. The only parameters that were correlated with PAP 
were the hemogram measurements of packed cell volume, hemoglobin concentration, and red 
blood cell distribution width. None of the metrics recorded via pulse oximetry or portable 
clinical analyzer were correlated with PAP despite overlap between the three technologies, 
which all measured packed cell volume and hemoglobin (Ahola et al., 2006). 
2.5.2 Clinical blood parameters and PH 
The body has several physiologic responses to both acute and chronic hypoxia. These 
physiologic responses serve to maintain oxygen delivery to peripheral tissues in order to supply 
the mitochondria with oxygen to maintain functions at the cellular, tissue, and systemic levels. In 
addition to the changes within the cardiopulmonary tissues themselves, the blood chemistry of an 
animal will also alter in an effort to preserve oxygen levels in the blood (Cueva, 1967; Weir et 
al., 1974; Ahola et al., 2006; West et al., 2013).  
Response of red blood cells and plasma volume to high altitude 
Reduced atmospheric oxygen availability poses a challenge to animals as the body must 
compensate for respiratory insufficiencies. One of the best-known adaptations to this reduction 
in available oxygen is the increase of red blood cells (RBC) per unit of blood (Bert 1878; West et 
al., 2013). This increase in RBC results in an increased oxygen carrying capacity within the 
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blood due to a greater volume of hemoglobin to bind and carry oxygen throughout the body (Bert 
1878; Viault, 1891; West, 1981; High altitude medicine and physiology 5th edition). However, 
despite the increase associated with hypoxia induced by high altitude, the benefits of an 
increased RBC count have been demonstrated to provide limited assistance to hypoxic humans in 
some instances (Winslow et al., 1985; Winslow and Monge, 1987; Calbet et al., 2002; West et 
al., 2013). 
Plasma volume is also impacted by duration at high altitude. In the early stages of high-
altitude exposure, plasma volume decreases. As duration at high altitude progressed, it was found 
that plasma volume increased but never reached the volume measured prior to altitude exposure 
(West et al., 2103). Sanchez et al. (1970) compared a high-altitude dwelling population to a sea-
level dwelling population in Peru in order to estimate differences in blood volume as compared 
to plasma volume. After compensating for weight differences, Sanchez et al. (1970) concluded 
that people from high altitude had a reduced plasma volume and increased overall blood volume 
compared to the people at low altitude. This observed increase in blood volume in conjunction 
with a reduced plasma volume could be due to a compensatory increase in red blood cells. 
Individuals that experienced acute hypoxia due to high altitude exposure exhibited plasma 
volume measures greater than or equal to initial measures after 1-3 days back at sea-level 
(Robach et al., 2000). 
Erythropoietin 
Erythropoiesis is the process of forming red blood cells (West et al., 2013). In the 
absence of hemorrhage, anemia, bone marow disorders, iron deficiencies or other conditions that 
impact hemoglobin, erythropoiesis is regulated by levels of erythropoietin. Erythropoietin is a 
hormone produced by the liver and kidneys (Eckardt, 1996). Levels of erythropoietin increase in 
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the presence of tissue hypoxia with the common causes of elevated erythropoietin being blood 
loss and hypoxia. In the presence of tissue hypoxia, oxygen-sensing cells within the inner cortex 
and outer medulla of the kidney respond by increasing erythropoietin secretion, thus, inducing 
erythropoiesis (Eckardt, 1996; Semenza, 2009).  
Hypoxic ventilatory response 
Erythropoiesis in response to tissue hypoxia increases the red blood cells in the 
circulatory system. However, in cases of acute hypoxia, erythropoiesis does not occur at a rate 
conducive to alleviating the stress of hypoxia immediately. In addition to elevated erythropoietin 
to stimulate red blood cell formation, the carotid body mediates a hypoxic ventilatory response 
(Fisher and Langston, 1967). Unlike the liver and kidneys, the carotid body responds to the 
partial pressure of oxygen in the arterial blood. When the arterial pressure of oxygen decreases, 
the carotid body detects the change and induces increased ventilation as a means to increase 
oxygen intake (Eckardt et al., 1989). Hypoxic ventilator response occurs within seconds. 
However, full erythropoietin responses take multiple days (Eckardt et al., 1989; Semenza, 2009).  
Maintenance of blood pH 
Blood pH is important due to its relationship with oxygen affinity and, subsequently, 
oxygen transport (West et al., 2013). When a lowland acclimated individual relocates to high 
altitude, peripheral chemoreceptors induce hyperventilation, resulting in decreased arterial 
carbon dioxide in the circulation which increases blood pH. High altitude natives have arterial 
pH values of 7.4. Based on comparable arterial pH values between lowland and highland 
dwellers, it is speculated that highland dwellers have a fully compensated respiratory alkalosis 
(Winslow and Monge, 1987). Conversely, lowland dwellers have an increased pH when exposed 
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to high altitudes. However, when given time to acclimate to the increased elevation, the pH 
declines towards the normal value of 7.4 (Dill et al., 1937).  
Oxygen dissociation curve 
The oxygen dissociation curve (ODC) provides insight into how well oxygen has been 
bound to red blood cells and delivered to tissues. The ODC characterizes oxygen’s affinity to 
bind to the hemoglobin within the red blood cells and is dependent upon pH, partial pressure of 
carbon dioxide, and 2,3-diphosphoglycerate in the blood. A shift to the left on the ODC is 
indicative of alkalosis (pH > 7.5) due to increased abundance of oxygen that is more tightly 
bound to hemoglobin. Conversely, a shift to the right on the ODC indicates acidosis (pH < 7.3). 
In the case of acidosis, partial pressure of carbon dioxide in the blood is elevated, resulting in a 
decreased affinity of oxygen to remain bound to hemoglobin. This decreased oxygen binding 
affinity results in easier release of oxygen to the tissues (T.N. Holt, personal communication).  
In addition to blood pH and partial pressure of carbon dioxide, 2, 3-diphosphoglycerate 
concentrations also impact the ODC. Concentrations of 2, 3-diphosphoglycerate are dependent 
on red blood cell metabolism. When red blood cell metabolism increases, the concentration of 2, 
3-diphosphoglycerate also increases as it is an end-product of this metabolic process. This 
increase is indicative of chronic hypoxia and results in an ODC shift to the right for easier 
oxygen release. Reduction of 2, 3-diphosphoglycerate means that red blood cells are more 
abundant in the blood, so the ODC will shift to the left and oxygen binding affinity to 
hemoglobin would increase (T.N. Holt, personal communication).  
Blood gas tensions and electrolyte measures 
Blood gas tensions are measured as a metric of blood acid-base chemistry. Measuring 
both venous and arterial blood gases provides insight into gas exchange processes and systemic 
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blood gas utilization. However, measurement of venous blood gases and references for venous 
blood gas metrics in humans, cattle, and other species are scarcely reported. Arterial blood gases 
are commonly reported when focusing on acid-base chemistry and provide insight into a number 
of physiological changes indicative of poor or declining health (West et al., 2013). While control 
measures for bovine diagnostics are limited, veterinarians that perform these tests on cattle have 
compiled their own control parameters of these blood panels that are not published (Table 2.2; 
Table 2.3). 
Table 2.2 Normal ranges of blood gas measures impacting acid-base chemistry of arterial and 
















70-80i   
35-40 (T.N. Holt, personal communication) 
PCO2 mmHg 35-45 35-44 
(J. Kaneko et al., 2008; T.N. Holt, 
personal communication) 
HCO3 mEq/L 22-26 
17-29 
25-35 
(J. Kaneko et al., 2008) 
(T.N. Holt, personal communication) 
pH -- 7.35-7.45 7.31-7.53 
(J. Kaneko et al., 2008; T.N. Holt, 
personal communication) 
TCO2 mEq/L -- 21-32 (J. Kaneko et al., 2008) 






Table 2.3 Normal ranges for blood electrolytes and components of blood chemistry in arterial 
















Sodium mEq/L -- 136-147 (T.N. Holt, personal communication) 
Potassium mEq/L -- 4.0-5.0 (T.N. Holt, personal communication) 
Chloride mEq/L -- 96-107 (T.N. Holt, personal communication) 
Calcium mg/dL -- 7.6-10.2 (T.N. Holt, personal communication) 
Phosphorus mg/dL -- 4.0-8.6 (T.N. Holt, personal communication) 
Magnesium mg/dL -- 1.6-3.6 (T.N. Holt, personal communication) 
Anion gap mEq/L -- 14-26 (T.N. Holt, personal communication) 
 
In cattle exposed to high altitudes, blood gas measurements are valuable because they can 
provide insight into an animal’s cardiopulmonary health and hypoxic status prior to exhibiting 
physical symptoms indicative of HMD or FHD. For example, reduced arterial partial pressure of 
carbon dioxide accompanied by elevated serum bicarbonate and an elevated base excess is 
indicative of compensatory hyperventilation induced by hypoxia. Elevated serum lactate 
measures may be indicative of enhanced glycolysis, which may be induced by hypoxia. 
Evaluation of oxygen saturation in both arterial and venous blood is utilized to calculate the 
arterial-venous oxygen saturation of hemoglobin (A-V difference). An A-V difference of 30% or 
greater can also be indicative of hypoxia. All of these parameters would indicate that further 
evaluation of an animal’s cardiopulmonary health may need to be evaluated, or if HMD or FHD 
is suspected, relocation to a lower altitude or feeding a different ration may be a viable option to 
alleviate signs of hypoxia (G.M. Krafsur, personal communication).  
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2.5.3 Sources of variation in clinical blood panels 
 Clinical assessment of blood samples, while informative in diagnosing patients and 
formulating a treatment plan, can be complicated by a number of factors that enhance the 
variation of the measures taken. Differences in laboratory as well as laboratory technician may 
increase variability of blood panel estimates. These can range from differences in standard 
laboratory handling procedures to variations in units of measurement, which can confound 
comparisons across laboratories if not detected. Blood panel results will also vary depending on 
age, sex, species, breed, and status within the respective livestock production setting. It is 
therefore of the utmost importance that such phenotypic data is available in order to determine 
which normal parameters are most feasible to utilize in making diagnoses. 
 Once samples are collected and analyzed, the interpretation of the results generated adds 
an additional level of complexity. Data should be compared to normal values generated from 
animals of similar age, sex, species, breed, and stage of production as the patient being 
evaluated. Further, the normal values utilized for diagnostic purposes should be validated either 
through the clinic or laboratory performing the blood panels, from reputable textbooks, or 
through peer reviewed journal publications. Lack of validation of the normal parameters being 
utilized to assess patient health, may result in discrepancies in the results as well as misdiagnoses 
in extreme cases.   
2.5.4 Limitations of clinical blood panels in cattle 
One of the primary challenges of utilization of modern technologies to measure blood 
gases and electrolytes is the lack of reference measures for comparative studies and diagnostic 
purposes. Research has demonstrated that metrics of cardiopulmonary health such as mean 
pulmonary arterial pressure (PAP) vary in cattle. More specifically, measurements may differ 
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based on breed, sex, age, production stage, etc. (Greatorex, 1957; Claxton and Ortiz, 1996). 
Therefore, a single reference value for each blood gas or blood electrolyte metric may present 
inaccurate conclusions and diagnoses when evaluating cattle. The Merck Veterinary Manual 
presents a single set of reference values for cattle, which is nondescript, not indicating age, 
breed, sex, or production stage (Fielder). While still a valuable resource for diagnostic purposes, 
as researchers work towards characterizing manifestations of PH in cattle, these gaps in 
knowledge are important to fill in order to make sure that the most accurate information possible 
is being implemented into future research efforts.  
2.6 Signs and symptoms of PH in cattle 
A number of complications exist in diagnosing PH in cattle. Symptoms commonly 
present in the latter stages of PH. Due to the late-stage diagnosis of PH, little can be done to save 
the animal (Holt and Callan, 2007). After signs have been recognized, cattle often die within 12 
weeks, with the majority of cattle succumbing to HF within one month (Glover and Newsom, 
1917; Pierson and Jensen, 1956). Crawford (2015) summarized ante-mortem and post-mortem 
signs and symptoms of PH in cattle (Table 2.4). However, further signs and symptoms are being 
evaluated to better detect incidences of PH. One of the new signs being used to evaluate 







Table 2.4 Ante-mortem and post-mortem signs and symptoms of HMD in cattle. (Crawford, 
2015) 
Ante-mortem Post-mortem 
Lethargy Increased hepatic enzymes 
Tachypnea (rapid breathing) Enlarged, hard liver 
Drooped ears Enlarged, dilated heart 
Rough hair coat Lesions 
Ataxia (lack of muscle control) 
 




Exophthalmia (protrusion of eyeballs) 
 
Ascites (fluid in abdomen) 
 
Generalized edema (intermandibular, 




Recumbent (lying down, inactive) 
 
Unable to rise 
 
Elevated heart and respiratory rates 
 











2.6.1 Post-mortem cardiac scores  
The diagnosis of HMD often does not occur until cattle have displayed visible symptoms 
or have succumbed to HF secondary to PH (Holt and Callan, 2007). Some cattle undergo 
vascular and cellular remodeling at a slower rate than those that have exhibited symptoms of 
HMD. These cattle may have survived through the finishing phase of production to be harvested 
and, as a result, are not classified as hypertensive or experiencing HMD. Therefore, a post-
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mortem cardiac scoring system has been designed by Colorado State University and the United 
States Department of Agriculture Meat Animal Research Center (USDA-MARC) (T. N. Holt, 
personal communication). This system has been designed in order to not only further validate 
PAP as an indicator trait of susceptibility to PH and development of HMD, but to distinguish 
cattle that have never been PAP tested and may be undergoing vascular remodeling and other 
cardiopulmonary changes indicative of PH (T. N. Holt, personal communication). 
 The cardiac scoring system consists of looking at the heart and assigning a numeric score 
from 1 to 5, with 1 indicating a normal heart and 5 indicating a severely remodeled heart upon 










• Normal conical shape 
• Normal left ventricle apex that is easily distinguished 
• Right ventricle is smaller than the left ventricle and ventricles are in normal proportions 
• Normal atrial anatomy such that the right atrium is smaller than the left atrium 
• No clinical evidence of infarction or aneurysm pending 
• No thinning of vessel walls 
• Normal pulmonary artery size 
2 
Mild Change 
• Normal conical shape 
• Blunting of left ventricle apex such that the apex is still distinguishable but losing some pointed shape 
• Right ventricle becoming larger than the left ventricle 
• Right ventricle is more pronounced 
• Right atrium beginning to enlarge to same sizer or slightly larger than the left atrium 
• No clinical evidence of infarction or aneurysm pending 
• Pulmonary artery beginning to exhibit mild enlargement 




• Beginning to lose conical shape 
• Blunting of left ventricular apex such that apical shape is still visible but deviating and beginning to take 
the shape of a reversed or backwards letter “D” 
• Right ventricle is larger than the left ventricle 
• Right ventricle is more pronounced 
• Right atrium is larger than the left atrium 
• Can present with clinical evidence of infarction or aneurysm pending 
• Pulmonary artery enlarged 




• Loss of conical shape 
• Loss of left ventricle apex 
• Right ventricle is larger than the left ventricle with the right ventricle becoming more pronounced and 
taking on a rounded shape 
• Reverse “D” shape of heart is apparent 
• Right atrium larger than the left atrium and is congested 
• Can present with clinical evidence of infarction or aneurysm pending 
• Pulmonary artery greatly enlarged 
• Upon palpation, cardiac muscle is becoming soft and without shape but still has some muscle tone 
5 
Severe Changes and Flaccid Heart 
• Severe loss of conical shape 
• Loss of left ventricular apex due to right ventricular rounding 
• Apparent reverse “D” shape of the heart 
• Right ventricle more pronounced and rounded 
• Right atrium larger than the left atrium and congested 
• Can present with clinical evidence of infarction or aneurysm pending 
• Pulmonary artery greatly enlarged 




Figure 2.2 Images depicting each cardiac score. (A) This is cardiac score of 1. Notice the conical 
shape of the heart and the proportions of the chambers of the heart. This heart appears normal. 
(B) This is a cardiac score of 2. The heart is losing shape in the right ventricle (oriented on the 
reader’s left side). However, the pulmonary artery appears normal and the overall conical shape 
of the heart is easily distinguished. (C) This is a cardiac score of 3. The right ventricle is 
beginning to bow outwards. The conical shape of the heart is becoming less prominent and more 
rounded. With the left ventricular blunting, the heart is beginning to take the shape of a 
backwards “D.” The pulmonary artery appears enlarged. (D) This is a cardiac score of 4. The left 
ventricle apex has nearly disappeared, the right side of the heart is larger than the left side, and 
the pulmonary artery is enlarged. The overall reverse “D” shape of the heart is easily observed. 
(E) This is a cardiac score of 5. The overall conical shape of the heart has disappeared, the 
reverse “D” shape is still evident, the pulmonary artery is enlarged, and the heart has taken an 
overall rounded shape. Upon palpation of the cardiac muscle depicted, a loss of tone would be 
evident. Further, the heart would feel floppy and lay flat on a table (Figure designed by author). 
2.7 PAP as an indicator trait for PH 
2.7.1 Genetics of PAP 
Mean pulmonary arterial pressure (PAP) measures PH and is also utilized to assess the 
risk of developing High Mountain Disease (HMD) resulting from the progression of PH (Holt 
and Callan, 2007). Through assessing PAP measurements, it has been concluded that genetic 
improvement to reduce incidence is possible due to the moderate heritability estimates that have 
been reported (Schimmel, 1981; Schimmel and Brinks, 1983; Enns et al., 1992; Shirley et al., 
2008; Zeng, 2016; Crawford et al., 2016). Further, PAP is polygenic, meaning that multiple loci 
on multiple chromosomes affect the expression of the PAP phenotype (Cánovas et al., 2016). 
Studies have elucidated various genes that may affect PAP in cattle, humans, or mice (Table 
2.6). However, this list is not exhaustive as most research has been conducted in mice or humans 
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rather than cattle. Research in cattle has used SNP chip genotype data which does not include 
every nucleotide within the bovine genome.  




Gene Name Function Citations 
EGLN1 EGL nine homolog 1 Post-translational formation of 
hydroxyproline in hypoxia-
inducible factor (HIF) alpha 
proteins 
  
Simonson et al., 2010; Buroker et al., 
2012; Ge et al., 2012; Xiang et al., 2013; 
Zeng, 2016  
EPAS1 Endothelial PAS 
domain protein 1 
 Induction of genes regulated by 
oxygen 
Scortegagna, et al., 2003; Buroker et al., 
2012; Xiang et al., 2013; Yang et al., 
2013; Newman et al., 2015; Crawford et 




Expression of target genes involved 
in cell proliferation, cell 
differentiation and in immune and 
inflammation responses 
  
Törüner et al., 2004; Simonson et al., 





Regulates adipocyte differentiation Törüner et al., 2004; Oka et al., 2006; 









Regulates blood pressure, salt 
concentrations, and fluid 
concentrations as part of the renin-
angiotensin system 
 
Buroker et al., 2010; Srivastava et al., 
2011; Luo et al., 2014; Zeng, 2016 
 
ASIC2 Acid sensing ion 
channel subunit 2 
Membrane ion channel; Activator 
of the calcineurin/NFAT signaling 
pathways  
Grifoni et al., 2008; Lu et al., 2009; 
Abboud and Benson, 2015; Zhou et al., 
2017; Crawford, 2019  
EDN1 Endothelin 1 Vasoconstrictor  Schiffrin, 2005; Murphy and Eisner, 2006; 
Castro et al., 2007; Deacon et al., 2010; 




FBN1 Fibrillin 1 Extracellular matrix glycoprotein Powell et al., 1997; Shen et al., 2011; 





subfamily M alpha 1 
Large conductance ion channel Tomas et al., 2008; Barnes et al., 2016; D. 
Brown (results unpublished); Crawford, 
2019 
  
NOX4 NADPH oxidase 4 Catalytic subunit the NADPH 
oxidase complex; Acts as an 
oxygen sensor 
Mittal et al., 2007; Li et al., 2008; Chen et 
al., 2012; Zhao et al., 2015; He et al., 




G-protein coupled receptor; 
Mediates inflammatory responses 
Hou et al., 1999; Nishida et al., 2008; 
Tovell et al., 2008; Nishimura et al., 2016; 




PLA2G4A Phospholipase A2 
group IVA 
Catalyzes the hydrolysis of 
membrane phospholipids to release 
arachidonic acid 
Osanai et al., 1998; Handlogten et al., 
2001; Magne et al., 2001; Ait-Mamar et 
al., 2005; Crawford, 2019 
  




Bush et al., 2004; van Rooij et al., 2004; 
Canaider et al., 2006; Grammer et al., 
2006; Crawford, 2019 
  
RGS4 Regulator G protein 
signaling 4 
Regulator/inhibitor of G-protein 
signaling 
Owen et al., 2001; Mittmann et al., 2002; 
Cho et al., 2003; Gu et al., 2010; Opel et 
al., 2015; Crawford, 2019 
  
THBS4 Thrombospondin 4 Adhesive glycoproteins that 
mediate cell-to-cell and cell-to-
matrix interactions 
Stenina et al., 2005; Gabrielsen et al., 
2007; Mustonen et al., 2012; Crawford, 
2019 
NFIA Nuclear Factor I A  Heaton et al., 2020 
ARRDC3 Arrestin domain 
containing 3 
 Oka, 2006; Zeng, 2016; Heaton et al., 
2020 
 
ROCK2 Rho associated coiled-
coil containing protein 
kinase 2 
serine/threonine kinase regulating 
cytokinesis, smooth muscle 
contraction, the formation of actin 
stress fibers and focal adhesions 
Zeng, 2016  
 
2.8 Physiological conditions in cattle resulting from PH 
2.8.1 High Mountain Disease (HMD) 
Introduction to HMD 
Certain cattle respond especially negatively to the hypoxic conditions of high altitude. As 
a result, these cattle develop PH that further progresses into a condition recognized as High 
mountain disease. This condition is one of the leading causes of morbidity and mortality for 
cattle at elevations of 1,500 m or greater (Holt and Callan, 2007). Annual incidence of HMD in 
cattle native to high altitudes is 3% to 5% (Holt and Callan, 2007). However, for non-native 
cattle relocated to high altitude, incidence of HMD increases to 10% to 40% of cattle (Grover et 
al., 1963; Will et al., 1970).  
Economics of HMD 
The economic impact of HMD on high altitude beef production systems has not been 
extensively characterized, but there are studies that have attempted to quantify the annual losses 
resulting from this condition. Holt and Callan (2007) estimated the economic losses due to HMD 
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to be about $60 million annually. However, since 2007, the economic losses may have increased 
due to our ability to better detect and diagnose HMD in cattle. Beef producers managing cattle at 
high altitudes are acknowledging HMD and its resulting economic implications due to cattle 
death loss. As a result, producers are not only investing in PAP testing their cattle, but 
considering PAP when making selection decisions or purchasing cattle (Holt and Callan, 2007; 
Kessler, 2013). Based on data from  Colorado State University Beef Improvement Center’s 
annual bull sale, bull buyers place emphasis on PAP in addition to traits such as weaning weight, 
frame score, yearling weight, calving ease, and stayability when choosing a herd bull. More 
specifically, bull buyers were willing to pay premiums for bulls with PAP scores of 46 mmHg or 
less (Kessler, 2013). The premiums for a low PAP bull often range from $2,000 to $5,000 per 
bull, offsetting some of the financial losses accrued due to cattle that succumb to HMD (Holt and 
Callan, 2007). 
PAP as an indicator of risk of HMD 
All types of PH will result in an elevated PAP, regardless of whether the manifestation of 
PH is acute or chronic. Due to this relationship, PAP has been incorporated into cattle production 
and is utilized as an indicator trait for genetic selection at high altitudes. More specifically, PAP 
is utilized to measure PH and assess an animal’s risk of developing HMD as a result (Holt and 
Callan, 2007). However, not all cattle that have an elevated PAP will develop HMD. It is 
important to recognize that PAP is a phenotype recorded in cattle in an effort to make selection 
decisions. A phenotype is dependent upon the genetics of the animal as well as the environment 
it is exposed to (Bourdon, 2000). Therefore, to fully understand PAP and its role in combatting 




Inheritance of HMD  
Differences in incidence of HMD have been reported between native and non-native 
cattle (Grover et al., 1963; Will et al., 1970; Holt and Callan, 2007). These findings are 
indicative of an adaptation to high altitude or a genetic propensity for cattle to survive in a 
hypoxic environment with PH. Similar conclusions have been drawn from studies in humans as 
well, further supporting the premise that differences in adaptability across different 
demographics and populations could derive from genetic differences (Maclnnis et al., 2010). 
Genes that may impact response to HMD continue to be studied in both humans and animals.  
2.8.2 Feedlot Heart Disease 
Another manifestation of PH in cattle occurs in feedlot settings. This condition, known as 
feedlot heart disease (FHD), has been observed in cattle that have never been exposed to high 
altitudes (Jensen et al., 1976; Pringle et al., 1991; Malherbe et al., 2012). The symptoms of FHD 
resemble those of HMD, leading many to wonder if the cardiopulmonary changes as a result of 
PH are the same. Research the epidemiology and physiology of FHD is scarce. In 1976, HF 
resulting from FHD was reported to impact 2.85 out of every 10,000 cattle (Jensen et al., 1976). 
Further, Neary et al. (2016) reported an increase in incidence of FHD from year 2000 to 2012, 
when adjusting for period of feedlot placement, risk category, sex, age, feedlot, and death loss 
due to other conditions such as digestive disorders. In contrast to the incidence of FHD reported 
by Jensen et al. in 1976, Neary et al. (2016) reported that incidence of FHD in 2012 increased to 
1.08 per 1,000 cattle. Upon further investigation, it was concluded that feedlot cattle treated for 
bovine respiratory disease (BRD) were three times more likely to succumb to HF in the feedlot. 
While death loss due to FHD is not as prevalent as digestive disorders or respiratory disease, the 
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increased prevalence of HF resulting from the condition is costly for the beef industry as half of 
the deaths reported occurred after 19 weeks in the feedlot (Neary et al., 2016).  
Despite quantifying the increased incidence of FHD, management strategies to detect cattle 
experiencing the condition and administer treatment for the condition have yet to be 
characterized. It is speculated that, like HMD, PAP would be the best indicator of risk of 
developing FHD since both derive from PH in susceptible cattle. However, in a feedlot setting, 
PAP testing cattle is not only costly but labor-intensive due to the immense volume of cattle in 
feedlots (T.N. Holt, personal communication). Further research needs to be conducted to 
determine how similar HMD and FHD are to one another and how to efficiently identify cattle 
experiencing FHD. Similar to HMD, genetics may play a role in susceptible cattle, which could 
be a less-invasive tool to determine how cattle will perform during the late-stages of finishing. 
Section 3: Sequencing Methodologies and Technologies  
3.1 Early sequencing 
Since Watson and Crick established the three-dimensional structure of DNA in 1953, the 
field of genetics has changed tremendously. However, many of the molecular breakthroughs that 
have resulted in the technologies and methodologies of next-generation sequencing, occurred 
decades after the structure of DNA had been published (Hutchison, 2007; Heather and Chain, 
2015). Despite the discovery of DNA prior to the establishment of first-generation sequencing 
technologies, it was not the first hereditary component to be sequenced. Instead, scientists 
focused the earliest sequencing efforts on RNA of small bacteria or other microorganisms. The 
small genome size accompanied with the single-stranded nature of RNA provided a less 
complicated template to cultivate the earliest sequencing strategies, which were adapted in order 
to also sequence DNA. 
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Many strategies of sequencing were developed throughout the first-generation 
sequencing era, but none were as widely adapted as Sanger’s chain-termination sequencing 
methodology, more commonly known as Sanger sequencing (Heather and Chain, 2015; Sanger 
et al., 1977a). Di-deoxy chain termination sequencing was an improvement from “plus and 
minus” sequencing as this methodology was quite inefficient and error-prone, and Maxam-
Gilbert sequencing, another methodology at the time, was laborious compared to Sanger 
sequencing (Sanger and Coulson, 1975; Sanger et al. 1977a; Sanger et al., 1977b).  
The basis of Sanger sequencing was to incorporate triphosphate analogs for each of the 
four nucleotide bases, which would each be placed in their own vesicle with a DNA template. 
The triphosphate analog corresponding to one of the four nucleotide bases terminates the DNA 
chain where that nucleotide appears in the DNA sequence. This is performed for all four 
nucleotides individually, and then the results are assessed by running the four samples in parallel 
via gel electrophoresis. After gel electrophoresis is complete, researchers would read the gel, 
assessing the distribution of bands across the four lanes to assemble the sequence (Atkinson et 
al., 1969; Sanger et al., 1977a).  
Sanger sequencing continued to be modified in the years that followed to streamline the 
procedures. Changes made to the initial protocol included altering the method of radio-labeling 
specific nucleotides in order to combine the triphosphate analogs from all four bases into a single 
tube of DNA template, thus reducing the labor leading up to gel electrophoresis. In addition to 
modifying the laboratory procedure itself, further cultivation of Sanger sequencing ultimately 
resulted in development of the first automated sequencing technology, which enabled researchers 
to sequence more complex genomes than had been possible to date (Smith et al., 1985; Heather 
and Chain, 2015).  
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The earliest automated sequencing machines, still part of the first-generation wave of 
sequencing, generated less than one kilobase of sequence from a run. However, strategies of 
shotgun sequencing allowed for contiguous reads to be aligned to one another to create longer 
read fragments for downstream applications (Anderson, 1981; Heather and Chain, 2015). The 
earliest sequencing technologies were further streamlined through the development of 
polymerase chain reaction (PCR) and other wet-laboratory techniques that more efficiently 
allowed for preparation of a purified sample prepared for sequencing. Further technological 
advances made way to automated sequencers able to sequence multiple samples in parallel. The 
ability to run many samples simultaneously allowed for researchers to begin characterizing larger 
genomes through large-scale collaborations such as the Human Genome Project (Heather and 
Chain, 2015). 
3.2 Next-generation sequencing 
The first-generation of sequencing technologies inspired the development of new 
sequencing methodologies from companies such as 454 and Solexa (Heather and Chain, 2015). 
Sequencing companies were becoming more prevalent and cultivating their own sequencers. 
Competition amongst these companies resulted in rapid improvements in technology to reduce 
sequencing costs per sample. Further, some companies succumbed to the vast competition, 
liquidating their assets or being absorbed by one of the more successful companies.  In the end, 
Illumina was most successful in meeting the demands of the scientific community throughout 
this time and continues to develop the most popular sequencing technologies available to date 




3.2.1 Sequencing by synthesis 
The most popular next-generation sequencing methodology utilizes a technology known 
as sequencing by synthesis (SBS). Sequencing by synthesis accounts for approximately 90% of 
the next-generation sequence data generated and comes in three forms of sequencing chemistry: 
pyrosequencing, sequencing by reversible termination, and sequencing by detection of hydrogen 
ions (Illumina; Ambardar et al., 2016). The SBS chemistry is designed to perform sequencing 
projects in parallel. Illumina’s newest sequencers utilize reversible termination sequencing, a 
technology that not only allows for greater throughput or sequencing capacity, but also reduces 
bias present in many prior methodologies through equal availability of reagents for all four 
nucleotides throughout the sequencing process (Ambardar et al., 2016). The overall SBS 
sequencing procedure outlined by Illumina consists of four major steps: sample or library 
preparation, cluster generation, sequencing, and data analysis. 
Library preparation 
The library preparation step can be performed utilizing a kit that contains all necessary 
reagents. The basic steps of a library preparation protocol consist of purification and 
fragmentation of the DNA template (M.D. Stenglein, J.S. Lee, and D.B. Sloan; personal 
communication) (Figure 2.3). Then one must add adapters specific to the Illumina instrument to 
be used, and through reduced cycle amplification, the sequencing binding site, sample index, and 
sequence regions complementary to the oligos on the Illumina flow cell for binding (Figure 2.4). 
This is performed for each library then they are pooled, diluted, and denatured before being 
loaded into a sequencing cartridge that contains all necessary reagents for the sequencing run. 






















Figure 2.4 An example of a DNA fragment with ligated adapter components and illustration of 
how each read is generated for a paired-end sequencing run. The DNA template or DNA insert is 
the sequence region of interest. The DNA template is flanked on either side by ligated adapters 
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added via reduced cycle amplification. Within the adapter region is the sequencer binding site 
(P5 or P7) that is compatible with one of the two oligos within the lanes of the Illumina flow cell. 
Next to the binding site is the specific index that is unique to one of the animals being 
sequenced. I7 and I5 correspond to Illumina’s index 1 and index 2 information, respectively. 
Samples can be dual indexed like is pictured above (I7 and I5 indexes) or single indexed (just I7 
is present). Next to the index within the adapter region is the sequence primer binding region 
(SP). The sequencing primer binding region is where the polymerase binds to generate each of 
the reads. Each of the arrows denote a different read generated for each template strand through a 
paired-end sequencing run. Read 2 and read 4 allow for the index information in the adapter 
sequences to be read such that samples may be segregated from the pooled sequence data after 
the run is complete. Read 1 and read 3 are the paired-end reads of the DNA template, which are 
ideal for a complex sequencing project because the mid-read overlap allows for increased 
accuracy of called base pairs in the middle of the DNA template. 
 
Cluster generation 
The second phase of the Illumina sequencing pipeline is known as cluster generation. 
Cluster generation is the process in which each DNA fragment is isothermally amplified. During 
this process, one of the two varieties of oligos present within a lane of the glass flow cell will 
bind to the complement sequence that was added to the DNA fragment via reduced cycle 
amplification. A polymerase will then bind at the sequencing binding site to create a complement 
of the hybridized fragment. The sample is then denatured, and the original fragment that was 
bound to the flow cell is washed off. Bridge amplification then occurs using the newly formed 
read, which will bind to the complement oligo within the lane creating a bridge-like shape. The 
polymerase then copies the strand, creating a double-stranded bridge. The two reads are then 
denatured, becoming two unique reads that will be used as templates the next cycle of bridge 
amplification. This is repeated for millions of sequencing clusters for clonal amplification of all 
DNA fragments. Next, all reverse strands generated are washed off of the flow cell and an 





 Upon completion of cluster generation, the actual sequencing process begins. All reverse 
reads are removed and the 3’ ends of the forward reads are bound by an inhibitor to avoid 
unwanted priming. The sequencing process begins with the addition of the first primer 
corresponding to the complement of the nucleotide present on the strand starting with the 
sequencing binding site. This process consists of fluorescently tagged nucleotides being added to 
the growing chain one at a time based on the sequence of the template. At the end of each cycle, 
a fluorescent light is emitted and imaged to collect the sequence data. The number of cycles is 
used to determine the read length generated. During the sequencing process, hundreds of 
millions of clusters are sequenced in parallel. 
After sequencing the first read, the read product is washed off of the flow cell so that a 
new read may be generated from the template. The index 1 read primer is hybridized to the same 
read template. This read is generated from the index 1 primer region to the oligo on the flow cell 
and then washed off. Currently, the 3’ end of the read is de-protected to re-enable binding to the 
flow cell. The read will form a bridge again by binding the 3’ end of the template to the 
complement oligo on the flow cell. At this point the index 2 read is generated and extends to the 
opposite oligo forming another double-stranded bridge. These strands are denatured to form 
individual linear strands. The original forward read is washed off the flow cell and the 3’ end of 
the remaining reverse read is blocked to prevent unwanted primer binding. This entire process is 
then repeated for the reverse read. Sequencing of the forward and reverse strands of multiple 
DNA template strands is repeated hundreds of millions of times to generate multiple reads that 




Upon completion of sequencing, reads can be demultiplexed using the unique index 
identifiers that were added in the library preparation steps. The demultiplexing process consists 
of taking pooled reads that were in the pooled library and sorting them into individual libraries 
again through the unique index information that was ligated to the fragments of each unique 
DNA library during the reduced cycle amplification step. Each sample can then be trimmed and 
assembled based on the overlap of reads to form contiguous reads (contigs) and scaffolds. These 
contigs and scaffolds can then be aligned to a reference genome or utilized to form a de novo 
assembly for further downstream analysis (Figure 2.5). 
 
Figure 2.5 The basic steps of sequence data analysis. 
 
3.2.3 SNP discovery 
The process of determining where variants or polymorphisms exist within a genome is 
known as SNP discovery. During this process, sequence samples are compared to a reference 
genome in order to detect base pair differences (Nielsen et al., 2018). Due to the immense size of 
mammalian genomes such as the bovine genome, which is 2.7 gigabases in size, robust software 
and computer programs are utilized to compare sequences and call variants. Many of these SNP 
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discovery tools such as CLC Genomics Workbench (Qiagen Bioinformatics) or Genome 
Analysis Toolkit (GATK) (McKenna et al., 2010) allow for case-control comparisons in order to 
detect SNP between two separate populations in a study. 
After SNP have been identified through comparisons of sequences, SNP must be 
investigated further in order to determine which genes contain SNP and what the functional 
consequences of each SNP may be. Tools such as the Ensembl Variant Effect Predictor (VEP) 
searches across the Ensembl database to determine functional consequences of a variant. The 
VEP indicates if a variant is an insertion, deletion, copy number variant, or structural variant. 
Further, the VEP will provide information about the genes and transcripts affected by a variant, 
the variant location, and the consequences of a variant on protein structure. The data provided 
about each variant provides insight into the physiological impact that a SNP may have on a gene 
and the overall function of an organism (Yates et al., 2020). 
The final step of SNP discovery is validation of SNP. This is conducted by comparing 
genotypes at each discovered SNP to a trait of interest in a population of thousands of animals. 
The SNP that are concordant across a particular phenotype for the desired trait are considered to 
be valid and can proceed to be utilized for selection purposes. Conversely, SNP that are not 
concordant across animals with a particular phenotype would be eliminated from the pool of 
discovered SNP (Kumar et al., 2012).  
Within livestock industries, SNP discovery is important for genomic selection. More 
specifically, SNP related to phenotypes of interest can be included on a SNP genotyping panel 
for genomic selection. Performing SNP discovery allows for relevant SNP to be incorporated 
into genetic evaluations and considered in breeding decisions.  
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3.2.4 Multi-omics analyses 
Some traits within the beef industry are difficult to select for or against due to their 
polygenic nature (Moser et al., 2015). Further, genetic markers or polymorphisms associated 
with a complex trait often impact other traits, often resulting in pleiotropy. The overlap of loci 
that regulate multiple phenotypes can result in indirect selection for undesirable traits (Saatchi et 
al., 2014). It is difficult to parse loci related to multiple phenotypes in order to understand gene 
regulation and interactions for a single phenotype. However, through incorporation of multiple -
omics technologies, a biological or physiological systems approach may be implemented to 
better understand genetic mechanisms underlying phenotypic expression for a given trait and 
create gene network models that depict how different genes and transcripts interact with one 
another to express a particular phenotype (Cánovas et al., 2014; Nguyen et al., 2018).  
Multi-omics analyses benefit animal breeding in several ways. First, through combining -
omics data, genes that may contain SNP valuable for genotyping may be easily identified and 
implemented in breeding programs. In addition, compilation of differential expression data and 
DNA sequence differences may be utilized to construct networks depicting how involved and 
interactive different loci are in phenotypic expression. In conjunction, pleiotropic effects may be 
closely evaluated in order to make genetic improvement for one trait while reducing the impact 
of selection against a separate economically relevant trait that shares an inverse relationship 
(Cánovas et al., 2014; Nguyen et al., 2018).  
3.2.5 Genomics in livestock management 
Commercial SNP genotyping has been widely adapted in the dairy and beef industries. 
Many breed associations are utilizing SNP panels to gather genomic information to enhance the 
accuracy of EPDs for genetic improvement. The resulting estimates of animal performance 
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incorporating SNP information is recognized as a genomic-enhanced EPD (GEPD). These 
measures are calculated by summing all marker effects across the genome that are associated 
with the phenotype of interest to form a direct genomic breeding value (DGV). These DGV are 
then combined with the phenotypic and pedigree information commonly utilized to calculate a 
standard EPD (Gray et al., 2012; Saatchi et al., 2012; Rolf et al., 2014). 
Addition of genomic information into genetic evaluations enhances the amount of 
information included in calculations. This addition of genomic information results in increased 
accuracy of selection as it aids in measuring the “true” relationships between individuals. This 
resulting increase in accuracy will be more beneficial for traits that are expensive to measure or 
for young animals with no phenotypic observations yet (Garrick, 2011). In addition, selection 
intensity can be increased through incorporation of genomic information. Evaluation of livestock 
based on GEPDs will have an increased accuracy, meaning that producers can select fewer 
replacements with greater confidence (Weller, 2016). Increasing selection intensity also 
increases the rate of genetic change, resulting in faster genetic improvement (Bourdon, 2000). 
Alongside increasing selection intensity, incorporation of genomic information also reduces the 
generation interval, increasing the rate of genetic change (Weller, 2016; Bourdon, 2000). 
Overall, incorporation of genomic information into genetic evaluations increases accuracy and 
efficiency of selection. 
There are multiple methods to calculate DGV for incorporation into genetic evaluations 
of livestock: (1) inclusion DGV estimations as a correlated trait; (2) inclusion of DGV as 
separate EPD measures; and (3) incorporating GEPD estimates into a selection index (Rolf et al., 
2014). All of these methodologies are two-step methods. However, direct or single-step methods 
have also been developed for estimation of GEPD. Direct calculations of GEPD utilize a 
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genomic relationship matrix rather than calculating marker effects first. A genomic relationship 
matrix takes into consideration identity by descent, identity by state, and pedigree relationships. 
This genomic relationship matrix is included in a best linear unbiased prediction (BLUP) 
analysis to calculate GEPD (Misztal et al., 2009).  
Section 4: 1000 Bulls Genome Project 
The cost of next-generation sequencing has decreased substantially over the past decade. 
However, it is still thousands of dollars to sequence a population of cattle to a depth that would 
allow for detection of novel variants. Therefore, consortia are being established for a number of 
species. Through these consortia, researchers can submit sequence data from their research to 
obtain membership and gain access an expansive database of sequence data. One such 
consortium is the 1000 Bulls Genome Project, which consists of sequence data from modern 
dairy and beef cattle breeds (Hayes and Daetwyler, 2019). 
The 1000 Bulls Genome Project aims to build a database of sequence variant genotypes 
from modern cattle breeds for genome-wide association studies (GWAS) and genomic prediction 
and enable the use of this data to identify mutations that may compromise cattle health, welfare, 
or productivity. Membership into this consortium is obtained through submission of a sequence 
data that satisfies the requirements indicated by the steering committee. Once membership has 
been obtained, members can download sequence data for utilization in future research endeavors. 
The data contained within this consortium has mutations or variants already identified, which can 
reduce the amount of work needed to perform GWAS or SNP discovery analyses (Hayes and 
Daetwyler, 2019).  
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Section 5: Conclusions 
 Pulmonary hypertension is increasing in prevalence within the beef industry, impacting 
not only high-altitude beef systems but also finishing cattle in the feedlots. With the recent 
cultivation of a PAP EPD, selection decisions can be made to combat PH in cattle. However, 
many challenges still exist as the beef industry work towards reducing incidence of PH. The first 
challenge to overcome is to determine if HMD and FHD are similar conditions that can be 
selected for in the same manner. In addition, the PAP EPD needs to continue to be enhanced in 
order to improve accuracy due the limited amount of PAP observations recorded annually. 
Through discovering SNP associated with PAP, a GEPD may be calculated that increases the 
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SUMMARY OF STUDY ANIMALS AND EXPERIMENTAL DESIGN 
3.1 Introduction  
This chapter describes the steers utilized in studies described in chapters 4 through 6.  
3.2 Animal selection 
Animals utilized in chapters 4 to 6 of this dissertation were cared for according to the 
guidelines of the Colorado State University Animal Care and Use Committee (16-6397A & 19-
8429A).  
Steers from the 2016 calf crop at the Colorado State University Beef Improvement Center 
(BIC; John E. Rouse Angus) underwent initial pulmonary arterial pressure (PAP) testing at 10-12 
months of age. Bulls and steers within the 2016 CSU BIC calf crop had an average PAP of 40.32 
+ 1.22 mmHg. In order to be included in this study, steers had to have an initial PAP 
measurement within one standard deviation of the population mean (41.38 + 0.46 mmHg; low 
risk of developing high mountain disease).  
Forty steers were allocated to one of four treatment groups (n=10/group). The four groups 
were high altitude stockered and grain-finished (Grain_HA), high altitude stockered and grass-
finished (Grass_HA), high altitude stockered and moderate altitude grain-finished 
(Ext_Mod_Stocker), moderate altitude stockered and grain-finished (Norm_Mod_Stocker). 
Stratification of the forty steers into finishing systems was performed based on their PAP, 















41.40 + 0.96A 313.00 + 5.62A 253.56 + 5.67A 
Grain_HA 
(n=10) 
41.20 + 0.96A 314.00 + 5.62A 270.90 + 5.67A 
Ext_Mod_Stocker 
(n=10) 
41.90 + 0.96A 309.00 + 5.62A 258.55 + 5.67A 
Norm_Mod_Stocker 
(n=10) 
41.00 + 0.96A 304.00 + 5.62A 262.18 + 5.67A 
A Within each column, different superscripts represent statistically significant differences of the 
means between management groups for the specified trait (P<0.05). 
3.3 Experimental design 
The stockering phase of this study commenced in April of 2017. All groups that were 
stockered at high altitude (Grain_HA, Grass_HA, Ext_Mod_Stocker) were maintained at BIC at 
an elevation of 2,150 m. Groups that were stockered at moderate altitude (Norm_Mod_Stocker) 
were managed at the Eastern Colorado Research Center (ECRC) at an elevation of 1,420 m. 
Steers stockered at the BIC were grazed in pastures comprised of timothy and bromegrass, while 
steers stockered at the ECRC were grazed in pastures consisting of western wheat, sand 
bluestem, blue grama and prairie sandreed grasses.  
In August 2017, steers were administered a finishing ration, which consisted of 13.35% 
crude protein and 1.47% net energy. Ext_Mod_Stocker steers were relocated from the BIC to 
ECRC in early August for finishing. Grain_HA and Grass_HA steers were finished at the BIC on 
the same ration as the Norm_Mod_Stocker and Ext_Mod_Stocker management groups. 





Figure 3.1 Summary of experimental design from allocation to treatment in February 2017 until 
harvest of each finishing system.  
Pulmonary arterial pressure was recorded on each steer every six to eight weeks per the 
procedure described by Holt and Callan (2007) with the final measurement occurring within two 
weeks of harvest. Body weights were also recorded at these times. Once the average body weight 
for steers in a finishing system reached approximately 544 kg, steers were harvested within 30 
days. Steers assigned to the Ext_Mod_Stocker and Norm_Mod_Stocker management groups 
were harvested in December of 2017. The Grain_HA steers were harvested in March 2018, and 
the Grass_HA steers were harvested in October 2018. After harvest, hot carcass weight (HCW), 
backfat thickness, yield grade (YG), ribeye area (REA), kidney, pelvis, and heart fat (KPH), 
marbling score (MARB), and quality grade (QG) were recorded. 
3.4 Carcass quality grades 
Quality grades were recorded on all steers after harvest according to the United States 
Department of Agriculture grading scale (Figure 3.2). The Norm_Mod_Stocker group had the 
highest quality grades of all finishing systems with 33.3% of the steers in that finishing system 
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graded prime-, 44.4%graded choice, and 22.2% graded choice-. Conversely, Grass_HA steers 
exhibited the lowest carcass quality grades with 20% graded choice-, 20% graded select+, 40% 
graded select-, and 20% graded standard+. All Ext_Mod_Stocker and Grain_HA steers were 
graded within the categories of choice and select.  
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DIFFERENTIATING THE ROLE OF ALTITUDE AND FINISHING STRATEGY ON 
PULMONARY ARTERIAL PRESSURE THROUGHOUT THE STOCKER AND FINISHING 
PHASES OF BEEF PRODUCTION 
4.1 Introduction 
High mountain disease (HMD) has challenged high altitude beef production systems for 
decades with reported herd death losses ranging from 2% to 25%. High mountain disease is 
characterized as remodeling of the cardiopulmonary system induced by pulmonary hypertension 
resulting from high altitude (>1,500 m) exposure (Jensen et al., 1976; Holt and Callan, 2007). 
This tissue remodeling results in increased cardiac strain and often culminates in right-sided 
heart failure (Jensen et al., 1976; Thomas et al., 2018). However, HMD is not the only 
pulmonary hypertension (PH) related disease that impacts the beef industry. 
A similar condition known as feedlot heart disease (FHD) has been a concern for cattle 
from all altitudes since being discovered in the 1970’s (Jensen et al., 1976). Research to date has 
suggested that while both HMD and FHD arise from vascular remodeling as a result of PH, they 
are separate conditions (Neary et al., 2015; Krafsur et al., 2017; Krafsur et al., 2019). Rapid 
weight gain that occurs in the latter stages of finishing cattle can result in late-term feedlot death 
(Neary et al., 2015; Neary et al., 2016; Krafsur et al., 2017; Krafsur et al., 2019). 
 The best indication of an animal’s risk of HMD or FHD is a mean pulmonary arterial 
pressure measurement (PAP), which provides insight regarding the pulmonary health status (i.e. 
pulmonary hypertension) of an animal. A PAP of 49 mmHg or greater indicates that the animal 
is hypertensive and has a high risk of developing heart failure (Holt and Callan, 2007). Research 
to date has characterized HMD and FHD, but there is still much to learn about these conditions 
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(Neary et al., 2015; Thomas et al., 2018; Krafsur et al., 2019). Little is known about the impact 
of both altitude and finishing strategy on PAP simultaneously during stocker and finishing 
phases of cattle production. Therefore, the objective of this study was to evaluate the impact of 
finishing strategy and altitude on PAP throughout the stocker and finishing phases of beef 
production. 
4.2 Materials and methods 
Steers in the study population were selected, allocated, and managed according to the 
experimental design outlined in chapter three of this Dissertation. 
Upon completion of data collection, automated model selection was performed using the 
dredge command from the multi-model inference (MuMIN) package in R (Bartoń, 2013; R core 
team, 2013). Effects considered in model selection predicting PAP were finishing strategy, 
period, and finishing strategy*period where period represents the time between the start of the 
study and the PAP measurement. This approach accounted for different sampling dates given 
steers were at multiple locations (Figure 4.1). Further, some finishing systems took longer to 
reach the average weight suitable for harvest, so coding the variable as Period allowed for 
comparisons of those pre-harvest time points. Period 1 corresponded to the initial PAP measure 
that was recorded prior to steers being assigned to a finishing system, and Period 5 corresponded 
to the final PAP measurement recorded within two weeks of harvest. A random effect of ID 
nested within finishing system was also fit for this model in order to account for variation across 
steers within the same finishing system. The best model for the analysis was selected based on 
the lowest corrected Akaike information criterion estimate (AICc). The final model included 




Figure 4.1 An outline of the experimental design that depicts how sampling time points were 
grouped into periods for comparisons across management groups. 
 
 The final model was fit using the linear mixed-effects (lmer) function from the linear 
mixed-effects using Eigen and S4 (lme4) package in R (Bates et al., 2015). Multiple covariance 
structures were evaluated with the model in order to determine the best covariance structure for 
the data. The first model was fit with a compound symmetry covariance structure, the second 
model was fit with unstructured covariances, and the third model was fit with an autoregressive 
covariance structure. The best covariance structure was determined based on which of the three 
models had the lowest AICc. Based on this criterion, covariances were fit as unstructured. 
Pairwise estimated marginal means (emmeans) analyses were performed to compare PAP across 
periods and to compare PAP across finishing strategies for each period (Searle et al., 1980). 




PAP did not differ between finishing systems at any Period within this study (Figure 4.2). 
Further, PAP did not differ across Periods 1 through 4 of the study. However, Period 5 PAP 
measurements differed from Periods 1 through 4 regardless of finishing strategy. 
 
Figure 4.2 The fluctuations of PAP over time by finishing system, where A and B denote 
differences in the least square means between Periods. 
4.4 Discussion 
 Mean pulmonary arterial pressures were similar among finishing systems at each period 
of this study. The Ext_Mod_Stocker steers that were moved from high altitude to moderate 
altitude mid-study for finishing still exhibited increased PAP as the study progressed. These 
results parallel the findings of Neary et al. (2015) that moved Angus steers from high altitude to 
moderate altitude for finishing, which exhibited an increased PAP over time regardless of 
altitude. Based on these results, neither finishing ration nor altitude appeared to be the primary 
cause of elevated PAP during the stocker and finishing phases of production. It appeared that 
both altitude and finishing ration contributed to the development of PH.  
72 
 
 Over the duration of this study, PAP increased. However, PAP measurements recorded in 
periods 1 to 4 did not differ from one another and suggested these steers were at moderate risk of 
developing heart failure. Periods 1 to 3 occurred during the stockering phase of production in 
which all steers were consuming pasture or hay. Therefore, during periods 1 to 3 altitude was the 
only management challenge imposed on the steers. During this time, the groups at high altitude 
exhibited slight increases in PAP, but they were not different from the Norm_Mod_Stocker 
steers that were at moderate altitude throughout the study. These results are congruent with those 
of Neary et al. (2015). At younger stages of production, cattle did not exhibit steep fluctuations 
in PAP. 
Period 4 was when PAP was recorded from steers consuming energy dense finishing 
ration. The HA_Grass steers were the only group that was not fed the finishing ration, yet they 
had PAP measurements similar to the steers on study during Period 4. It is hypothesized that, 
when Period 4 PAP measurements were recorded, steers had not yet gained enough weight to 
elevate PAP in contrast to those PAP measures recorded in Period 5. Neary et al. (2015) 
demonstrated that PAP increased regardless of altitude as steers progressed through the finishing 
phase. Krafsur et al. (2019) observed obesity-induced onset of PH progressing to heart failure, 
that paralleled the change from the stocker to finishing stages of production. However, the PAP 
measurements recorded in Period 4 did not agree with the findings of Neary et al. (2015) and 
Krafsur et al. (2019). This could be due to Period 4 measurements being recorded early enough 
in the finishing phase to not capture the increases of PAP at the expense of increased rate of gain. 




 Mean pulmonary arterial pressure measurements recorded in Period 5 (pre-harvest) were 
greater than those recorded in Periods 1 to 4 regardless of finishing system. Based on Holt and 
Callan (2007), these steers were at high risk of developing heart failure. All steers had high PAP 
measurements pre-harvest regardless of finishing strategy or altitude. Ext_Mod_Stocker steers 
had a Period 5 PAP that was elevated compared to all other periods, which coincides with the 
conclusion of Neary et al. (2015) that alveolar hypoxia continued once steers were relocated to a 
moderate altitude for finishing. Therefore, altitude was not the only factor impacting PAP. This 
was also demonstrated through the changes from PAP in the Norm_Mod_Stocker group. Moving 
steers to moderate altitude and still observing elevated PAP measures ruled out hypobaric 
hypoxia as the only contributing factor of elevated PAP. Jensen et al. (1976) hypothesized that 
hypoventilation contributed to increased PAP. Hypoventilation may result from increased fat 
deposition or rumen size that compresses the lungs and results in rapid shallow breathing (Jensen 
et al., 1976, Krafsur et al., 2019). 
 In conclusion, steers exhibited elevated PAP over the finishing phase of production 
regardless of finishing strategy or altitude. These findings suggested that, while management and 
environment contributed to the development of PH, they were not the only cause of increased 
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CHARACTERIZING THE IMPACT OF ALTITUDE AND FINISHING SYSTEM ON MEAN 
PULMONARY ARTERIAL PRESSURE AND CARCASS CHARACTERISTICS IN ANGUS 
CATTLE 
5.1 Introduction 
 High mountain disease (HMD) is a cardiopulmonary condition observed in cattle grazing 
at elevations greater than 1,500 m (Holt and Callan, 2007; Crawford et al., 2017; Pauling et al., 
2018). The condition is caused by pulmonary hypertension (PH) resulting from chronic exposure 
to environmental hypoxia (Hecht et al., 1962). Cattle intolerant of hypoxic conditions often 
undergo pulmonary vascular remodeling, cardiopulmonary insufficiencies, right heart failure, 
and death. High mountain disease impacts three to five percent of cattle at high altitude on 
average, but some ranchers have reported death losses as great as twenty-five percent (Holt and 
Callan, 2007; Neary et al., 2013ab; Bruns et al., 2015). 
 Once cattle start showing clinical signs of PH, there are limited therapeutic remedies. The 
best indicator of risk of HMD is mean pulmonary arterial pressure (PAP) measured in cattle 
managed at high altitudes. Mean pulmonary arterial pressure is a veterinary procedure measured 
by threading a catheter containing a transducer through the jugular vein and right side of the 
heart in order to measure pressure in the pulmonary artery. This measurement indicates the 
animal’s risk of developing HMD. Low-risk cattle have PAP measurements less than or equal to 
41 mmHg, moderate-risk cattle will have a PAP ranging from 42 to 48 mmHg, and high-risk 
cattle have a PAP of 49 mmHg or greater (Holt and Callan, 2007). However, PAP is influenced 
by many factors such as age, breed, and altitude (Enns et al., 1992; Holt and Callan, 2007; Neary 
et al., 2015a, b; Crawford et al., 2017). 
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 Symptoms similar to HMD have been observed in a portion of feedlot cattle never 
exposed to high altitude. The phenomenon of pulmonary hypertension occurring in feedlot cattle 
is described as feedlot heart disease (FHD). This disease can cause late-term feedlot death 
(Jensen et al., 1976; Neary et al., 2015ab). Common symptoms of HMD and FHD include, but 
are not limited to, lethargy, jugular vein distension, submandibular edema, and ascites (Holt and 
Callan, 2007; Krafsur et al., 2019). However, it is speculated that the conditions reflect distinct 
etiologies owing to the differing management practices that exist between ranches and feedlots. 
Krafsur et al. (2019) reported that the physiology of FHD is characterized as significant 
pathophysiologic remodeling of the left ventricle and pulmonary venous circulation 
accompanying right heart and pulmonary arterial remodeling. Whereas, HMD has been 
described as pulmonary hypertension and right ventricular dysfunction (Rhodes, 2005).  
Similarities and differences between HMD and FHD are still being investigated. Therefore, the 
objective of this study was to evaluate the influence of altitude and finishing ration on mean 
pulmonary arterial pressure and carcass characteristics.  
5.2 Materials and methods 
 The steers utilized in this study were selected, managed, and allocated to treatments 
according to the procedures outlined in chapter 3. Steers were assigned to one of four groups: 
high altitude stockered and grain-finished (HA_Grain), high altitude stockered and grass-finished 
(HA_Grass), high altitude stockered and moderate altitude grain-finished (Ext_Mod_Stocker), 
moderate altitude stockered and grain-finished (Norm_Mod_Stocker).   
The traits of interest for this study were pre-harvest PAP (PAP recorded within two 
weeks of harvest), hot carcass weight (HCW), backfat thickness (BF), kidney, pelvis, and heart 
fat (KPH), ribeye area (REA), yield grade (YG), marbling score (MARB), and quality grade 
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(QG). The carcass metrics were recorded by employees at the harvest facilities. Prior to analysis, 
MARB was converted from a categorical variable to a numerical marbling score utilizing the 
guidelines outlined by the Centralized Ultrasound Processing Laboratory (2007). 
Upon completion of data collection, automated model selection was performed using the 
dredge command from the multi-model inference (MuMIN) package in R (R core team, 2013) 
with statistical significance being accepted when probability greater than F was <0.05. Random 
effects considered in model selection predicting pre-harvest PAP were initial PAP and age, and 
finishing system was included as a fixed effect. Random effects included for selecting the most 
appropriate model for HCW, backfat, KPH, REA, YG, and MARB were harvest age, initial PAP, 
pre-harvest PAP. Finishing system was included as a fixed effect for the model selection of the 
aforementioned carcass characteristics. The resulting models for dependent variables pre-harvest 
PAP, HCW, backfat, KPH, REA, MARB and YG (Table 5.1) were fitted. The estimated 
marginal means were utilized to compare means across finishing systems for pre- harvest PAP 






Table 5.1. Final model selected for each trait of interest utilizing the multi-model inference 



















X  X   0.012 
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HCW   X   0.670 
Backfat   X X  0.552 
KPH X  X   0.939 
REA    X  0.188 
YG   X X X 0.544 
MARB   X X  0.487 
5.3 Results 
 Finishing system influenced pre-harvest PAP as HA_Grass steers had a PAP that was 
greater than Ext_Mod_Stocker steers (P=0.006) as well as Norm_Mod_Stocker steers 
(P=0.024). Steers in the HA_Grain finishing system were similar to the other three finishing 
systems when comparing pre-harvest PAP measures (Table 5.2). 
 Hot carcass weights (HCW) varied across finishing strategies (P<0.05). Specifically, 
steers stockered and grass finished at high altitude (HA_Grass) exhibited the lowest mean HCW 
compared to all other finishing systems (P<0.001) Steers of the Ext_Mod_Stocker treatment 
exhibited the second lowest HCW (P<0.001). Conversely, HA_Grain steers had the greatest 
HCW of the finishing systems (P<0.001) with Norm_Mod_Stocker steers exhibiting the second 
largest HCW (P<0.001) (Table 5.2). 
 Steers stockered and grain finished at high altitude (HA_Grain) exhibited an average 
carcass backfat thickness greater than Ext_Mod_Stocker (P= 0.002) and Norm_Mod_Stocker 
(P=0.03) steers. Backfat did not differ between HA_Grass steers and all other finishing systems. 
Furthermore, Ext_Mod_Stocker and Norm_Mod_Stocker steers did not exhibit differences in 
backfat (Table 5.2). 
 Yield grades differed such that HA_Grain steers exhibited a greater average yield grade 
than Ext_Mod_Stocker (P=0.001) and Norm_Mod_Stocker (P=0.021) steers, but not HA_Grass 
steers. Differences in yield grade were not significant when comparing HA_Grass, 
Ext_Mod_Stocker, and Norm_Mod_Stocker steers to one another (Table 5.2). 
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Steers in the HA_Grain finishing system had the greatest KPH (P>0.001). However, no 
differences in KPH were observed between the HA_Grass, Ext_Mod_Stocker, and 
Norm_Mod_Stocker finishing systems (Table 5.2).  
 Ribeye area differed across finishing systems such that Ext_Mod_Stocker steers had an 
average ribeye area that was larger than that of HA_Grain (P<0.001) and HA_Grass (P<0.001) 
steers, but not Norm_Mod_Stocker steers. The steers that were stockered and grass finished at 
high altitude (HA_Grass) had the smallest ribeye area (P<0.001; Table 5.2). 





Table 5.2 Mean pre-harvest PAP measurement, hot carcass weight (HCW), backfat, yield grade (YG), ribeye area (REA), kidney, 





















54.80 + 1.54A 322.50 + 3.08A 0.89 + 0.23AB 2.85 + 0.24AB 27.69 + 0.41A 1.26 + 0.16A 7.46 + 1.84AB 605 
HA_Grain 
(n=10) 
52.60 + 1.80AB 421.84 + 3.58B 1.42 + 0.05A 3.45 + 0.04A 29.97 + 0.48B 2.99 + 0.03B 6.27 + 0.30AB 407 
Ext_Mod_Stocker 
(n=10) 
46.60 + 1.93B 339.74 + 3.83C 0.76 + 0.18B 2.79 + 0.18B 32.77 + 0.51C 1.73 + 0.12A 4.01 + 1.10A 307 
Norm_Mod_Stocker 
(n=10) 
47.60 + 1.95B 382.38 + 3.86D 0.91 + 0.18B 2.94 + 0.18B 31.24 + 0.51BC 1.72 + 0.13A 5.41 + 1.10B 307 




Ext_Mod_Stocker carcasses had lower marbling scores than Norm_Mod_Stocker 
carcasses (P<0.05), but not HA_Grass or HA_Grain carcasses (Table 3). However, 
Ext_Mod_Stocker carcasses had better quality grades than those of the Grass_HA group (Figure 
1). Norm_Mod_Stocker carcasses had the best quality grades, with all carcasses being graded 
prime-, choice, or choice-. Conversely, Grass_HA carcasses had the poorest quality grades of all 
finishing systems. Collectively, the majority of carcasses, regardless of finishing ration, were 
graded within the range of choice+ to choice- (Figure 5.1).  
 
Figure 5.1 Comparison of quality grade across finishing systems. 
5.4 Discussion 
 All finishing strategies within this study exhibited PAP measurements that would classify 
the steers as either moderate or high risk of developing pulmonary hypertension (Holt and 
Callan, 2007). However, the HA_Grass steers exhibited a higher average PAP than either 
Ext_Mod_Stocker or Norm_Mod_Stocker steers. HA_Grain steers were intermediate between 
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HA_Grass steers and the steers finished at moderate altitude when comparing pre-harvest PAP 
measures. The groups finished at moderate altitude had an average PAP consistent with a 
moderate risk of developing pulmonary hypertension, while the steers residing at high altitude 
for the duration of the study had an average PAP consistent with a high risk of developing 
pulmonary hypertension (Holt and Callan, 2007). Based on these results, it would appear that 
duration of exposure to altitude may pose a greater impact than finishing ration since the steers at 
high altitude took longer to reach finishing weights and were exposed to hypoxic conditions for 
the entire study.  
It is important to note that within the HA_Grass finishing group, there was a single steer 
that had a pre-harvest PAP of 115 mmHg, which increased the average PAP of that group of 
steers. The HA_Grain finishing group had a steer with a pre-harvest PAP of 87 mmHg, which 
increased the average PAP of that group, but not to the same extent as the data point in the 
HA_Grass population. However, these data were included in the analysis due to their biological 
importance in addressing how steers respond to finishing strategies and altitude. Further, the 
percentage of the overall population that had “extreme” PAP measures was 2 out of 40 or 5% of 
the study population which is consistent with the percentage of cattle impacted by HMD in beef 
operations according to Holt and Callan (2007). Overall, it appears that duration of exposure to 
altitude may influence PAP more than finishing ration. Additional studies with larger numbers of 
cattle representing ranches across the western United States and Great Plains region may 
elucidate whether altitude is truly more impactful on PAP than finishing diet. 
HCW differed across all finishing systems. HA_Grain steers had the heaviest carcasses, 
and HA_Grass steers had the lightest carcasses. These results agree with previous studies that 
concluded that when the amount of forage in the diet increases during the backgrounding and 
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finishing phases, HCW decreases (Cox et al., 2006; Pordomingo et al., 2012). Furthermore, 
Pordomingo et al. (2012) report that these changes are likely due to reduced average daily gain 
related to consumption of a predominantly forage-based diet. However, this was one of the first 
studies to evaluate carcass characteristics of Angus steers managed at moderate and high 
altitudes. Based on these results, it appears that finishing diet poses a greater impact on HCW 
than finishing altitude.  
 HA_Grain steers had greater backfat than steers finished at moderate elevation and 
HA_Grass steers. HA_Grass steers had similar backfat thicknesses to those finished at moderate 
elevation. Results for backfat thickness disagree with findings by Prodomingo et al., who 
concluded that as hay or forage content increased in the diet, backfat thickness decreased (2012). 
The elevated backfat thickness on HA_Grain carcasses may be attributed to scheduling conflicts 
with the abattoir that harvested the steers. If these steers were harvested two weeks sooner, we 
speculate that the backfat thickness recorded for HA_Grain steers would be comparable to that of 
the other finishing systems. 
HA_Grain steers had greater YG than either group of steers grain finished at moderate 
elevation, but not HA_Grass steers. Contrary to the results from this study, Bennet et al. (1995), 
Camfield et al. (1999), and Cox et al. (2006) reported that pasture-fed steers exhibited lower YG 
than grain fed steers. A study by Garmyn et al. (2010) reported that grain finished heifers have 
greater YG than grass finished heifers. However, Bennett et al. (1995) reported no differences in 
yield grade between grass finished and grain finished steers. The finding that HA_Grass steers 
did not have lower YG than all grain finished groups on this study does not agree with results 
from previous studies and could indicate that high altitude impacts carcass quality. While little 
research has been conducted to evaluate the impact of altitude on carcass characteristics, a study 
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by Panjono et al. (2008) reported that altitude impacted meat color in Hanwoo cattle but saw no 
difference in YG between lowland and highland raised cattle. 
 HA_Grain steers had greater KPH than all other finishing systems.  Cox et al. (2006) 
reported similar KPH between grass and grain finished steers. However, Garmyn et al. (2010) 
found that heifers finished on a concentrate grain-based diet had greater KPH than heifers 
finished on pasture. The fundamental difference between the studies by Cox et al. (2006) and 
Garmyn et al. (2010) was the gender within each study. This is relevant because research has 
established that there were differences in fat deposition between steers and heifers (Berg et al., 
1979). Due to the two-week delay in harvesting HA_Grain steers, it is likely that KPH was 
increased during this time. Further studies should be conducted to validate whether HA_Grain 
steers would have increased KPH if harvested sooner. However, based on these results, it does 
not appear that altitude affected KPH. 
 HA_Grass steers had smaller REA than HA_Grain and Ext_Mod_Stocker, but not 
Norm_Mod_Stocker steers. These results agree with the report from Pordomingo et al. (2012), 
who suggested that grass finished cattle had smaller REA than steers finished on grain. However, 
Pordomingo et al. (2012) did not evaluate changes in altitude in addition to comparison of 
finishing strategies. Panjono et al. (2008) reported no difference in REA between lowland and 
highland finished cattle, but this study was conducted with Hanwoo cattle, whereas this 
dissertation only involved Angus cattle. 
Ext_Mod_Stocker steers had lower MARB than Norm_Mod_Stocker steers, but not 
steers finished at high altitude. While HA_Grain steers produced the heaviest carcasses with the 
greatest amount of backfat, they did not differ from the other finishing systems when comparing 
MARB. Muir (1998) reported inconsistencies across multiple experiments evaluating HCW, 
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backfat, and MARB in multiple breeds of cattle. Results compiled suggested that the differences 
in marbling following grain finishing may be attributed to how cattle deposit fat and put on 
weight more than feed type. Therefore, factors such as breed, genetics, and how these measures 
were recorded could account for variability in MARB records. Further, Muir (1998) 
recommended using caution when comparing meat quality traits associated with fatness due 
inconsistent relationships between marbling and other fatness traits in experiments.  
 Results from this study were concordant with previous literature, which reported that 
quality grade was greater in grain finished beef than pasture raised beef (Bennet et al., 1995; 
Camfield et al., 1999; Cox et al., 2006). HA_Grass steers had the poorest quality grades of all 
finishing systems, while Norm_Mod_Stocker steers had the best quality grades. 
Ext_Mod_Stocker steers had poorer quality grades than HA_Grain steers, indicating that altitude 
did not impact quality grade. This coincides with findings from Panjono et al. (2008) which 
concluded that differences did not exist between lowland and highland finished Hanwoo cattle. 
However, little research has been conducted to evaluate the impact of altitude on quality grade in 
Angus cattle.  
In summary, increased PAP was observed at ranches at both high and moderate altitudes, 
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EXAMINATOIN OF ARTERIAL AND VENOUS BLOOD PARAMETERS ACROSS 
ALTITUDES AND FINISHING STRATEGIES THROUGHOUT THE STOCKER AND 
FINISHING PHASES OF PRODUCTION 
6.1 Introduction 
 Cattle managed at altitudes greater than 1,500 m are exposed to reduced barometric 
pressures and reduced oxygen availability, resulting in pulmonary hypertension (PH). Select 
cattle that have been maintained at high altitude undergo pulmonary vascular remodeling as a 
result of PH and develop a condition known as High Mountain Disease (HMD). High Mountain 
Disease impacts 3% to 5% of cattle native to high altitude regions (Holt and Callan, 2007). 
However, incidence in cattle from altitudes less than 1,500 m that are relocated to high altitude 
production settings can be as great as 10% to 40% (Grover et al., 1963; Will et al., 1970). The 
best indicator of an animal’s risk of developing HMD is measuring mean pulmonary arterial 
pressure (PAP) at 1 year of age, which has become a common practice for many ranchers with 
cattle at high altitudes (Holt and Callan, 2007). 
 A condition similar to HMD has been discovered in cattle in feedlots. These cattle were 
never exposed to high altitude production settings, indicating that PH may have a greater impact 
on the beef industry than previously estimated. This condition, known as Feedlot Heart Disease 
(FHD), while similar to HMD when evaluating symptoms, is a separate manifestation of PH 
(Jensen et al., 1976; Pringle et al., 1991; Malherbe et al., 2012; Neary et al., 2016; Krafsur et al., 
2017; Krafsur et al., 2019). The rapid weight gain associated with finishing results in the 
development of PH in cattle that have been in feedlots for 19 weeks or more (Neary et al., 2016). 
This condition, like HMD, can result in congestive heart failure prior to harvest. The annual 
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death losses due to FHD are estimated to impact 1.08 out of 1,000 cattle as of 2012, following a 
trend of increased incidence since 1976 (Jensen et al., 1976; Neary et al., 2016). Despite 
quantifying the increased incidence of FHD, management strategies to detect cattle experiencing 
the condition and administer treatment for the condition have yet to be characterized. It is 
speculated that, like HMD, PAP would be a strong indicator of risk of developing FHD since 
both derive from PH in susceptible cattle. However, in a feedlot system, PAP testing cattle is not 
only costly but labor-intensive due to the immense concentration of cattle (T.N. Holt, personal 
communication).  
 In addition to PAP, blood parameters such as blood gases and electrolytes have been 
utilized in human medicine for diagnostic purposes (Singh et al., 2013). However, these 
parameters have not been tested widely in cattle exposed to hypoxic conditions that may result in 
development of HMD or FHD in susceptible cattle. A study in 2013 reported arterial blood gas 
data in calves up to six months of age as well as cows 24 to 27 months of age (Neary et al., 
2013). Results from that study indicated that cattle were developing respiratory alkalosis. Despite 
these findings, PAP remains the best indicator of an animal’s risk of developing either HMD or 
FHD. Additional research evaluating blood gas parameters and their utilization in distinguishing 
cattle at the greatest risk of developing HMD or FHD needs to be conducted in order to 
determine if these parameters can enhance the way veterinarians approach these two conditions.  
 In addition to understanding blood parameters to enhance risk assessment of cattle 
exposed to hypoxic conditions that may challenge their cardiopulmonary health, it is unknown 
whether altitude, rapid weight gain, or a combination of both pose a greater impact on 
susceptible cattle. Therefore, the objective of this study was to evaluate the impact of altitude 
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and finishing system on arterial and venous blood parameters throughout the stocker and 
finishing phases of beef production.   
6.2 Materials and Methods 
6.2.1 Experimental Design 
 Steers in the study population were selected, allocated, and managed according to the 
experimental design outlined in chapter III of this Dissertation. At each sampling period, arterial 
and venous blood samples were collected in a 2mL syringe. Arterial blood samples were 
collected from an auricular artery in the right ear. Venous blood samples were collected from the 
pulmonary artery. Arterial and venous blood gases and electrolytes were measured chute-side 
immediately using the Abaxis i-Stat 1 (Abaxis Inc., Union City, CA) blood gas analyzer for 
veterinary diagnostics. Arterial blood gases were measured using CG8+ cartridges, and venous 
blood gases were measured using CG4+ cartridges for the i-Stat 1 analyzer. These two cartridge 
varieties measured 21 blood chemistry, gases, and electrolytes (Table 6.1).  
Table 6.1 Blood parameters measured from arterial and venous blood samples for each steer 
presented as an abbreviation and corresponding definition.  
Arterial blood parameters 
(CG8+ cartridge) 
Venous blood parameters 
(CG4+ cartridge) 
PaCO2- arterial partial pressure of CO2 PvCO2- venous partial pressure of CO2 
pH pH 
TaCO2- total CO2 in arterial blood TvCO2- total CO2 in venous blood 
saO2- arterial oxyhemoglobin saturation svO2- venous oxyhemoglobin saturation 
PaO2- arterial partial pressure of O2 PvO2- venous partial pressure of O2 
HCO3- blood bicarbonate HCO3- blood bicarbonate 
BE- base excess BE- base excess 
Hct- hematocrit Lac- blood L-lactate 
Hgb- hemoglobin 
 
Na- sodium concentration 
 
iCa- ionized calcium concentration 
 
K- potassium concentration  
 




In addition to the arterial blood gas parameters above, partial pressure of oxygen in the 
alveoli was calculated (Equation 6.1). Then the alveolar-arterial oxygen pressure gradient was 
calculated (Equation 6.2) in order to determine if a ventilation-perfusion mismatch reduced 
concentrations of oxygen in arterial blood (Neary et al., 2013; T.N. Holt, personal 
communication). 
Equation 6.5 Partial pressure of oxygen in the alveoli (mmHg), where FiO2 is the fraction of 
inspired air (0.21),  BP is barometric pressure (mmHg),  pH2O is the water vapor pressure at 
body temperature (52.4 mmHg at 39C), PaCO2 (mmHg), and RQ is the respiratory quotient 
(0.9) (Tim Holt, personal communication).  
PAO2 = FiO2 (BP – pH2O) – (PaCO2/RQ) 
 
Equation 6.6 Alveolar-arterial oxygen pressure gradient (mmHg), which is the differential 
between the partial pressure of oxygen in the alveoli (PAO2; mmHg) and the partial pressure of 
oxygen in the arterial blood (PaO2; mmHg)  
A-a O2 pressure gradient = PAO2 – PaO2 
6.2.2 Statistical Analysis 
Arterial Samples 
Model selection was performed using the dredge command multi-model inference 
(MuMIN) package in R statistical software (Bartoń, 2013; R core team, 2013). This function fit 
all possible models, including sampling period (Period), finishing system, and the interaction 
between finishing system and period as possible fixed effects. Period corresponded to the time 
that blood gas measurements were collected for each finishing system and resulted from the 
recoding of the number of days the steers were on study prior to harvest. This recoding from 
days on study to Period accounted for different dates of sampling for the same time point since 
steers were at multiple locations (Figure 6.1). Further, some finishing systems took longer to 
reach the average weight suitable for harvest, so coding the variable as Period allowed for 
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comparisons of those pre-harvest time points. Period 0 was the initial time point in which steers 
were selected for the study based on their PAP measurements, but no blood parameters were 
collected on this date. Period 1 corresponded to the first sampling recorded after steers were 
assigned to a finishing system, and Period 4 corresponded to the final sampling within two weeks 
of harvest. A random effect of ID nested within finishing system was also fit for this model to 
account for variation across steers within the same finishing system, but it was not detected as 
significant during model selection. The best model for the analysis was selected based on the 
lowest corrected Akaike information criterion estimate (AICc). The final model included 
finishing system and Period as fixed effects. 
 
Figure 6.1 An overview of the experimental design including sampling dates. Note that Period 3 







 Not all steers were sampled at every time point. Some steers had poor sample quality on 
the day of collection, which resulted in missing or unusable data. Further, one steer died between 
sampling periods 3 and 4. The number of steers sampled and included for analysis for each 
sampling period has been summarized in Table 6.2. 
Table 6.2 A summary of the number of animals included in analysis for each finishing system by 
sampling period, where nT represents the total number of steers prior to that sampling period, and 
ne represents the number of steers excluded for a given sampling period for each finishing 
system. The “Reason” column for each period lists why a steer was excluded from the analysis 
for that time point. 
 Period 1 Period 2 Period 3 Period 4 
Finishing System nT ne Reason nT ne Reason nT ne Reason nT ne Reason 




10 0 -- 10 0 -- 
Grain_HA 10 0 -- 10 0 -- 10 0 -- 10 0 -- 




10 0 -- 
Norm_Mod_Stocker 10 0 -- 10 0 -- 10 0 -- 10 1 Died* 
* The steer death was unrelated to this study according to the results of a necropsy performed by a board-certified 
pathologist. 
 
The final model for each blood parameter was fit using the linear mixed effects (lme) 
function from the linear mixed effects using Eigen and S4 (lme4) package in R (Bates et al., 
2015). Multiple covariance structures were evaluated for each model in order to determine the 
best covariance structure for the data. The first model was fit with a compound symmetry 
covariance structure, the second model was fit with unstructured covariances, and the third 
model was fit with an autoregressive covariance structure. The best covariance structure was 
determined based on which of the three models had the lowest AICc. Based on this criterion, 
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covariances were fit as unstructured. Pairwise estimated marginal means (emmeans) analyses 
were performed to compare each blood parameter across Periods, between finishing systems, or 
across finishing system for each Period, depending on the variables included in the most suitable 
model for each dependent variable (Searle et al., 1980). Statistical significance was accepted 
when probability greater than F was < 0.05. 
Venous Samples 
The statistical methods for the venous blood parameters were the same as those used for 
the arterial blood gases. However, the periods for which data was analyzed differed. Venous 
blood parameter data was lost for periods 1 and 3 due to a software update of the iStat1 
equipment. However, since periods 2 and 4 accounted for the end of the stocker and finishing 
phases respectively, the data was still informative in addressing the objectives of this research. 
Therefore, the same statistical methods as the arterial blood parameter analysis were followed for 
periods 2 and 4 of the venous data.  
6.3 Results 
6.3.1 Arterial Blood Parameters 
 Automated model selection revealed that the most relevant models to describe each blood 
parameter (Table 6.3). The interaction of finishing system and period was included in the model 
equations for Hb, Hct, HCO3, tCO2, pO2, BE, Na, iCa, and Glu. Finishing system and period 
were both included in the model for sO2, but not the interaction between the two fixed effects. 
Finishing system was the only effect included in the models for pH and pCO2. However, period 
but not finishing system was informative when estimating K.  
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Table 6.3 The most appropriate models for each arterial blood parameter based on the lowest 











Hb X X X 
Hct X X X 
HCO3 X X X 
TaCO2 X X X 
PaCO2 X 
  
PaO2 X X X 
saO2 X X 
 
BE X X X 
Na X X X 





Glu X X X 
  
The Ext_Mod_Stocker steers had a greater (P=0.0041) arterial pH than the 
Norm_Mod_Stocker steers, but not Grass_HA or Grain_HA steers (Table 6.4). Grass_HA and 
Grain_HA steers had arterial pH measurements that were intermediate to the 
Norm_Mod_Stocker and Ext_Mod_Stocker finishing systems, having similar pH measurements 









Table 6.4 Arterial pH changes by finishing system regardless of sampling period expressed as 
mean + standard error. 
Finishing System Arterial pH 
Grass_HA 7.531 + 0.009AB 
Grain_HA 7.541 + 0.009AB 
Ext_Mod_Stocker 7.555 + 0.010A 
Norm_Mod_Stocker 7.521 + 0.009B 
  
Arterial hemoglobin measures fluctuated throughout the four sampling periods (Table 
6.5). Norm_Mod_Stocker steers had a lower (P<0.0239) arterial hemoglobin in period 1 than all 
other finishing systems at this time point. However, all steers, regardless of finishing strategy, 
had similar hemoglobin levels for sampling period 2. Ext_Mod_Stocker steers had lower 
(P<0.0185) hemoglobin levels in period 3 than Grass_HA and Grain_HA steers but not 
Norm_Mod_Stocker steers, which were intermediate between the high-altitude finishing systems 
and the Ext_Mod_Stocker steers. Ext_Mod_Stocker steers had lower (P<0.0205) arterial 
hemoglobin measures in period 4 than all other finishing systems. Norm_Mod_Stocker steers 
had arterial hemoglobin levels that were greater (P=0.0205) than the Ext_Mod_Stocker steers 
and similar to the Grass_HA steers in period 4. Grain_HA steers had greater (P<0.0063) period 4 
arterial Hb levels than Ext_Mod_Stocker steers and Norm_Mod_Stocker steers. Arterial Hb in 
Grass_HA steers for period 4 was similar to that of Norm_Mod_Stocker and Grain_HA steers, 





Table 6.5 Change in arterial hemoglobin over time by finishing system expressed as mean + 
standard error.  
 Arterial Hb  
(g/L) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 9.210 + 0.305A 9.440 + 0.322A 9.530 + 0.305A 10.980 + 0.305AB 
Grain_HA 9.970 + 0.305A 9.750 + 0.305A 9.750 + 0.305A 11.960 + 0.305A 
Ext_Mod_Stocker 9.920 + 0.305A 9.620 + 0.322A 8.250 + 0.305B 9.190 + 0.305C 
Norm_Mod_Stocker 7.970 + 0.305B 9.550 + 0.305A 8.800 + 0.305AB 10.490 + 0.322B 
 
 In period 1, Norm_Mod_Stocker steers had a lower (P< 0.014) Hct than all other 
finishing systems on study (Table 6.6). All finishing systems had similar Hct measurements in 
period 2. Grain_HA and Grass_HA steers had similar Hct measures in period 3 that were larger 
(P<0.022) than those of Ext_Mod_Stocker steers, but not Norm_Mod_Stocker steers. 
Norm_Mod_Stocker steers had similar Hct measures to all other finishing systems in period 3. 
Ext_Mod_Stocker steers had the lowest (P<0.018) period 4 Hct of all finishing systems. 
Norm_Mod_Stocker steers had a larger (P=0.018) Hct than Ext_Mod_Stocker steers, but a 
smaller (P=0.007) Hct than Grain_HA steers. Grass_HA steers had a period 4 Hct greater 
(P=0.0003) than the Ext_Mod_Stocker steers, but similar to the Grain_HA and 








Table 6.6 Change in arterial hematocrit over time by finishing system expressed as mean + 
standard error. 
 Arterial Hct 
(%) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 27.400 + 0.902A 27.800 + 0.951A 28.000 + 0.902A 32.300 + 0.902AB 
Grain_HA 29.300 + 0.902A 28.700 + 0.902A 28.700 + 0.902A 35.200 + 0.902A 
Ext_Mod_Stocker 29.200 + 0.902A 28.300 + 0.951A 24.300 + 0.902B 27.000 + 0.902C 
Norm_Mod_Stocker 23.500 + 0.902B 28.100 + 0.902A 25.900 + 0.902AB 30.900 + 0.951B 
 
Arterial HCO3 levels differed between finishing systems over time (Table 6.7). In periods 
1and 2, Norm_Mod_Stocker steers had lower arterial HCO3 levels than all other steers on study 
(P<0.0006). Grass_HA, Grain_HA, and Ext_Mod_Stocker steers had similar arterial HCO3 
levels for periods 1 and 2. All steers had similar bicarbonate measures in periods 3 and 4.  
Table 6.7 Change in arterial bicarbonate over time by finishing system expressed as mean + 
standard error. 
 Arterial HCO3 
(meq/L) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 27.400 + 0.949A 32.300 + 1.000A 27.300 + 0.949A 28.800 + 0.949A 
Grain_HA 28.900 + 0.949A 32.900 + 0.949A 28.100 + 0.949A 27.600 + 0.949A 
Ext_Mod_Stocker 29.400 + 0.949A 33.100 + 1.000A 27.500 + 0.949A 25.700 + 0.949A 
Norm_Mod_Stocker 23.500 + 0.949B 25.100 + 0.949B 26.400 + 0.949A 26.500 + 1.000A 
 
Total arterial CO2 differed between finishing systems over time (Table 6.8). 
Norm_Mod_Stocker steers had a reduced TaCO2 compared to all other finishing systems 
(P<0.0253) in periods 1 and 2, which had similar TaCO2 measurements to one another. 
Grain_HA steers had a greater period 3 TaCO2 than Norm_Mod_Stocker steers (P=0.038) but not 
Grass_HA or Ext_Mod_Stocker finishing systems. Further, Grass_HA and Ext_Mod_Stocker 
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steers had TaCO2 levels similar to the Norm_Mod_Stocker steers in period 3. Grass_HA steers 
had a greater (P=0.046) TaCO2 than Ext_Mod_Stocker steers for period 4. Grain_HA and 
Norm_Mod_Stocker had TaCO2 levels similar to both Grass_HA and Ext_Mod_Stocker steers.  
Table 6.8 Changes in total carbon dioxide in arterial blood by finishing system over time 
expressed as mean + standard error.  
 TaCO2  
(mmHg) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 28.400 + 0.966A 33.300 + 1.018A 29.200 + 0.966AB 30.000 + 0.966A 
Grain_HA 29.000 + 0.966A 33.700 + 0.966A 31.000 + 0.966A 28.800 + 0.966AB 
Ext_Mod_Stocker 30.400 + 0.966A 33.900 + 1.018A 28.500 + 0.966AB 26.400 + 0.966B 
Norm_Mod_Stocker 24.500 + 0.966B 26.100 + 0.966B 27.300 + 0.966B 27.600 + 1.018AB 
 
Arterial PCO2 differed between finishing systems at high altitude and finishing systems at 
moderate altitude (Table 6.9). Grass_HA and Grain_HA steers had similar PaCO2 measurements. 
Ext_Mod_Stocker and Norm_Mod_Stocker also had similar PaCO2, regardless of sampling 
period. The high-altitude finishing groups had greater PaCO2 than those finished at moderate 
altitudes (P<0.015). 
Table 6.9 Changes in partial pressure of carbon dioxide of arterial blood by finishing system 




Grass_HA 34.700 + 0.514A 
Grain_HA 34.600 + 0.508A 
Ext_Mod_Stocker 32.500 + 0.514B 





 Grass_HA and Grain_HA steers had lower (P<0.0197) PaO2 measurements in period 1 
than Norm_Mod_Stocker steers (Table 6.10). Grain_HA steers had PaO2 measures in period 2 
less (P=0.0114) than Norm_Mod_Stocker steers. Ext_Mod_Stocker steers had a PaO2 
measurement that was intermediate between the aforementioned groups in periods 1 and 2. In 
period 3, Ext_Mod_Stocker steers had greater PaO2 than either Grass_HA or Grain_HA finishing 
groups (P<0.0059). Norm_Mod_Stocker steers had greater PaO2 than Grass_HA steers in period 
3 (P=0.0047), but not Grain_HA or Ext_Mod_Stocker steers. Grain_HA and Grass_HA steers 
had similar PaO2 in period 4 as did Ext_Mod_Stocker and Norm_Mod_Stocker steers. However, 
Ext_Mod_Stocker and Norm_Mod_Stocker steers had greater PaO2 in period 4 than Grass_HA 
and Grain_HA steers (P<0.0018). 
Table 6.10 Changes in arterial partial pressure of O2 over time by finishing system expressed as 
mean + standard error. 
 PaCO2 
(mmHg) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 50.10 + 3.05A 56.90 + 3.22AB 50.10 + 3.05A 54.50 + 3.05A 
Grain_HA 43.60 + 3.05A 53.50 + 3.05A 55.60 + 3.05AB 56.00 + 3.05A 
Ext_Mod_Stocker 54.40 + 3.05AB 55.60 + 3.22AB 70.00 + 3.05C 71.90 + 3.05B 
Norm_Mod_Stocker 62.80 + 3.05B 67.00 + 3.05B 64.80 + 3.05BC 78.10 + 3.22B 
 
 Arterial sO2 differed between finishing systems (Table 6.11). Grass_HA and Grain_HA 
steers had similar saO2 levels for periods 1 through 4. Ext_Mod_Stocker and 
Norm_Mod_Stocker steers had similar saO2 levels for all four periods. However, 
Ext_Mod_Stocker and Norm_Mod_Stocker steers had greater saO2 than Grass_HA and 




Table 6.11 Changes in Arterial saturated oxygen over time by finishing system expressed as 
mean + standard error. 
 SaO2 
(mmHg) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 84.80 + 1.39A 90.50 + 1.43A 89.10 + 1.39A 90.70 + 1.40A 
Grain_HA 84.60 + 1.39A 90.30 + 1.40A 88.90 + 1.39A 90.50 + 1.39A 
Ext_Mod_Stocker 90.00 + 1.39B 95.70 + 1.43B 94.30 + 1.39B 95.90 + 1.40B 
Norm_Mod_Stocker 90.50 + 1.39B 96.10 + 1.40B 94.70 + 1.39B 96.40 + 1.42B 
 
 Mean alveolar-arterial oxygen pressure gradient differed by period (Table 6.12). The 
period 4 oxygen pressure gradient measurements were less (P<0.0398) than those of periods 1 
and 2. The mean alveolar-arterial oxygen pressure gradient in period 3 was similar to the 
measurements from all other sampling periods. 
Table 6.12 Mean alveolar-arterial oxygen pressure gradient by period expressed as mean + 
standard error. 
Period 
A-a O2 Pressure Gradient 
(mmHg) 
1 24.10 + 1.37A 
2 20.60 + 1.41A 
3 19.80 + 1.37AB 
4 15.30 + 1.39B 
 
 Arterial BE changed over time for each finishing system (Table 6.13). 
Norm_Mod_Stocker steers had a lower (P<0.0001) BE than Grass_HA, Grain_HA, and 
Ext_Mod_Stocker steers for periods 1 and 2. In periods 3 and 4, all finishing systems had similar 
BE measurements.  
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Table 6.13 Changes in arterial base excess over time for each finishing system expressed as 
mean + standard error.  
 Arterial BE 
(meq/L) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 4.20 + 1.09A 10.44 + 1.15A 4.40 + 1.09A 6.10 + 1.09A 
Grain_HA 6.20 + 1.09A 11.10 + 1.09A 6.10 + 1.09A 4.40 + 1.09A 
Ext_Mod_Stocker 6.80 + 1.09A 11.44 + 1.15A 5.20 + 1.09A 3.10 + 1.09A 
Norm_Mod_Stocker 0.30 + 1.09B 2.30 + 1.09B 3.80 + 1.09A 3.67 + 1.15A 
 
 Norm_Mod_Stocker steers had greater (P<0.0239) arterial Na levels than all other 
finishing systems for periods 1 and 2 (Table 6.14). Norm_Mod_Stocker and Ext_Mod_Stocker 
steers had similar period 3 Na levels. Norm_Mod_Stocker, Grass_HA, and Grain_HA steers had 
similar period 3 Na levels. However, Ext_Mod_Stocker steers had greater (P<0.0172) arterial Na 
than Grass_HA and Grain_HA steers. In period 4, Grass_HA steers had the largest (P<0.0001) 
Na measure of all finishing systems. Grain_HA steers had a period 4 Na measure that was less 
(P<0.0001) than the Grass_HA steers, but greater (P<0.0002) than the Ext_Mod_Stocker and 
Norm_Mod_Stocker finishing systems. 
Table 6.14 Change in arterial sodium over time by finishing system expressed as mean + 
standard error. 
 Arterial Na 
(mmol/L) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 137 + 0.615A 138 + 0.648A 137 + 0.615A 152 + 0.615A 
Grain_HA 138 + 0.615A 139 + 0.615A 138 + 0.615A 141 + 0.615B 
Ext_Mod_Stocker 137 + 0.615A 138 + 0.648A 141 + 0.615B 136 + 0.615C 




 Arterial ionic calcium measures were similar among finishing systems for periods 1 
through 3 (Table 6.15). In period 4, Ext_Mod_Stocker steers had an iCa level that was less than 
that of the Grain_HA steers (P=0.0083), but not Grass_HA or Norm_Mod_Stocker steers. 
Grain_HA steers had an iCa level in period 4 that was similar to that of the Grass_HA and 
Norm_Mod_Stocker finishing systems. Similarly, the Norm_Mod_Stocker and Grass_HA 
finishing systems had similar iCa measures in period 4.  
Table 6.15 Changes in arterial ionic calcium over time by finishing system expressed as mean + 
standard error. 
 Arterial iCa 
(mmol/L) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 1.081 + 0.030A 1.057 + 0.031A 1.086 + 0.030A 1.125 + 0.030AB 
Grain_HA 1.107 + 0.030A 0.986 + 0.030A 1.024 + 0.030A 1.155 + 0.030AC 
Ext_Mod_Stocker 1.125 + 0.030A 1.022 + 0.031A 1.030 + 0.030A 1.020 + 0.030B 
Norm_Mod_Stocker 1.033 + 0.030A 1.032 + 0.030A 1.011 + 0.030A 1.114 + 0.031ABC 
 
 Arterial Glu differed between finishing systems over the four sampling periods (Table 
6.16). Glucose levels in period 1 differed such that Norm_Mod_Stocker steers had greater 
(P=0.0194) Glu levels than Grass_HA steers, but not Grain_HA or Ext_Mod_Stocker steers, 
which were intermediate between the two groups. All finishing systems had similar Glu 
measures for period 2. Ext_Mod_Stocker steers had a greater (P<0.0451)  Glu level than 
Grass_HA and Norm_Mod_Stocker steers in period 3. Grain_HA steers were similar to all other 
finishing systems when comparing Glu in period 3. In period 4, Grain_HA, Ext_Mod_Stocker, 
and Norm_Mod_Stocker steers had similar Glu levels, which were larger (P<0.0001) than the 
Glu measure recorded for the Grass_HA finishing system. 
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Table 6.16 Changes in arterial glucose over time by finishing system expressed as mean + 
standard error. 
 Arterial Glu 
(mmol/L) 
Finishing System Period 1 Period 2 Period 3 Period 4 
Grass_HA 79.40 + 2.44A 75.90 + 2.57A 77.90 + 2.44A 70.90 + 2.44A 
Grain_HA 85.10 + 2.44AB 74.50 + 2.44A 81.20 + 2.44AB 94.90 + 2.44B 
Ext_Mod_Stocker 82.00 + 2.44AB 74.30 + 2.57A 90.00 + 2.44B 89.50 + 2.44B 
Norm_Mod_Stocker 89.60 + 2.44B 80.80 + 2.44A 80.90 + 2.44A 91.10 + 2.57B 
  
 Arterial potassium levels were similar across finishing systems, but differed by period 
(Table 6.17). In periods 1, 3, and 4 steers had similar potassium levels. However, in period 2, 
steers had lower (P<0.0019) potassium levels than in periods 1, 3, and 4.  
Table 6.17 Changes in arterial potassium by period expressed as mean + standard error. 
Period Mean Arterial K 
1 3.530 + 0.064A 
2 3.190 + 0.066B 
3 3.620 + 0.064A 
4 3.660 + 0.065A 
6.3.2 Venous Blood Parameters 
Automated model selection revealed the most relevant models to describe each venous 
blood parameter (Table 6.18). The interaction of finishing system and period was included in the 
model equations for pH, HCO3, TvCO2, BE, and Lac. Period was informative in estimated PvO2, 
but not other effects that were tested in automated model selection. Further, PvCO2 and svO2 had 
no significant effects in the best model according to corrected AIC. Despite no significant 
effects, a model was fit including period as the only fixed effect in order to depict that there were 
no differences between periods.  
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pH X X X 
HCO3 X X X 
TVCO2 X X X 
PVCO2 






   
BE X X X 
Lac X X X 
 
 Venous pH differed across sampling periods and finishing systems (Table 6.19). 
Norm_Mod_Stocker steers had a lower (P=0.0022) pH than all other steers in period 2. 
However, in period 4, all steers had similar pH measurements. 
Table 6.19 Mean venous pH by finishing system and sampling period. All values have been 
expressed as the mean + standard error. 
 Mean Venous pH 
Finishing System Period 2  Period 4  
Grass_HA 7.545 + 0.013A 7.471 + 0.013A 
Grain_HA 7.548 + 0.013A 7.487 + 0.013A 
Ext_Mod_Stocker 7.528 + 0.013A 7.463 + 0.013A 
Norm_Mod_Stocker 7.456 + 0.014B 7.475 + 0.013A 
 
Bicarbonate levels in the venous blood differed between finishing systems for periods 2 
and 4 (Table 6.20). Norm_Mod_Stocker steers had lower (P<0.0001) venous HCO3 than all 
other steers in period 2. In period 4, Norm_Mod_Stocker and Ext_Mod_Stocker steers had 
similar HCO3 concentrations that were lower (P< 0.03) than those of Grain_HA steers but not 
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Grass_HA steers. Grass_HA steers had HCO3 concentrations that were comparable to all other 
finishing systems.  
Table 6.20 Venous bicarbonate by finishing system over time expressed as mean + standard 
error. 
 Venous HCO3 
(meq/L) 
Finishing System Period 2 Period 4 
Grass_HA 14.10 + 0.71A 7.20 + 0.71AB 
Grain_HA 13.10 + 0.71A 9.20 + 0.71B 
Ext_Mod_Stocker 12.78 + 0.74A 5.67 + 0.74A 
Norm_Mod_Stocker 4.33 + 0.74B 6.33 + 0.74A 
 
 Total venous CO2 differed between finishing systems for each sampling period (Table 
6.21). Levels of TvCO2 mirrored the results for venous HCO3 such that Norm_Mod_Stocker 
steers had lower (P<0.0001) TvCO2 than all other steers in period 2. In period 4, 
Norm_Mod_Stocker and Ext_Mod_Stocker steers had TvCO2 levels similar to one another and to  
Grass_HA steers, but less (P<0.0311) than Grain_HA steers. Further, Grass_HA steers and 
Grain_HA steers had TvCO2 measurements that were similar to one another.  
Table 6.21 Total CO2 in venous blood for each finishing system by period. Measures have been 
expressed as mean + standard error. 
 TvCO2 
(mmHg) 
Finishing System Period 2 Period 4 
Grass_HA 37.9 + 0.65A 32.1 + 0.65AB 
Grain_HA 36.8 + 0.65A 33.9 + 0.65B 
Ext_Mod_Stocker 37.0 + 0.69A 30.7 + 0.69A 





 Partial pressure of CO2 in the venous blood did not differ between finishing systems or 
sampling periods (Table 6.22). All PvCO2 measures were similar to one another. 





Period 2 41.7 + 0.69A 
Period 4 42.0 + 0.69A 
 
 Partial pressures of O2 in the venous blood differed between sampling periods but not 
finishing systems (Table 6.23). There was a greater (P=0.0387) mean PvO2 recorded for steers in 
period 4 than in period 2. 





Period 2 29.9 + 0.51A 
Period 4 31.5 + 0.51B 
  
Oxyhemoglobin saturation in the venous blood did not differ by finishing system or 
sampling period (Table 6.24). The svO2 levels remained constant for periods 2 and 4. 
Table 6.24 Oxyhemoglobin saturation in venous blood samples over the two sampling periods 




Period 2 63.9 + 1.39A 






 Base excess measures in the venous blood differed between finishing systems for the two 
sampling periods (Table 6.25). In period 2, Norm_Mod_Stocker steers had a BE measure less 
(P<0.0001) than that of all other finishing systems. Ext_Mod_Stocker and Norm_Mod_Stocker 
steers had similar period 4 BE levels to each other as well as to steers in the Grass_HA finishing 
system. Grain_HA steers had a greater (P<0.0332) BE than Norm_Mod_Stocker and 
Ext_Mod_Stocker steers, but not Grass_HA steers.  
Table 6.25 Venous base excess for each finishing system over time expressed as mean + standard 
error. 
 
Venous Base Excess 
(meq/L) 
Finishing System Period 2  Period 4 
Grass_HA 14.10 + 0.71A 7.20 + 0.71AB 
Grain_HA 13.10 + 0.71A 9.20 + 0.71B 
Ext_Mod_Stocker 12.78 + 0.74A 5.67 + 0.74A 
Norm_Mod_Stocker 4.33 + 0.74B 6.33 + 0.74A 
  
L-lactate concentrations in venous blood samples differed between finishing systems by 
period (Table 6.26). All finishing systems had comparable lactate concentrations in period 2. 
However, in period 4, Grain_HA steers had a greater (P=0.0371) venous lactate concentration 
than Grass_HA steers but not Norm_Mod_Stocker or Ext_Mod_Stocker steers. 
Norm_Mod_Stocker and Ext_Mod_Stocker steers had similar period 4 Lac levels to one another 
and were similar to both the Grass_HA and Grain_HA finishing systems. 
 
 
Table 6.26 Venous L-lactate concentrations for each finishing system over the two sampling 
periods expressed as mean + standard error. 




Finishing System Period 2  Period 4  
Grass_HA 1.02 + 0.49A 1.59 + 0.49A 
Grain_HA 1.29 + 0.49A 3.49 + 0.49B 
Ext_Mod_Stocker 2.44 + 0.52A 2.51 + 0.52AB 
Norm_Mod_Stocker 2.67 + 0.52A 2.11 + 0.52AB 
 
6.4 Discussion 
6.4.1 Arterial Hematology 
pH 
Arterial pH was affected by finishing system, but not sampling period. A normal adult 
bovine arterial pH should be between 7.35 and 7.45. Cattle with arterial pH measures less than 
7.35 are considered acidotic. Conversely, cattle with an arterial pH greater than 7.45 are 
considered alkalotic (Smith et al., 2014; T.N. Holt, personal communication). Based on these 
parameters, all finishing groups were experiencing alkalosis. In order to determine the likely 
cause of alkalosis, arterial levels of PCO2 and HCO3 should be evaluated in conjunction with the 
pH estimates (T.N. Holt, personal communication). Arterial PCO2 levels for all finishing systems 
were less than 35 mmHg, indicative of respiratory alkalosis. Based on the fluctuation of HCO3 
levels throughout the four sampling periods, it appears that some steers might have been 
experiencing partially compensated respiratory alkalosis. This was evident by the slight decrease 
in HCO3 over time in an effort to decrease pH in the presence of low PCO2 levels (Prasse and 
Sexton, 1972; Patel et al., 2019; C.W. Miller, personal communication; T.N. Holt, personal 
communication). An alternative cause of alkalosis is metabolic alkalosis, but based on the low 
levels of PCO2 measured in each finishing system, it was determined that respiratory alkalosis 
was the likely cause of alkalosis in these steers (T.N. Holt, personal communication). The arterial 
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pH estimates for steers on this study were similar to those by Neary et al. (2016), who reported 
an average pH of 7.47 + 0.13 in cows 24 to 27 months of age at high altitude and concluded that 
cows were experiencing respiratory alkalosis. 
Hemoglobin 
Hemoglobin levels in arterial blood changed over time according to finishing system. 
However, despite the high-altitude exposure of the Grass_HA, Grain_HA, and Ext_Mod_Stocker 
finishing systems, hemoglobin levels were still within the normal range of 8-15 g/dL for cattle 
(Fielder, 2015a). In period 1, Norm_Mod_Stocker steers had a lower hemoglobin level than all 
other steers on study, and these steers were the only ones at moderate altitude at this time. The 
larger period 1 hemoglobin concentrations for the three finishing systems that were at the BIC 
were likely a physiologic response to increase arterial oxygen carrying capacity in the presence 
of reduced atmospheric oxygen at high altitude. However, this increase in hemoglobin also 
results in an increased binding affinity of oxygen to hemoglobin, which results in reduced 
oxygen uptake by systemic tissues (Storz, 2016; Patel et al., 2019; T.N. Holt, personal 
communication).   
In period 2, there were no differences in hemoglobin concentrations across the four 
finishing systems. Further, all finishing systems had hemoglobin measures within normal range. 
Despite being at moderate elevation, the Norm_Mod_Stocker steers exhibited an increase in 
arterial hemoglobin from period 1 to period 2. This difference in hemoglobin concentration may 
be due to season. Warmer summer months results in heat stress for most cattle, and the most 
common response to heat stress in cattle is increased respiration rate or hyperventilation 
(Kadokawa et al., 2012; Das et al., 2016). This increase in arterial hemoglobin likely resulted 
from heat stress-induced hyperventilation. 
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Period 3 was the first period in which Ext_Mod_Stocker steers were relocated to ECRC 
for finishing along with the Norm_Mod_Stocker steers. The Ext_Mod_Stocker Steers had the 
lowest hemoglobin level. Norm_Mod_Stocker steers had a hemoglobin level intermediate 
between the Ext_Mod_Stocker and Grass_HA and Grain_HA steers, which remained at high 
altitude. Like in period 1, steers at high altitude had an elevated hemoglobin level compared to 
those at moderate altitude attributable to differences in atmospheric oxygen availability (Storz, 
2016). However, all finishing systems had hemoglobin levels within the normal range. 
Ext_Mod_Stocker steers had the lowest hemoglobin level of all finishing systems in 
period 4. Grain_HA steers had hemoglobin levels greater than both finishing systems at 
moderate altitude, but not Grass_HA steers which had a hemoglobin level comparable to 
Grain_HA and Norm_Mod_Stocker steers. The period 4 hemoglobin estimates for all finishing 
systems were within the normal range for cattle. However, the differences between 
Ext_Mod_Stocker and all other finishing systems indicates that more than altitude, the resulting 
barometric pressure, and atmospheric oxygen availability impacted hemoglobin levels in these 
cattle. If the altitude of management was the sole contributor to arterial hemoglobin 
concentrations, then Ext_Mod_Stocker and Norm_Mod_Stocker steers would have had similar 
average hemoglobin levels in period 4. These findings affirm that finishing diet and rapid weight 
gain also contribute to the hypoxic state of steers and can result in PH (Jensen et al., 1976; 
Pringle et al., 1991; Malherbe et al., 2012; Neary et al., 2016; Krafsur et al., 2017; Krafsur et al., 
2019). The Norm_Mod_Stocker steers in this case exhibited signs of PH that may progress to 




Results for arterial hematocrit recapitulated the findings for arterial hemoglobin 
concentration. Since hemoglobin and hematocrit relate to one another, this was a logical finding. 
Hematocrit estimates the proportion of red blood cells to total blood volume, and hemoglobin is 
contained within red blood cells. Therefore, the measures of these parameters are dependent 
upon one another. Hematocrit and hemoglobin may vary based on hydration status which alters 
plasma volume (Billett, 1990). Further, in chronic hypoxic conditions, cattle undergo 
erythrocytosis in order to increase oxygen carrying capacity as was discussed with arterial 
hemoglobin levels (Storz, 2016). This increase in red blood cells and hemoglobin also increased 
hematocrit. 
Base Excess 
 Base excess differed between finishing systems for each sampling period. In periods 1 
and 2, Norm_Mod_Stocker steers had a lower BE than all other finishing systems. Further, the 
Norm_Mod_Stocker steers were the only finishing system in periods 1 and 2 that had BE values 
that were within the normal range of -2 to 2 (Taussig and Landau, 2008). No BE differences 
between finishing systems were observed for periods 3 and 4. All finishing systems had BE 
estimates that were above the normal range in periods 3 and 4. Overall, base excess indicates 
acid-base imbalances in blood that result from illness or changes in diet (Constable, 2002). 
Further, it can account for metabolic causes of fluctuations in blood pH and is an indicator of 
serum lactate levels (Chomsky-Higgins and Harken, 2017). Considering this information 
alongside pH observations indicative of alkalosis, these steers were impacted by either altitude, 
diet, or a combination of both, which resulted in acid-base fluctuations that elevated BE as well 
as pH, HCO3, and PCO2. While BE data supports the findings of respiratory alkalosis in this 
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research, it has not been reported in any similar studies comparing finishing altitude and diet of 
cattle during the stocker and finishing phases of production.  
6.4.2 Arterial Blood Gases 
Partial Pressure of Carbon Dioxide 
 Partial pressure of carbon dioxide differed between finishing systems but not sampling 
periods. Ext_Mod_Stocker and Norm_Mod_Stocker steers had PCO2 concentrations that were 
similar to one another, but less than those of Grass_HA and Grain_HA steers, which also had 
similar concentrations to one another. The arterial PCO2 concentrations observed in Grass_HA 
and Grain_HA steers were close to, but still slightly lower, than the normal range (Fielder et al., 
2015b). The Ext_Mod_Stocker and Norm_Mod_Stocker finishing systems had PCO2 
concentrations that were further below the normal range than those steers finished at high 
altitude (Fielder et al., 2015b). Decreased PCO2 is indicative of alkalosis, as was mentioned 
when evaluating arterial pH. As a result, altered blood bicarbonate levels have been known to 
change in an effort to lower pH back within the normal range for cattle (Prasse and Sexton, 1972; 
Patel et al., 2019; C.W. Miller, personal communication; T.N. Holt, personal communication). 
These results were concordant with findings by Neary et al. (2013), who evaluated arterial PCO2 
in calves up to six months of age and cows 24 to 27 months of age at high altitude and found that 
cattle were experiencing respiratory alkalosis. 
Total Carbon Dioxide 
 Total carbon dioxide differed between finishing systems across sampling periods. In 
periods 1 and 2, Norm_Mod_Stocker steers had lower TCO2 than all other finishing systems, 
which had similar measures to one another. Grain_HA steers had greater TCO2 than 
Norm_Mod_Stocker steers, but not Grass_HA or Ext_Mod_Stocker steers, which were 
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intermediate and had TCO2 measures that were similar to both finishing systems. Grass_HA 
steers had greater arterial TCO2 than Ext_Mod_Steers, but not Norm_Mod_Stocker and 
Grain_HA steers, which had measures similar to both finishing systems. Despite these reported 
differences, all measurements were within normal ranges for bovine arterial blood (Fisher et al., 
1980; Blood Gases, 2019). No prior research has been conducted to evaluate TCO2 at varying 
altitudes with different finishing strategies. However, previous studies evaluated arterial 
bicarbonate, and total carbon dioxide has been established as an alternate way to estimate 
bicarbonate (Neary et al., 2013; Blood Gases, 2019).  
Partial Pressure of Oxygen 
Arterial PO2 concentrations accepted as normal for cattle range from 80 to 100 mmHg 
(Fisher et al., 1980; Fields, 2015b). However, at altitudes greater than 1,500 m arterial PO2 
values have been observed to decline below the normal range to 70 to 80 mmHg (T.N. Holt, 
personal communication). All finishing systems were below the normal ranges for arterial PO2 
according to their altitudes at each sampling period. Neary et al. (2013) also reported low arterial 
PO2 concentrations in calves and cows born and raised at high altitudes. Alveolar-arterial oxygen 
pressure gradient values were calculated in order to elucidate whether a ventilation and perfusion 
mismatch may be resulting in lower arterial PO2 (Neary et al., 2013; T.N. Holt, personal 
communication; Hantzidiamantis and Amaro, 2019).  
Oxyhemoglobin Saturation 
Oxyhemoglobin saturation was below normal ranges (Nagy et al., 2003; Neary et al., 
2013). This depressed percentage of oxyhemoglobin saturated can be attributed to the low 
arterial PO2 levels noted for all finishing systems across all sampling periods. The oxygen 
dissociation curve (ODC), a sigmoidal curve that describes the relationship between oxygen and 
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its affinity to bind to hemoglobin for delivery to tissues (C.W. Miller, personal communication; 
T.N. Holt, personal communication; Neary et al., 2013). As described by Neary et al. (2013), the 
sigmoidal shape of the ODC results in a steep decline in binding of oxygen to hemoglobin as 
arterial PO2 reaches 60 mmHg and below. Similar results have been reported in calves and cows 
born and managed at high altitude. As indicated by Neary et al. (2013), oxygen extraction 
fraction would be the best measure to elucidate issues with oxygen delivery.  
Alveolar-Arterial Oxygen Pressure Gradient 
 Mean alveolar-arterial oxygen pressure gradient differed by sampling period but not by 
finishing system. Despite differences between periods, all steers had pressure gradient values 
greater than 10 mmHg. Elevated alveolar-arterial oxygen pressure gradient values reflect 
impaired oxygen transport from alveoli to the arterial blood, which is also recognized as a 
ventilation-perfusion mismatch (Lekeux et al., 1984; Nagy et al., 2003; Neary et al., 2013; T.N. 
Holt, personal communication). Neary et al. (2013) reported elevated mean alveolar-arterial 
oxygen pressure gradient in cows 24 to 27 months of age. Based on these data, impaired 
perfusion of oxygen across the alveolar membrane to the arterial blood has reduced arterial 
partial pressure of oxygen measurements. 
6.4.3 Arterial Electrolytes and Chemistry 
Bicarbonate 
 Bicarbonate differed across finishing systems and periods. In periods 1 and 2 
Norm_Mod_Stocker steers had arterial bicarbonate concentrations that were less than all other 
finishing systems, which had similar concentrations to one another. However, in period 2, 
Grass_HA, Grain_HA, and Ext_Mod_Stocker finishing systems had elevated bicarbonate levels 
that reflected possible alkalosis (Smith et al., 2014; Fielder, 2015a). The results from period 2 
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indicated alkalosis, which when combined with arterial pH and base excess data supports the 
finding of respiratory alkalosis in steers. In periods 3 and 4, all steers had similar bicarbonate 
concentrations that were within normal range. These fluctuations in bicarbonate over time served 
to reduce pH when steers exhibited alkalotic acid-base parameters (Prasse and Sexton, 1972; 
Patel et al., 2019; C.W. Miller, personal communication; T.N. Holt, personal communication). 
Sodium 
 Serum sodium levels in the arterial blood differed between finishing systems over the 
four sampling periods. In periods 1 and 2, Norm_Mod_Stocker steers had serum sodium levels 
greater than those of the Grass_HA, Grain_HA, and Ext_Mod_Stocker finishing systems. In 
period 3, Ext_Mod_Stocker steers had greater serum sodium concentrations than either 
Grass_HA or Grain_HA steers, but not those in the Norm_Mod_Stocker steers, which had a 
concentration similar to all three finishing systems. Grass_HA steers had a period 4 serum 
concentration greater than all other finishing systems. Grain_HA steers had a serum 
concentration for period 4 that was less than Grass_HA, but greater than the Ext_Mod_Stocker 
and Norm_Mod_Stocker finishing systems, which had similar serum sodium concentrations to 
one another. Despite the differences reported between finishing systems for each sampling 
period, all serum sodium levels were within normal range (Smith et al., 2014). 
Fluctuations in serum sodium have been utilized to interpret hydration status of cattle. As 
an animal loses fluid, the sodium levels in the serum will increase due to an increased proportion 
of sodium ions to plasma volume (Smith et al., 2014). Sodium levels have also been recognized 
to be indicative of developing left heart failure in humans, which is an obesity-related model 
late-term finishing cattle have been compared to in literature (Lee and Packer, 1986; 
Gheorghiade et al., 2007; Forfia et al., 2008). Further, a study in 2008 linked hyponatremia to 
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human patients with pulmonary hypertension, concluding that decreases in sodium are related to 
right heart failure in patients with pulmonary hypertension (Forfia et al., 2008). However, no 
research has evaluated these findings in cattle experiencing pulmonary hypertension induced by 
either altitude or obesity, and based on the results from this study, there was no evidence of 
sodium levels that corroborated the results reported in humans.  
Potassium 
 Arterial serum potassium differed by sampling period but not by finishing system. Period 
2 serum potassium levels were less than those of all other periods. The decreased serum 
potassium in period 2 was at a level that may be indicative of moderate hypokalemia, resulting in 
reduced gut motility and increased recumbency in affected cattle (Constable, 2014). However, no 
increase in recumbent behavior was noted by ranch managers at either location. Period 2 was in 
the middle of the summer season, so steers may have been experiencing heat stress. Beede et al. 
(1983) reported that dairy cows in heat stress conditions exhibited reduced feed intake, thus, 
decreased potassium intake. Further, cows were losing additional potassium through sweating. 
Given that potassium levels returned to normal in period 3, after the summer season, steers may 
have been responding adversely to the summer heat, resulting in a slight decrease in serum 
potassium levels. Overall, serum potassium levels appeared normal. 
Ionized Calcium 
 Ionized calcium did not differ between finishing systems for periods 1 through 3. In 
period 4, Grain_HA steers had greater ionized calcium levels than Ext_Mod_Stocker steers, but 
not Norm_Mod_Stocker or Grass_HA steers, which had measurements that were similar to both 
finishing systems as well as each other. All finishing systems were within the normal range for 
ionized calcium for their given age range (Lincoln and Lane, 1990; Agnes et al., 1993; Neary et 
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al., 2013). Overall, ionized calcium levels have remained consistent in the body despite increases 
in total calcium, which have been affected by increased protein-bound calcium or complexed 
calcium. In the presence of acid-base disturbances such as alkalosis, reductions in ionized 
calcium may be observed (Smith et al., 2014). However, despite observed alkalosis based on 
arterial pH, hemoglobin, hematocrit, and base excess, it does not appear that the alkalotic state of 
steers reduced ionized calcium levels. If the differences in acid-base chemistry were not large 
enough, ionized calcium may have been able remain within normal ranges despite an alkalotic 
state.  
Glucose 
 Arterial glucose differed by finishing system over time. In period 1, Norm_Mod_Stocker 
steers had a greater glucose level than Grass_HA steers, but not Ext_Mod_Stocker or Grain_HA 
steers, which had glucose measurements intermediate between the two groups. However, in 
period 2, all steers had similar glucose measurements. During periods 1 and 2 all finishing 
systems were being stockered at their respective location and were, therefore, not being 
administered any sort of supplemental feed other than normal mineral supplementation. Instead, 
all 40 steers were on forage. These roughage-dense phases of feeding likely account for the 
similarities between finishing systems in period 2. This has been demonstrated through multiple 
studies that reported differences in plasma glucose levels between high-forage and low-forage 
diets fed to sheep or dairy cows such that high-forage diets reduced plasma glucose 
concentrations (Bickerstaffe et al., 1974; Evans and Buchanan-Smith, 1975; Evans et al., 1975). 
Further, as roughage was replaced with a concentrate or finishing ration, the rate of glucose 
metabolism increased, likely due to increased digestible energy in the diet (Ulyatt et al., 1974; 
Evans et al., 1975). However, the differences in period 1 do not reflect the reports comparable to 
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glucose levels on forage. The Grass_HA, Grain_HA, and Ext_Mod_Stocker steers were 
managed at the same high-altitude location during period 1 and were on the same forage. 
Norm_Mod_Stocker steers were at the moderate altitude location, where the pastures contain 
different forage types than the high-altitude location. Differences in forage types between the 
Norm_Mod_Stocker steers and the other 3 finishing systems, likely accounted for some of the 
differences noted between finishing systems in period 1.  
 Ext_Mod_Stocker steers had greater glucose levels than Grass_HA and 
Norm_Mod_Stocker steers, but not Grain_HA steers in period 3. Further, Grass_HA, 
Norm_Mod_Stocker, and Grain_HA steers had similar glucose levels at this sampling period. 
Period 3 was the first sampling period after commencement of the finishing phase of the study. 
All steers were fed a concentrate diet except for those in the Grass_HA finishing system. 
However, Ext_Mod_Stocker steers had greater plasma glucose than Norm_Mod_Stocker steers 
despite having the same diet, altitude, and management. This could indicate that some sort of 
compensatory change occurred as a result of relocation of the Ext_Mod_Stocker steers from high 
to moderate altitude as well as the change in climate from summer to fall. It has been well-
documented in literature that various forms of stress, such as heat and altitude, can result in 
reduced grazing or feed consumption (Bianca, 1965; Pereira et a., 2007). Not only were 
Ext_Mod_Stocker steers relocated to a lower altitude between periods 2 and 3, but they also 
endured a season change from summer to fall, which reduced the temperature. As a result, 
Ext_Mod_Stocker steers may have exhibited increased intake compared to period 2. Further, 
these steers were transitioned from a forage-based diet to a finishing ration, which was more 
nutrient dense. These changes likely contributed to an elevated plasma glucose level in 
Ext_Mod_Stocker steers compared to Norm_Mod_Stocker steers in period 3.  
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 All steers administered a finishing ration exhibited glucose levels that were similar to one 
another and greater than Grass_HA steers in period 4. Previous research reported that as cattle 
were placed on increased amounts of concentrates or finishing ration versus forage, plasma 
glucose levels also increased, likely due to increased digestible energy that promotes 
gluconeogenesis (Ulyatt et al., 1974; Evans et al., 1975). Further the differences in high forage 
and low or no forage diets has been recognized to result in differences in glucose levels such that 
greater forage in the diet resulted in reduced plasma glucose (Bickerstaffe et al., 1974; Evans and 
Buchanan-Smith, 1975; Evans et al., 1975). Overall, plasma glucose increased during finishing 
due to the nutrient dense ration that was administered to all steers except those in the Grass_HA 
finishing system.   
6.4.4 Venous Hematology 
pH 
 In period 2, Grass_HA and Grain_HA had venous pH levels slightly above the normal 
range (Smith et al., 2014). Norm_Mod_Stocker and Ext_Mod_Stocker steers had pH measures in 
period 2 that were within normal range. However, in period 4, all finishing systems had pH 
levels within normal range (Smith et al., 2014). No studies to date have reported venous blood 
gases in steers exposed to various altitudes during the stocker and finishing phases of production. 
However, based on the mean arterial pH parameters reported for each of the finishing systems, it 
would appear that blood pH has been maintained throughout the circulation.  
The renal system has been noted as a vital organ system in the maintenance of blood pH 
through its excretion of H+ ions, absorption of HCO3, and creation of more HCO3 in order to 
maintain blood pH around the range of 7.31-7.53 (Smith et al., 2014; Hamm et al., 2015). 
Therefore, urinalysis and other metrics of renal function may be useful in estimating the efficacy 
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of the renal system in its maintenance of blood pH. Further, such analysis could serve as an early 
indicator of renal failure in the event that an animal has begun to experience organ failure in the 
end stages of HMD or FHD.  
Base Excess 
 Despite having a lower period 2 BE estimate than all other finishing systems, 
Norm_Mod_Stocker steers had venous BE levels above the normal range. Likewise, 
Ext_Mod_Stocker, Grain_HA, and Grass_HA steers had elevated period 2 BE levels. Elevated 
BE levels were also noted in all finishing systems for period 4. These BE levels have been noted 
to be indicative of alkalosis (Taussig and Landau, 2008). Overall, the venous blood pH levels did 
not agree with findings of alkalosis, but arterial results of blood gases and hematology were 
indicative of respiratory alkalosis. Therefore, there could have been a renal system reaction to the 
elevated arterial pH resulting in its mitigation in the venous blood. No research has been 
conducted to report BE in venous blood of cattle exposed to varying altitudes and diets during 
the stocker and finishing phases of beef production. Further research should be conducted to 
evaluate renal function and to gather further data of BE in cattle exposed to hypoxic conditions.    
6.4.5 Venous Blood Gases 
Partial Pressure of Carbon Dioxide 
Partial pressure of CO2 in the venous blood did not change between finishing systems or 
sampling periods. Further, the mean PvCO2 values that were reported for period 2 and period 4 
were within the normal range for bovine venous blood (Smith et al., 2014). Based on the low 
PaCO2 and normal PvCO2 observations noted in this research, steers were experiencing 
compensated respiratory alkalosis. The primary means to alleviate alkalosis in affected cattle has 
been the renal system. In the presence of a PaCO2 below normal range, the renal system will 
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offset the acid-base imbalance by excreting HCO3 in the urine and reabsorbing H+ ions in the 
nephrons of the kidneys (Smith et al., 2014). Neary et al. (2013) has published the only study 
evaluating blood parameters in cattle exposed to high altitudes, and while findings of that study 
agreed with those of PaCO2 data in this research, they did not evaluate PvCO2 data. Despite this 
difference, it appears that results were concordant between this study and Neary et al. (2013), 
who also reported compensated respiratory alkalosis in calves up to six months of age and cows 
24 to 27 months of age.  
Total Carbon Dioxide 
 Total CO2 in the venous blood differed between finishing systems for both periods that 
venous data was available. According to the normal ranges reported by Smith et al. (2014), the 
three finishing systems that remained at high altitude for the stocker phase of the study had 
TVCO2 levels that exceeded the acceptable range. However, Norm_Mod_Stocker steers had a 
normal TvCO2 in period 2. This could be attributed to increased stress during the summer months 
that resulted in hyperventilation of steers, thus, an increase in circulating CO2 in the bloodstream 
that may manifest as either HCO3 or CO2. Further analysis investigating fluctuations of 
respiratory rates could elucidate if this was occurring. In period 4, all finishing systems had 
TvCO2 levels that were within the normal range (Smith et al., 2014). No studies to date have 
evaluated TvCO2 in cattle exposed to different finishing strategies and altitudes. However, it has 
been documented that TCO2 measurements are utilized in lieu of measuring HCO3 (Blood Gases, 
2019). Neary et al. (2013) reported HCO3 levels, but not for venous blood measures. Therefore, 
this is the first study that has reported TvCO2 for steers fed different finishing rations and 
managed at different altitudes. 
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Partial Pressure of Oxygen 
 Partial pressures of O2 in the venous blood was below the normal range for steers in both 
sampling periods of this study (T.N. Holt, personal communication). This result was expected 
given the low PaO2 that was also recorded in this study. The A-a O2 pressure gradient indicated 
that a perfusion issue existed such that O2 was not crossing the alveoli to oxygenate the arterial 
blood. Given that the PaO2 measurements were below normal range, it was expected that PvO2 
would also be less than the expected range for healthy adult cattle. Neary et al. (2013) reported 
differences in PaO2 that were also indicative of an alveolar perfusion insufficiency, but PvO2 was 
not evaluated.  
Oxyhemoglobin Saturation 
 Oxyhemoglobin saturation in the venous blood was less than that of the arterial blood, 
which was expected since systemic tissues extract oxygen from the arterial blood for 
maintenance of physiologic function. Further, the svO2 measures recorded were within the 
expected range (Smith et al., 2014). Therefore, oxygen extraction by the tissues was normal. 
Despite the amount of O2 entering the arterial blood via alveolar perfusion being less than the 
normal range for cattle, the percentages of O2 bound to hemoglobin in both venous and arterial 
blood samples were normal. Further, the svO2 measures indicated that tissues were likely still 
receiving adequate oxygenation for maintenance. In order to validate these findings further, this 
study should be replicated in order to measure saO2, svO2, and cardiac output. Measuring cardiac 
output would elucidate any changes indicative of insufficient oxygen delivery to the tissues since 
one of the body’s responses to low oxygen delivery to the tissues is to increase cardiac output in 
order to increase oxygen transport (C.W. Miller, personal communication; Smith et al., 2014). 




 Venous HCO3 for periods 2 and 4 was below the normal range for all finishing systems 
(Smith et al., 2014). Contrary to the arterial blood for period 2, venous blood for the same time 
point indicates a reduction in HCO3 such that it was well below the accepted range. This 
reduction was likely due to the observed alkalotic state of steers at this sampling period. As a 
physiological response in regulating blood acid-base balance, the renal system acts as a regulator 
of HCO3 in the blood (Hamm et al., 2015). Therefore, it is likely that excess levels of HCO3 were 
excreted to maintain an acceptable blood pH. Interestingly, the BE levels in the venous blood did 
not reflect a reduction in HCO3, which should have lowered the pH and BE levels. No research 
has been conducted evaluating venous blood parameters in steers during the stocker and 
finishing phases at high altitudes. Follow-up research evaluating venous blood parameters and 
urinalysis would better reflect the changes that may be occurring via either excretion of HCO3 in 
urine or reabsorption of HCO3 by the nephrons within the renal system. 
Lactate 
 In period 2, all steers had comparable Lac levels that were within the middle and upper 
levels of the normal reported range in cattle. However, in period 4, steers within the Grain_HA 
finishing system had a mean Lac measurement above the accepted range of 0.54 to 2.22 mmol/L 
(Figueiredo et al., 2006; Smith et al., 2014). Elevated Lac levels are indicative of poor perfusion 
of systemic tissues. These elevated Lac levels may be caused by dehydration, excessive muscle 
activity, increased anaerobic metabolism, or hypoperfusion, among other stressors (Broder and 
Weil, 1964; Weil and Afifi, 1970; Vincent et al., 1983; Bakker et al., 1991; Mizock and Falk, 
1992; Bakker et al., 1996; Gernardin et al., 1996; Figueiredo et al., 2006). Reindl et al. (1998) 
speculated that pulmonary vascular tone may lead to pulmonary hypertension as well as alveolar 
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hypoperfusion in humans experiencing heart failure. Neary et al. (2013) reported elevated arterial 
L-lactate levels due to substantial anaerobic respiration of cows and calves. However, Neary et 
al. (2013) did not report venous lactate measurements. Based on previous research and results 
from this study, it is probable that elevated Lac levels observed in this study could be attributed 
to respiratory alkalosis or the onset of heart failure in susceptible cattle. However, histopathology 
results are not available yet. 
6.5 Conclusions 
 Overall, arterial blood parameters were indicative of respiratory alkalosis in steers. 
Regardless of finishing system, steers exhibited signs of alkalosis. Further, most of the venous 
blood parameters were within normal ranges, which was indicative of compensation in the renal 
system in order to maintain acceptable acid-base blood chemistry. The findings of respiratory 
alkalosis were concordant with findings by Neary et al. (2013). However, this was the first study 
that evaluated the roles of altitude and finishing strategy on blood parameters during the stocker 
and finishing phases of beef production. In conclusion, altitude and diet both impacted blood 
parameters in steers that were stockered and finished at moderate or high altitudes. Future 
research should evaluate these parameters at low altitudes with each of the finishing diets in 
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CHAPTER 7  
VARIANTS ASSOCIATED WITH PULMONARY HYPERTENSION IN ANGUS CATTLE 
DETECTED WITH WHOLE GENOME SEQUENCE 
7.1 Introduction  
 Pulmonary hypertension (PH) in cattle has been thoroughly characterized since its initial 
discovery (Glover and Newsom, 1915; Hecht et al., 1962; Krafsur et al., 2020). Further, 
substantial research has investigated mean pulmonary arterial pressures (PAP), which is still 
recognized by the beef industry as the best indicator of an animal’s PH status and risk of 
developing high mountain disease (HMD; Will et al., 1962; Grover and Reeves, 1962; Grover et 
al., 1963; Holt and Callan, 2007; Pauling et al., 2018; Speidel et al., 2020). In addition to 
understanding the signs, symptoms, and pathology of the condition, studies have reported 
heritability estimates for PAP that have indicated the trait is moderately heritable (Schimmel, 
1981; Schimmel, 1983; Enns et al., 1992; Shirley et al., 2008; Crawford et al., 2016; Pauling, 
2018). Therefore, genetic improvement has been made possible through PAP expected progeny 
difference (EPD) estimates available through relatively limited resources for ranchers to consider 
in breeding and selection decisions (Enns et al., 2011; Pauling et al., 2017; Thomas et al., 2017; 
American Angus Association, 2019).  
 Development of EPD for traits such as PAP has been challenging since the accuracies of 
PAP EPD estimates are lower than those of more commonly measured traits due to the limited  
number of observations (Glover and Newsom, 1915; Hecht et al., 1962; Neary et al., 2014; Zeng, 
2016). In cases such as these, genomic information has been useful to enhance accuracies for 
EPD estimates through genome-enhanced EPD (gEPD) or marker assisted selection (MAS) 
(Northcutt, 2010; Garrick, 2011; Rolf et al., 2014). 
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 Research to date that has investigated potential variants and genes associated with PAP 
has revealed several regions within the genome that could be valuable for selection. However, 
these research efforts were limited with many efforts focusing on either SNP chip genotype data, 
transcriptome data, exome data, or searching specific regions of the bovine genome, which 
leaves regions of the bovine genome uninvestigated (Newman et al., 2011; Newman et al., 2015; 
Zeng, 2016; Crawford, 2019). Therefore, the objective of this study was to utilized whole 
genome sequence of steers and bulls of different PAP risk categories to discover candidate 
variants and genes that may be useful for selection to reduce incidence of HMD in cattle.  
7.2 Materials and Methods 
7.2.1 Selection of Angus cattle for sequencing 
Thirty Angus bulls and steers were selected based on their PAP measurements and 
pedigree information. Through selection of cattle based on these criteria, the population to be 
sequenced contained both high and low PAP cattle and represented genetics from registered 
American Angus sires that are prevalent in many pedigrees and have been popular for artificial 
insemination. Sequencing candidates were from two ranches in Colorado. Five bulls were 
managed at Battle Creek Ranch LLC (Parshall, CO; 2,438 m altitude). Twenty-five bulls and 
steers were from the Colorado State University Beef Improvement Center (BIC; 2,150m). Cattle 
sourced from the BIC for whole-genome sequencing were a combination of herd bulls (n= 4), 
steers from a growth and development study (n=12), and steers from a comparative finishing 
system study across high and moderate altitudes (n=8) (Table 7.1).  











2012 Angus RNA 
sequence study 
12 Saratoga, WY 2,150 S 
High: 64.00 + 9.40 
Low: 36.50 + 1.43 
2016 Angus finishing 







High: 73.25 + 9.50 
Low: 40.75 + 1.49 
Battle Creek Ranch 5 Parshall, CO 2,460 B 
High: 51.00 + 2.08 
Low: 41.00 + 1.00 
CSU Beef 
Improvement Center 
5 Saratoga, WY 2,150 B 
High: 71.50 + 18.5 
Low: 38.33 + 0.33 
 
The twelve steers from the growth and development study were BIC steers born in 2012. 
These steers were a subset of the sample population in a study that compared high and low PAP 
steers administered a bull development ration (target body weight gain 1.5 kg/d) as a model for 
yearling bull performance. As part of this study, PAP measurements were recorded at three 
separate time points, so the subset of steers selected for sequencing were sorted into either low or 
high PAP categories for future comparisons based on their first on-ranch PAP measure. Further, 
these steers were considered of value for variant detection due to the RNA sequence data that 
was generated for each of the twelve steers for various cardiopulmonary tissues. Through 
combination of the transcriptomic data from this prior study (Crawford, 2019) and the genomic 
data generated in the current study, a multi-omics approach was possible. Thus, these steers were 
considered an informative subset within the whole-genome sequence population.  
 Eight of the BIC steers were a subset from a study that evaluated how diet and altitude 
impacted PAP postweaning. From each of four finishing strategies highlighted in Chapter 3, one 
high PAP and one low PAP steer from each group were chosen for whole-genome sequencing. 
Sequence information from this study was valuable because the PAP measurements were 
induced by physiologic response to altitude and diet, which provides additional phenotype data 
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to accompany the sequence data of the overall study population as described in Chapters 3 
through 6. 
7.2.2 Blood collection and storage 
 Blood samples were collected from 18 of the 30 bulls and steers via jugular venipuncture 
in a squeeze chute at the ranch where the animals were maintained. Samples were collected in 10 
mL EDTA tubes and stored on ice for transport to the laboratory. Blood samples were 
centrifuged for 30 minutes at 2,500 rpm to fractionate the blood components. The white blood 
cell layer or “buffy coat” was evacuated for each sample and placed in a 1.5 mL microcentrifuge 
tube. The buffy coat was then suspended up to a volume of 1 mL in 1x phosphate buffered saline 
and stored at -20C until DNA was extracted for sequencing.  
7.2.3 DNA extraction and quality assessment 
 Genomic DNA was extracted from blood (n=18) or liver caudate (n=12) from each 
animal using the Qiagen DNeasy Blood and Tissue Kit (Cat. No. 69504) according to the 
instructions provided for each sample type. Sample quality was determined utilizing a NanoDrop 
One (Thermofisher Scientific) to assess sample purity and a Qubit 4 Fluorometer using the broad 
range DNA assay (Cat. No. Q32850; Thermofisher Scientific) in order to assess sample 
concentrations (Table 7.2). Samples that did not have a satisfactory concentration according to 
the Rapid Genomics submission guidelines were cleaned and resuspended via an ethanol 
precipitation. In cases where an individual consistently had low DNA yields from extraction 
attempts, samples for that animal were combined and an ethanol precipitation was performed to 
increase concentration. 
 
Table 7.2 A table of the absorbance ratios and concentrations measured by Nanodrop and Qubit 
machines that indicate acceptable DNA quality for submission for sequencing. The 260/230 ratio 
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measures the absorbance of nucleic acids (260 nm) compared to the absorbance of organic 
materials such as ethanol or phenol (230 nm). The 260/280 ratio measures the absorbance of 
nucleic acids (260 nm) compared to the absorbance of proteins (280 nm). Concentration is not 
noted for Nanodrop measurements because the Qubit has greater specificity in measuring 







Nanodrop > 1.80 > 2.00 - 
Qubit - - > 30 
 
 Once samples were extracted and met sequencing standards, samples were assessed via 
an Agilent 2200 TapeStation machine with the Genomic DNA Screen Tape Analysis. The 
TapeStation assessed samples for DNA degradation and measured fragment sizes (Figure 7.1). 
This was the final quality assessment step prior to plating submission for DNA library 
preparation and next-generation sequencing and demonstrates that the samples were of 
acceptable quality and integrity for the proceeding steps. 
 
 
Figure 7.1 Tapestation images for a subset of animals to be submitted for sequencing. Lane A 
contains a DNA ladder, and lanes B through H contain genomic DNA from randomly selected 
samples that were submitted for sequencing. The large bands at the top of the gel image indicate 
A B C D E F G H 
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quantities of in-tact DNA in large enough fragments to submit for library preparation and 
subsequent sequencing. Note that an error occurred with the sample in lane E, which resulted in 
it appearing to have a low concentration with smaller fragments than other samples. This sample 
was tested a second time to verify sample integrity. 
7.2.4 Dilution and plating of samples 
 Once all DNA samples were assessed for quantity, quality, and integrity, they were plated 
on a 96-well full-skirted plate. The well plate was then submitted to Rapid Genomics 
(Gainesville, FL) for library preparation and sequencing. Samples were diluted prior to plating 
with the intent to achieve a well volume of 40 ul each while maintaining a concentration above 
30 ng/ul per well (Appendix A). The plating volumes and concentrations needed to be similar for 
the automated pipetting processes necessary for library preparation and subsequent sequencing.
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7.2.5 Library preparation and sequencing  
 Extracted DNA from each bull or steer was submitted to Rapid Genomics for library 
preparation and subsequent sequencing. The library preparation was performed using a 
proprietary protocol to fragment the DNA into 150 base pair fragments then ligate adapters and 
barcodes compatible with an Illumina sequencing run. The samples were then pooled and 
sequenced using Illumina NovaSeq technology to generate 150 base paired-end reads with 30x 
median coverage.  
7.2.6 Bioinformatic analysis 
 Samples were de-multiplexed by the bioinformatics team at Rapid Genomics 
(Gainesville, FL). The de-multiplexed reads were then processed and analyzed using CLC 
Genomics Workbench version 11 (Qiagen Bioinformatics).  First, read quality was assessed using 
the “Create Sequencing QC Report” tool from the “NGS Core Tools” section of the software’s 
toolbox. An adapter list was then created that contained all i5 and i7 adapter sequences that 
needed to be trimmed off of the reads. Reads were then trimmed using the “Trim Reads” tool 
within the “NGS Core Tools” section of the CLC toolbox using the default settings. A second 
QC report was then generated to verify that the trimming was effective. The trimmed reads were 
then aligned to the ARS-UCD1.2 (RefSeq ID: GCF_002263795.1) bovine reference genome 
assembly using the “Map Reads to Reference” tool within the “NGS Core Tools” section of the 






Table 7.3 Settings used to map sequence reads to the reference genome in CLC Genomics 







Match Score Cost of a match between the 
reference and the sequence 
1 
Mismatch Score Cost of a mismatch between 
the reference and the sequence 
2 
Insertion Cost Cost of an insertion in the read 
resulting in a gap in the 
reference sequence 
3 
Deletion Cost Cost of a gap in the read 
resulting in an insertion in the 
reference 
3 
Length Fraction Minimum fraction of the 
length of a read that must 
match the reference 
0.5 
Similarity Fraction Minimum fraction of  the read 




Known variants were called for the mapped sequences using the “Fixed Ploidy Variant 
Detection” tool within the “Resequencing Analysis” section of the CLC toolbox (Table 7.4). 
These files were then sorted into HPAP or LPAP groups such that any animal with a PAP > 49 
mmHg were classified as HPAP (n=14), and any animals with a PAP < 49 mmHg was classified 









Table 7.4 Settings used for the “Fixed Ploidy Variant Detection” tool to call variants in CLC 











Minimum probability for 
which variants will be called 
90% 
Reference Masking Ignore positions with coverage 
above a designated level 
100,000 (default) 
Read Filters Ignore broken pairs De-selected 
Minimum Coverage Minimum number of reads 
covering a region for a variant 
to be called 
10 
Minimum Count Minimum number of reads to 
contain a variant for it to be 
called 
2 
Minimum Frequency Minimum frequency for a 
variant to be called 
5% 
Base Quality Filter Minimum quality necessary 
for a variant to be called 




Compares observed read 
direction distributions 
compared to those expected 
for a region 
Selected and default 
values used 
 
7.2.7 Variant detection  
 Variants detected in both HPAP and LPAP cattle were compared using CLC Genomics 
Workbench. First, single tracks were generated for both HPAP and LPAP groups using the 
“Compare Variants Within Group” tool. The called variant tracks for each LPAP animal were 
compiled into a single track with the frequency percentage set to 1%, which would include any 
called variants present in a single animal. The same procedure was then performed for the HPAP 
group. In order to increase stringency of the comparisons between HPAP and LPAP cattle, the 
files were also compiled with the frequency percentage set to 100%, meaning that a variant had 
to be called in the individual files for each of the animals in that PAP category in order to be 
included in the single HPAP or LPAP track generated.  
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 The compiled HPAP and LPAP variant tracks were then compared to one another using 
the “Compare Variants Between Groups” tool such that the 1% frequency HPAP and LPAP files 
were compared to one another, and the 100% frequency HPAP and LPAP files were compared to 
one another. Utilization of this function compares an input file to a designated file to call variant 
similarities or differences contained within the input file. For example, if the LPAP file was the 
input file that was compared to the HPAP file (LPAP vs HPAP), the tool would output a file of 
variants present in the LPAP file that were either identical or different from the HPAP file 
depending on whether the user instructed the tool to call for similarities or differences. 
Conversely, the inverse comparison was made such that the HPAP file was now the input file, 
which was compared to the LPAP file (HPAP vs LPAP). When evaluating variant similarities, 
the LPAP vs HPAP and HPAP vs LPAP results were identical. However, the variant differences 
were dependent on which file was the input file, meaning that the results from the LPAP vs 
HPAP comparisons were not the same as those of the HPAP vs LPAP comparisons.  
Once the similarities and differences between HPAP and LPAP cattle were detected, the 
resulting files were annotated using the variant annotation that was compatible with the reference 
genome used. Further, functional consequences were evaluated to determine which variants may 
result in amino acid changes, loss of function, or other disruptions within the genome.  
7.3 Results 
 The average number of reads generated exceeded 25 million per animal (Table 7.5). Of 
those generated reads, about 24.9 million per animal were successfully mapped to the ARS-
UCD1.2 reference genome. Within the mapped reads for each animal, at least 45,599 known 
variants were called when compared to the reference genome.  
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Table 7.5 Statistics for the number of reads generated per animal, the number of mapped reads 
per animal, and the number of called variants per animal. All means have been expressed as 
mean + standard error.  
 
Mean Minimum Maximum 
Total Number of Reads 25,553,713.6 + 7,049,402.1 3,713,082 149,616,664 
Number of Mapped Reads 24,900,678.5 + 6,862,141.7 3,649,144 145,757,570 
Number of Called Variants 275,346.8 + 99,472.4 45,599 2,530,785 
 
The LPAP and HPAP categories had 3,421,234 and 1,512,287 variants respectively that 
were prevalent in at least 1% of samples. Comparison of these 1% filtered variant files for HPAP 
and LPAP categories revealed 977,861 common variants between the two populations (Figure 
7.3). There were 514,050 variants unique to HPAP cattle and 2,214,162 variants unique to LPAP 
cattle.  
 
Figure 7.2 Comparison of variants between HPAP and LPAP cattle. Variants were compiled into 
HPAP and LPAP files for comparisons if they were present at a 1% frequency, meaning that the 
variant appeared in at least one animal within each of the two PAP categories.  
 
 Both LPAP and HPAP samples were also filtered at 100% frequency, meaning that a 
variant had to be called in all samples within a PAP category to be included in subsequent 
analysis steps. This resulted in 15,775 and 19,765 variants present in LPAP and HPAP groups 
respectively. Further, comparison of the 100% filtered variant files for HPAP and LPAP 






HPAP and LPAP cattle. Only 2,750 of the 13,858 variants common between the two PAP 
categories were recorded in dbSNP. There were 1,690 variants unique to HPAP cattle and 5,543 
variants found exclusively in LPAP cattle. Only 1,142 of the 5,543 variants unique to HPAP 
cattle were documented in dbSNP. Further, 263 of 1,690 variants unique to LPAP cattle were 
documented in dbSNP. 
 
Figure 7.3 Comparison of variants between HPAP and LPAP cattle. Variants were compiled into 
HPAP and LPAP files for comparisons if they were present at a 100% frequency, meaning that 
the variant appeared in at least one animal within each of the two PAP categories. 
 
 Variants detected that were unique to HPAP cattle and were prevalent in 100% of the 
HPAP sequencing population spanned all 29 autosomes and the X chromosome (Figure 7.5). The 
chromosome with the fewest detected variants was chromosome 24. Conversely, autosomes 16 








Figure 7.4 The distribution of variants detected at 100% prevalence and were unique to HPAP 
cattle by chromosome. 
 Variants that were prevalent in 100% of the LPAP cattle sequenced were also evaluated 
by chromosome (Figure 7.6). The distribution of detected variants spanned all 29 autosomes as 
well as the X chromosome. Autosome 24 had the fewest variants detected. Further, autosomes 7, 
17, 21, and the X chromosome had the most abundant variants detected that were unique to 


































Figure 7.5 Variants that were prevalent in 100% of the LPAP cattle population and were unique 
to LPAP cattle distributed by chromosome on which they were located. 
 Variants that were prevalent in all cattle within each PAP category had concordant 
variants detected between HPAP and LPA cattle that spanned all 29 autosomes as well as the X 
chromosome (Figure 7.7). Autosomes 20 and 24 had the fewest detected variants. Conversely, 
autosomes 7 and 17 as well as the X chromosome contained the most variants concordant 































Figure 7.6 Variants common between both LPAP and HPAP cattle by chromosome. Note that 
only variants present in 100% of the LPAP and HPAP cattle respectively were compared to 
develop this subset of variants. 
7.4 Discussion 
 The initial analysis in which a variant had to only be in one animal from either the LPAP 
or HPAP group to be included in the analysis revealed over 2 million variants warranting further 
investigation. Due to the immense number of variants detected with these parameters, a more 
stringent frequency was implemented to filter variants that may be less informative in 
understanding the PAP phenotype. The more stringent frequency of 100% eliminated additional 
variants, resulting in subsequent annotation and analysis of only those variants that appeared in 
all cattle within a PAP phenotype category.  
 The number of variants discovered was greater than that of Newman et al. (2011) who 
investigated 6,344 SNP from 8,011 variants detected from SNP chip genotype data. Further, the 
number of variants detected initially in this research was greater than those reported by Zeng 





























the final list of variants for future analysis was less than those investigated by Zeng (2016). 
Similarly, Cockrum et al. (2019) investigated SNP associated with yearling PAP as well as 
growth traits in cattle using Illumina BovineSNP50 data via GWAS. That study yielded 37 
variants of interest associated with PAP. 
 Most variants for HPAP cattle were located on autosomes 16 and 17 as well as the X 
chromosome. Further, most variants for LPAP cattle were located on autosomes 7, 17, and 21 as 
well as the X chromosome. These results reflected findings from previous research in which 
windows on autosome 7 and the X chromosome were associated with two category yearling PAP 
(Zeng, 2016). However, that study focused on SNP chip data in a genome-wide association study 
(GWAS) and compared 1 mb SNP windows to an older version of the bovine reference genome. 
This author also reported windows on autosomes 11 and 20 that accounted for more than 1% of 
the genetic variation of non-transformed two category yearling PAP (Zeng, 2016). Cockrum et 
al. (2019) detected eight variants on autosome 7 out of the 37 variants that were associated with 
PAP. Further, autosomes 16 and 21 each had one variant associated with PAP in the same study. 
However, the authors did not report any variants detected on autosome 17 or the X chromosome. 
While fewer variants were noted within autosomes 11 and 20 than other locations within the 
genome, the number of variants detected on these chromosomes were greater than those reported 
by Zeng (2016) or Cockrum et al. (2019).  
Newman et al. (2011) reported SNP located on chromosomes 1, 3, 10, 24, and 29. While 
none of these chromosomes had the most variants detected of all chromosomes in this research, 
the number of variants that were detected on these chromosomes exceeded those detected by 
Newman et al. (2011). Like Zeng (2016), Newman et al. (2011) used an older reference genome 
assembly and did not utilize whole genome sequence data. Instead, they utilized low density SNP 
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genotyping data to detect SNP relevant to PAP, and then performed targeted RNA sequencing 
for those regions to evaluate fold-change differences. Overall, the approach in the current 
research was more exhaustive in detecting variants than studies that have evaluated markers 
associated with PAP to date through incorporation of 30x whole genome sequence data, and as a 
result, more variants were detected on each of the bovine chromosomes.  
 The regions of interest that differed between HPAP and LPAP cattle will be investigated 
further in the next chapter. Focus of variant detection would emphasize genes recognized for 
their association with PH in cattle from previous research (Table 7.6). Regions flanking these 
genes will also be investigated for variants that may be informative in estimating susceptibility of 
developing HMD of cattle in high altitude production systems. Additional genes may be detected 
based on concordance between transcriptome and genome sequence data. The ultimate objective 
of combining data from this chapter with transcriptome data was to find genes and variants for 












Table 7.6 Genes from previous research that will be investigated using multi-omics data.  
Gene Gene Description Chr. Position Citations 
BMPR2 Bone morphogenetic 
protein receptor type 
2 
2 90,864,689-91,017,391 West et al., 2004 
NFIA Nuclear factor I A 3 84,197,144 - 84,620,790 Heaton et al., 2020 
ARRDC3 Arrestin domain 
containing 3 
7 90,839,580 - 90,853,625 Oka, 2006;  
Zeng, 2016;  
Heaton et al., 2020 
ROCK2 Rho associated 
coiled-coil containing 
protein kinase 2 
11 86,489,069 - 86,618,649 Zeng, 2016  
EPAS1 Endothelial PAS 
domain protein 1 
11 28,735,330 - 28,825,665 Gale et al., 2008; 
Newman et al., 2015; 
Zeng, 2016; 
Heaton et al., 2016; 
Crawford et al., 2016 
 
In addition to genomic differences, variants that were similar between LPAP and HPAP 
were also detected in this study. While these variants may not be informative for diagnostic 
purposes or distinguishing between HPAP and LPAP cattle, they were collected for further 
investigation and inclusion as marker effects to estimate gEPD for PAP. These markers would 
enhance the accuracy of genetic predictions for PAP (Northcutt et al., 2010; Thomas et al., 2013; 
Garrick and Fernando, 2013; Zeng et al., 2016). Further, these markers would be useful as the 
beef industry works to provide selection tools for high altitude beef production systems. Only a 
limited number of resources have cultivated a PAP EPD for selection, with one of the most 
notable being the American Angus Association (American Angus Association, 2019). Through 
detection and validation of markers associated with the PAP phenotype, more selection tools can 
be made available for producers looking to reduce incidence of PH and subsequent HMD within 





 These results demonstrated a vast number of variants that may be informative for 
selection of cattle with reduced risk of developing HMD resulting from PH. Through stringently 
filtering the called variant files (vcf), those variants that were not prevalent in all cattle within a 
PAP category were eliminated prior to comparisons of HPAP and LPAP cattle. Variants were 
detected that differed between PAP categories, which, once validated, may be informative in 
distinguishing cattle less suitable for high altitude production settings. Further, variants that were 
similar between production systems may be useful to enhance accuracies of GEPD estimations 
for PAP. Despite the discovery of these markers, the genes and functional consequences still 
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CHAPTER 8  
DETECTION OF VARIANTS IN THE BOVINE GENOME ASSOCIATED WITH MEAN 
PULMONARY ARTERIAL PRESSURE AND HIGH MOUNTAIN DISEASE 
8.1 Introduction 
Increased affordability of sequencing technologies has resulted in thousands of animals 
being sequenced. In addition, sequencing efforts have been conducted with increased depth and 
coverage (Muir et al., 2016). For example, chapter 7 described 30 Angus cattle sequenced at 30x 
coverage. Through increased sequencing efforts as well as increased sequencing depth and/or 
coverage, novel variants may be discovered within a genome. Further, reduced costs associated 
with sequencing lends to the ability to deploy multi-omic and bioinformatic strategies to 
characterize genes, transcripts, and proteins within a species (Heather and Chain, 2015; Muir et 
al., 2016; Cánovas et al., 2014; Nguyen et al., 2018). 
Within the beef industry, genomic information for selection has been contributed through 
SNP chip genotypes that cover the genome at varying densities. However, when assessing this 
information, regions of the bovine genome may be underserved or overlooked due to reduced 
coverage in a particular region (Hickey, 2013). These discrepancies complicate variant discovery 
efforts. 
Variant discovery or detection can be important for development of genetic predictions 
for new traits, polygenic traits, or traits with few records. An example of a newer trait with few 
records is mean pulmonary arterial pressure (PAP), an indicator trait important for beef 
production systems that manage cattle at altitudes of 1,500 m or greater in order to select against 
high mountain disease (HMD). Due to the cost of measuring PAP and limited global regions 
concerned with PAP, limited records have been reported to breed associations for genetic 
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evaluations (Holt and Callan, 2007). Therefore, the estimates of expected progeny differences 
(EPD) for PAP have been accompanied by low accuracies of estimates. Accuracies of these 
EPDs can be increased by incorporation of genomic markers to create genome-enhanced EPDs 
(Glover and Newsom, 1915; Hecht et al., 1962; Northcutt, 2010; Garrick, 2011; Rolf et al., 2014; 
Neary et al., 2014; Zeng, 2016).  
Research efforts to detect markers associated with PAP have used SNP genotype data or 
have focused on specific regions within the genome. However, the increased affordability of 
sequencing allows for more robust data to be generated to search the bovine genome for variants 
that may have been missed through previous variant detection efforts (Heather and Chain, 2015; 
Muir et al., 2016). Therefore, the objective of this study was to utilize RNA sequence to guide 
variant detection efforts within exons of bulls and steers with varying PAP risk categories. The 
research objective was addressed through four aims: (1) detection of variants in transcriptome 
data that vary between three category (high PAP sick (HPAPS); high PAP healthy (HPAPH); 
low PAP (LPAP)) and two category (high PAP (HPAP); low PAP (LPAP)) groups for each 
tissue; (2) determination of concordant variants across tissues; (3) investigation of regions within 
the common transcriptome variant list for variants, genes, or regions of increased interest 
pertaining to PAP phenotype; (4) evaluation of genes or regions of the genome associated with 
PAP that were detected using whole genome sequence data. Through isolation of regions of 
interest from genome sequence that accompanies the transcriptome data, variants may be 
detected for downstream validation.  
8.2 Materials and methods 
8.2.1 Selection of cattle, sample collection, and storage of samples 
Thirty Angus bulls and steers were selected for sequencing based on their PAP 
measurements and pedigree information. These animals were from four different sources 
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described in Chapter 7. Template DNA was extracted from all thirty animals using either blood 
samples or liver caudate samples, which were processed and maintained as previously described 
(Chapter 7).  
8.2.2 RNA sequence data 
 Twelve samples with varying PAP risk categories from a bull development study at the 
CSU Beef Improvement Center had RNA sequence that was generated from previous research 
efforts. Transcriptome sequences were available for right ventricle, pulmonary artery, left 
ventricle, aorta, lung, and Longissimus dorsi across each of the twelve steers. Steers had PAP 
measurements recorded at three separate time periods and were then selected for sequencing 
based on the three separate time points. Graphs of PAP over time for hypertensive and 




Figure 8.1 Image generated by Crawford (2019) that provides graphical representation of how PAP measures for the RNA sequence 
population changed over time prior to harvest. 
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The RNA sequences from these twelve steers also have DNA sequence to accompany 
them. When combining two data sources it is important to acknowledge factors that could impact 
the results of the study. These two sequence types (RNA and DNA) were sequenced in different 
years, at different sequencing facilities, utilizing different Illumina sequencer models. In 
addition, the sequencing coverage and depths likely differ from one another, which could result 
in differences in the variants called in the individual sequence types. The genomic data was 
sequenced to a median coverage of 30x, but the median coverage of the RNA sequence data in 
this study is unknown. Due to the increased affordability of sequencing since the RNA sequence 
data was generated in 2014, it was speculated that the coverage of the RNA sequence was less 
than that of the DNA sequence (Muir et al., 2016).  
8.2.3 Bioinformatic analysis 
 Initial processing of the transcriptome data generated was performed by the research team 
at University of California- Davis that conducted the sequencing. At this time, all reads were 
demultiplexed, adapters were trimmed from the reads, and low-quality reads were either trimmed 
or separated from the data that was of acceptable quality. The trimmed data files were then 
processed and analyzed using CLC Genomics Workbench version 11 (Qiagen Bioinformatics). 
First, reads were aligned to the bovine reference genome, ARS-UCD1.2, using the RNA Seq 
Analysis tool.  
8.2.4 Variant detection 
 Once reads were mapped to the ARS-UCD1.2 bovine reference genome, the files sorted 
by tissue (right ventricle, left ventricle, pulmonary artery, aorta, lung, and longissimus dorsi) as 
well as PAP risk categories (LPAP, HPAPH, and HPAPS; LPAP and HPAP). These variant 
tracks were then annotated with the annotation corresponding to ARS-UCD1.2. Variants within 
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the mapped files were called utilizing the Fixed Ploidy Variant Detection tool. Upon completion 
of variant calling, comparisons of variant tracks were performed according to a procedure 









8.2.5 Variant filtering 
 Transcriptome data for each tissue were analyzed separately by first filtering variants 
within each PAP category at a filtration rate of 100%. This filtration rate meant that a variant had 
to be called in all animals within the PAP category in order for it to be included in the next 
analytical step. Once this was performed for all PAP phenotypes within each of the six tissues, 
the variants were compared and contrasted to between PAP categories using the “Compare 
Sample Variants” tool to obtain variants that were the same and variants that were different 
between the different categories, keeping in mind that comparisons were order-dependent. These 
data were utilized to create Venn diagrams illustrating three category and two category PAP 
variants for each tissue (Microsoft Office, version 16.16.21).  
 Variants for each PAP category were then compared across all tissues in order to 
establish which variants were consistently called across all tissues for a particular PAP risk 
category. These variants were then compared to the genomic data that was described in chapter 
7. Common variants between these two data types were then compared and contrasted to 
determine which variants may be most informative when evaluating the trait of PAP in cattle. 
These variants were then summarized by chromosome, evaluated for their proximity to a gene, 
and searched within Ensembl Genome Browser database ascertain known gene functions (Yates 
et al., 2020).  
8.3 Results 
8.3.1 Variants detected within transcriptome data 
 The number of variants detected in each tissue for three PAP category comparisons 
revealed different numbers of variants detected for each PAP category and tissue (Figure 8.3). 
Right ventricle samples revealed 4,889 variants unique to HPAPS cattle. Further, there were 
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9,289 and 2,159 variants unique to HPAPH and LPAP cattle respectively. Left ventricle analyses 
resulted in 10,449 variants detected only in HPAPS cattle, while 7,235 and 1,132 variants were 
only found in HPAPH and LPAP cattle respectively. The most variants detected for a single PAP 
category was detected in the pulmonary artery samples. There were 25,080 variants unique to 
HPAPS cattle. Pulmonary artery sequence analysis also revealed 4,382 variants exclusively in 
HPAPH cattle and 4,671 variants exclusive to LPAP cattle. For the aorta sequences, 13,603, 
5,593, and 4,089 variants were unique to HPAPS, HPAPH, and LPAP cattle respectively. The 
longissimus dorsi results revealed 10,291 variants only in HPAPS cattle. There were also 5,925 







Figure 8.3 Three category PAP (high PAP healthy (HPAPH); high PAP sick (HPAPS); low PAP (LPAP)) comparisons by tissue, 
where each number represents the number of variants that were detected for each individual category or comparison of categories.
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Like three category PAP, two category PAP was also compared for all of the tissues 
sequenced across the thirty animals (Figure 8.4). In right ventricle sequences, HPAP cattle had 
3,555 variants that were different from LPAP cattle. Conversely, LPAP cattle had 5,674 unique 
variants detected in the right ventricle. Cattle within the HPAP category had 5,453 unique 
variants found in left ventricle sequence data, and cattle within the LPAP category had 3,870 
variants not found in HPAP cattle. In pulmonary artery sequence data, LPAP cattle had nearly 
twice as many variants with 10,224 unique variants versus 5,277 in HPAP cattle. There were 
3,739 detected exclusively in HPAP cattle from aorta sequence, which was less than the 9,123 
variants unique to LPAP cattle in the same tissue. Both PAP categories were similar in the 
number of unique variants detected in lung tissue, with LPAP cattle having 5,876 variants and 
HPAP cattle having 5,432 variants. Cattle in the LPAP category had twice as many unique 












8.3.2 Concordant variants detected across all tissues 
 When comparing three category PAP variants detected in RNA across multiple tissues, 
3,485 variants were detected that were unique to HPAPS cattle (Figure 8.5). Further, HPAPH 
cattle had 1,810 variants only detected in that PAP category. Comparatively, only 461 variants 
were identified exclusively in LPAP cattle. Common variants were noted between the three PAP 
categories such that 4,801 variants were common across all categories. There were 699 variants 
observed in both HPAPS and LPAP cattle. Cattle in the HPAPH and LPAP categories had 452 
variants in common, and cattle in the HPAPS and HPAPH categories had 1,230 common 
variants.  
 
Figure 8.5 Comparison of detected variants in the RNA samples across all tissues for three 
category PAP.  
 Evaluation of variants detected in RNA across all tissues for two category PAP revealed 
4,808 variants that were common between LPAP and HPAP cattle (Figure 8.6). Individually, 













Figure 8.6 Comparison of detected variants in the RNA samples across all tissues for two 
category PAP. 
8.3.3 Concordant variants between RNA and DNA 
 RNA and DNA were compared for LPAP cattle and HPAP cattle separately, revealing 
which variants were concordant between the two sequence data sources (Figure 8.7). There were 
42 variants concordant between DNA and RNA sequence for LPAP cattle. For HPAP cattle, 
there were 562 concordant variants.  
LPAP HPAP 




Figure 8.7 Comparisons of DNA and RNA variants for LPAP and HPAP cattle. 
 
 Variants concordant between DNA and RNA data sources for LPAP and HPAP cattle 
respectively were then compared to one another (Figure 8.8). This comparison yielded 39 
common variants between HPAP and LPAP cattle. Conversely, there were 3 variants that were 
unique to LPAP cattle and 523 variants unique to HPAP cattle.  
RNA DNA 
15,733 6,385 42 
LPAP 
RNA DNA 





Figure 8.8 Comparison of concordant variants in RNA and DNA for each LPAP and HPAP.  
 Variants were then assessed by chromosome on which they were located for HPAP 
(Figure 8.9) and LPAP (Figure 8.10) groups respectively. In HPAP cattle, most of the variants 
were located on chromosome 16, and in LPAP cattle, two out of the three variants were located 
on the X chromosome.  
 
Figure 8.9 Variants that were concordant in RNA and DNA sequence and exclusive to HPAP 
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Figure 8.10 Variants that were detected in RNA and DNA and exclusive to LPAP cattle 
organized by chromosome.  
8.3.4 Description of regions of interest 
Of the variants detected in both DNA and RNA, those that were within 1,000 base pairs 
of a gene or RNA were considered worthy of further investigation. The three variants that were 
detected in both the DNA and RNA of LPAP cattle were not located within a gene or within 
1,000 base pairs of a gene. However, in HPAP cattle, three variants on chromosome 2 were near 
a small nuclear RNA (snRNA) that may be of interest when evaluating the PAP phenotype 
(Table 8.2). Chromosome 10 contained 63 variants that were called within a single protein 
coding gene. There were 85 variants detected within 1,000 base pairs of one of three protein 
coding genes on chromosome 16. Further, within the 3 genes on chromosome 16, there were 21 
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Table 8.1 Summary of the number of variants that met the final filtration criteria based on 
proximity to a gene. Chromosome denotes the chromosome number, number of variants includes 
the number of variants that met the criteria on that chromosome, and proximity to gene lists 
whether variants were considered to be near a gene (less than 1,000bp away) or within the gene 
itself. Note that the numbers in parentheses for the “Proximity to gene” column denote the 
number of variants near or within a gene based on the total number of variants given in the 




Proximity to gene 
2 3 Near 




28 5 Within 
 
 The six genes that were near detected variants were researched in the Ensembl Genome 
Browser to determine gene names and locations (Table 8.3). This revealed three novel genes, 
two known protein coding genes, and a small nuclear RNA (snRNA) that accompanies a gene.  
Table 8.2 Gene annotation information for the six genes that were near variants or contained 
variants with their Ensembl ID, gene name, gene description, location (chromosome : position in 
base pairs), and gene type 
Ensembl ID Gene Name Description Location Gene Type 
ENSBTAG00000052593 U6 U6 spliceosomal RNA 2: 2,097,072-2,097,178 snRNA 
ENSBTAG00000034998 
SIMC1 




ENSBTAG00000049875 Novel gene Unknown 16: 818,146-818,352 Protein coding 
ENSBTAG00000048925 Novel gene Unknown 16: 819,140-819,436 Protein coding 
ENSBTAG00000050274 Novel gene Unknown 16: 820,704-820,967 Protein coding 
ENSBTAG00000021497 CDH23 Cadherin related 23 28: 27,570,723-27,963,222 Protein coding 
8.4 Discussion 
8.4.1 Tissue-specific transcriptome variants 
 Even with stringent filtering parameters, thousands of variants were detected for each 
tissue when comparing cattle based on PAP categories. The transcriptome data from these steers 
were previously evaluated in a targeted discovery approach in which a subset of genes related to 
calcium transport, availability, and utilization in cardiopulmonary tissues were evaluated with 
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PAP as the trait of interest (Crawford, 2019). The fundamental difference between this study and 
that of Crawford (2019) was the overall scope of the discovery effort. This study assessed the 
entire breadth of the transcriptome data to detect variants related to either two category or three 
category PAP by tissue.  
8.4.2 Concordant variants across all tissues 
 Variants that were concordant in the transcriptomes of all steers within each PAP 
category were then compared across tissues. Through this approach the number of regions to 
investigate was further reduced. In addition, variants that were not present in all steers for all 
tissues were then eliminated from future steps. This approach allowed for detection of the 
variants highly likely related to PAP phenotype. A similar approach was applied to detect genetic 
variants associated with splicing, finding that variants of interest were present in many tissues 
(Xiang et al., 2017). Based on the conclusion from Xiang et al. (2017), this approach was 
implemented to detect variants that may be most likely to impact PAP phenotype. Further, this 
approach reduced the number of variants to be compared to the genomic data.  
8.4.3 Concordant variants in RNA and DNA 
Concordant variants in the RNA and DNA data were stringently evaluated due to the 
small number of animals in comparison to the immense amount of sequence data for each 
animal. Therefore, if a variant did not appear in all HPAP cattle or all LPAP cattle, it was 
excluded from downstream PAP category comparisons. This data sorting procedure greatly 
reduced the number of variants investigated. However, in addition to the stringency of the 
filtering process, variants may have been eliminated from downstream evaluation due to 
differences in sequencing coverage between the RNA and DNA sequence data or due to 
hemizygosity in the population. 
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The RNA and DNA data were generated at separate locations in different years using 
different Illumina sequencing platforms. In addition to these differences, the amount of data 
generated through each sequencing run differed. These differences in sequencing depth, 
coverage, and other parameters differed primarily because of increased affordability of 
sequencing between the two runs (Heather and Chain, 2015). Because the depth and coverage 
differed between the two data sets, variants that were called in the genomic data may have gone 
undetected in the transcriptome sequence (Sims et al., 2014). Therefore, more variants and genes 
may be present in all HPAP or LPAP cattle within this study population, but they were not 
detected in the RNA sequence and were therefore excluded from the final PAP category 
comparisons.  
The resulting variants detected within the X chromosome in this study may be of interest 
for future research. However, prior to accepting any variants on this particular chromosome, the 
variants in question need to be evaluated in females with PAP records via a genotype to 
phenotype association study. Variants on the X chromosome that are not valuable in predicting 
PAP phenotype may have been detected through this study due to hemizygosity at the loci on the 
X chromosome. Because all cattle sequenced were male, hemizygosity was an important 
consideration during variant detection efforts due to a single X chromosome being present 
without possibility of being masked or altered in expression by the presence of a second X 
chromosome as would be observed in female cattle.  
8.4.4 Variant descriptions 
 There were six genes that contained variants common to RNA and DNA sequence for all 
HPAP cattle within the study population. None of the genes that were found had been reported in 
previous gene and variant discovery efforts pertaining to PAP (Newman et al., 2011; Newman et 
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al., 2015; Heaton et al., 2016; Zeng, 2016; Crawford, 2019; Heaton et al., 2020). These genes 
and the variants within or flanking them should not be considered as superior to those discovered 
in previous literature, but should instead be considered an addition to the list of regions to 
include when working to cultivate selection tools for breeders using PAP as a trait in their 
breeding objective to combat HMD. It is well documented that PAP has a moderate heritability 
and is polygenic (Schimmel, 1981; Schimmel, 1983; Enns et al., 1992; Shirley et al., 2008; 
Cockrum et al., 2014; Zeng, 2016; Crawford, 2016). Therefore, inclusion of new genes and (or) 
variants would be in addition to those already identified.  
 The first gene observed in this study was located on chromosome 2. While the current 
bovine annotation recognizes the region as a snRNA, it’s a highly conserved spliceosomal RNA 
that accompanies a single-copy gene. The U6 snRNA is part of a family of U RNAs that play 
various roles in the processing of genetic information and ultimately how a particular gene is 
expressed. The U6 snRNA often pairs with U4 snRNA to form a ribonucleoprotein complex that 
interacts with pre-mRNA to generate a spliceosome. Overall, this complex is responsible for 
splicing introns and joining exons for a particular region during transcription (Chen and Moore, 
2015).  
Within bovine genetics, research involving U6 snRNA has investigated the modification 
of this U RNA type for the purpose of RNA interference of short hairpin RNA as a means of 
gene-knockdown. The utilization of RNA interference allows for activation or inactivation of a 
gene of interest based on the ability of U6 snRNA to interact at a sequence-specific region of the 
genome (Lambeth et al., 2005).  
Through the aforementioned research efforts describing the overall role and use of U6 
snRNA, the potential for negative effects of variants in and around these regions was evident. 
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Within the context of PAP, if a variant were present in this particular region, it could negatively 
impact the ability of splicing in a particular region, which could result in mutations within 
surrounding genes. While the three variants that were indicated in this region were only flanking 
the U6 region, they were within 206 bases of the region and could interact or interfere with 
splicing. Further, the relationship between variants in this region and the HPAP phenotype in 
cattle is uncharacterized. Future research in this region should focus on exploration of this region 
of the genome to see if mutations in this region pose a specific consequence in translation and 
transcription and ultimately alter gene expression. If alterations in transcript abundance and 
overall gene expression exist in this region, variants in this region may be informative for 
selection of cattle that perform better at high elevations.  
Sixty-three variants were found within a single gene on chromosome 10. The gene was 
annotated in the bovine reference genome as SUMO interactive motif containing 1 (SIMC1). 
Description of SIMC1 in cattle has been limited in literature. However, human research has 
described the gene as a regulator of autolysis for calpain-3 (CAPN3) (Ono et al., 2013). The gene 
has been identified as part of the calpain family of Ca2+- regulated cysteine proteases and 
predominantly impacts skeletal muscle. Previous studies have reported that this gene has been 
related to intracellular processes such as cell proliferation, cell apoptosis, and muscle atrophy in 
humans (Roperto et al., 2010; Paco et al., 2012; Felicio et al., 2013; Wang et al., 2013; Liu et al., 
2015). The Human Gene Expression Atlas reported expression of CAPN3 in epithelial cells of 
the bronchioles in the presence of carcinogenic compounds from tobacco smoke. In addition, 
other studies in humans reported deletions downstream of CAPN3 resulting Sotos syndrome, 
curvature of the spine, heart defects, and kidney defects (Ko, 2013; Dikow et al., 2013; 
Klaassens et al., 2014; Begum et al., 2016). 
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Both SIMC1 and CAPN3 have been located within the Bos Taurus genome 
(ARS_UCD1.2). However, while these genes were detected on chromosome 5 of the human 
genome, they are found on chromosome 10 of the bovine genome (Ensembl Release 101; Yates 
et al., 2020). Further, while no studies in cattle have evaluated SIMC1, there have been 
numerous studies describing the role of CAPN3. Most notably, variations in CAPN3 have been 
linked to tenderness in beef products through mechanisms of sarcomere remodeling and 
mitochondrial protein turnover (Cohen et al., 2006; Robinson et al., 2012; Barendse et al., 2008; 
Liu et al., 2015). While CAPN3 has been related to meat quality, it has not been evaluated within 
cardiopulmonary tissues or investigated within the context of PH in cattle. Given the expansive 
research of this gene in human literature, it is possible that CAPN3 may impact the 
cardiopulmonary tissue in the presence of variation within the SIMC1 gene. However, extensive 
research evaluating genomics, transcriptomics, and PAP phenotype within these genes would 
need to be performed in order to elucidate a relationship between PH and loci of interest within 
SIMC1 and CAPN3.  
 Three genes were found on chromosome 16. However, all three of these genes were 
classified as “novel” when they were investigated in Ensembl Genome Browser (Release 101; 
Yates et al., 2020). Each of these genes contained a single transcript but had no description or 
other classifying information. This lack of information may mean that the annotation did not 
include any information on these particular genes, or that ontological data has been submitted but 
not yet updated on any bioinformatic resource. Regardless, further research into these genes may 
be beneficial when working to characterize PAP phenotypes from a genetic perspective.  
Cadherin related 23 (CDH23) has not been characterized in bovine research. However, it 
has been documented in humans as being related to cell adhesion and has been expressed in 
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tissues including brain, kidney, heart, lung, nose, eye, and ear. Further, research has indicated 
that, when upregulated, CDH23 may play a role in early metastasis of breast cancer cells 
(Apostolopoulou and Ligon, 2012; Takahashi et al., 2016). Further, ontology of this gene has 
revealed that in addition to cellular adhesion, CDH23 may also play a role in calcium transport 
(The UniProt Consortium, 2019). Within the context of PH, variants in this gene may reduce 
cardiopulmonary efficiency by interfering with calcium transport and resulting muscle 
contractility. Further, if variants in this gene resulted in cell to cell adhesions, a reduced 
efficiency in the heart or lungs may be observed, which may result in increased sensitivity to 
changes in altitude or other pulmonary diseases. This gene should be investigated in other cattle 
with known PAP categories in order to validate the role of CDH23 in cattle at high altitudes.  
8.5 Conclusions 
 Through a multi-step filtration process, multi-omics data were utilized to detect variants 
associated with specific PAP phenotypes within coding regions of the bovine genome. This 
process revealed six genes for further exploratory efforts and variant validation. Of those, three 
were novel, not being characterized in the current genome annotation, which leaves the roles of 
those genes unknown. Two genes were protein coding genes that, while less characterized in 
cattle, had thorough descriptions in humans and mice that indicated they could play a role in 
what PAP phenotype an animal may develop. The last region was an snRNA that accompanies a 
gene, which, while less informative than other protein coding genes that were found, interacts 
with a gene in humans that may be relevant to cattle and how they express the PAP phenotype in 
hypoxic conditions.  
 These six variants, which have not been evaluated for their relationship to PAP in 
previous literature, should be investigated further in order to detect intergenic variants, 
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differential expression, and other information that may allow for better understanding of the 
genetics underlying PAP. Further, these variants along with variants from previous research 
efforts (Appendix B) should be validated on a larger population with known PAP phenotypes in 
order to determine which variants would be of value to genetic improvement programs if 
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 ✧ Battle Creek Ranch bulls 
❊ CSU Beef Improvement Center bulls 
▲ CSU Beef Improvement Center 2012 born steers from RNA sequencing study 






LIST OF GENES TO INVESTIGATE FURTHER 
 




1 882,081-1,002,223 Protein coding 
Bush et al., 2004; van Rooij et al., 2004; 
Canaider et al., 2006; Grammer et al., 2006; 
Crawford, 2019 
ENSBTAG00000052593 U6 U6 spliceosomal RNA 2 2,097,072-2,097,178 snRNA 




protein receptor type 2 
2 90,864,689-91,017,391 Protein coding West et al., 2004 
ENSBTAG00000046277 RGS4 
Regulator G protein 
signaling 4 
3 6,290,852-6,298,224 Protein coding 
Owen et al., 2001; Mittmann et al., 2002; Cho et 
al., 2003; Gu et al., 2010; Opel et al., 2015; 
Crawford, 2019 





5 116,438,987-116,507,065 Protein coding 
Törüner et al., 2004; Simonson et al., 2010; 




7 90,839,580 - 90,853,625 Protein coding 
Oka, 2006; 
Zeng, 2016; 
Heaton et al., 2020 
ENSBTAG00000034998 SIMC1 
SUMO interactive 
motifs containing 1 
10 5,026,117-5,109,495 Protein coding Ono et al., 2013; Jennings, 2020 
ENSBTAG00000012866 THBS4 Thrombospondin 4 10 11,005,591-11,060,139 Protein coding 
Stenina et al., 2005; Gabrielsen et al., 2007; 
Mustonen et al., 2012; Crawford, 2019 
ENSBTAG00000008868 CAPN3 Calpain 3 10 37,711,578-37,766,813 Protein coding 
Cohen et al., 2006; Barendse et al., 2008; 
Roperto et al., 2010; Paco et al., 2012; Robinson 
et al., 2012; Felicio et al., 2013; Wang et al., 
2013; Liu et al., 2015 
ENSBTAG00000002278 FBN1 Fibrillin 1 10 61,653,913-61,919,176 Protein coding 
Powell et al., 1997; Shen et al., 2011; Jeppesen 
et al., 2012; Chen et al., 2014; Crawford, 2019 
ENSBTAG00000005847 ROCK2 
Rho associated coiled-
coil containing protein 
kinase 2 
11 86,489,069 - 86,618,649 Protein coding Zeng, 2016 
ENSBTAG00000003711 EPAS1 
Endothelial PAS 
domain protein 1 
11 28,735,330 - 28,825,665 Protein coding 
Gale et al., 2008; Newman et al., 2015; 
Zeng, 2016; 
Heaton et al., 2016; 
Crawford et al., 2016 
ENSBTAG00000020399 RNF139 ring finger protein 139 14 15,593,322-15,607,732 Protein coding Wang et al., 2017 
ENSBTAG00000008432 NUP98 
nucleoporin 98 and 96 
precursor 




15 52,784,745-52,790,305 Protein coding 
Hou et al., 1999; Nishida et al., 2008; Tovell et 
al., 2008; Nishimura et al., 2016; Sunggip et al., 
2017; Crawford, 2019 
ENSBTAG00000049875 Novel gene Unknown 16 818,146-818,352 Protein coding Jennings, 2020 
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Ensembl ID Gene name Gene description Chromosome Position Gene Type Citations 
ENSBTAG00000048925 Novel gene Unknown 16 819,140-819,436 Protein coding Jennings, 2020 




16 67,906,979-68,081,283 Protein coding 
Osanai et al., 1998; Handlogten et al., 2001; 








19 47,798,389-47,819,083 Protein coding 
Buroker et al., 2010; Srivastava et al., 2011; 
Luo et al., 2014; Zeng, 2016 
ENSBTAG00000025200 ASIC2 
Acid sensing ion 
channel subunit 2 
19 16,022,746-17,228,096 Protein coding 
Grifoni et al., 2008; Lu et al., 2009; Abboud and 
Benson, 2015; Zhou et al., 2017; Crawford, 
2019 
ENSBTAG00000001823 STC2 stanniocalcin 2 20 
4,999,725-5,011,125 
 





22 56,709,248-56,835,386 Protein coding 
Törüner et al., 2004; Simonson et al., 2010; 
Zeng, 2016; Heaton et al., 2016 
ENSBTAG00000008096 EDN1 Endothelin 1 23 44,156,426-44,163,955 Protein coding 
Schiffrin, 2005; Murphy and Eisner, 2006; 
Castro et al., 2007; Deacon et al., 2010; Calabro 
et al., 2012; Bkaily et al., 2015; Crawford, 2019 
ENSBTAG00000053296 EGLN1 EGL nine homolog 1 28 4,087,440-4,150,379 Protein coding 
Simonson et al., 2010; Buroker et al., 2012; Ge 
et al., 2012; Xiang et al., 2013; Zeng, 2016 
ENSBTAG00000021497 CDH23 Cadherin related 23 28 27,570,723-27,963,222 Protein coding 
Apostolopoulou and Ligon, 2012; Takahashi et 





subfamily M alpha 1 
28 32,616,314-33,387,186 Protein coding 
Tomas et al., 2008; Barnes et al., 2016; D. 
Brown (results unpublished); Crawford, 2019 
ENSBTAG00000018540 NOX4 NADPH oxidase 4 29 6,120,515-6,303,004 Protein coding 
Mittal et al., 2007; Li et al., 2008; Chen et al., 
2012; Zhao et al., 2015; He et al., 2017; 
Crawford, 2019 
 
